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ABSTRACT
Apoptosis of neutrophil granulocytes is an essential process in the resolution of the
inflammatory response, providing a safe mechanism for down-regulation of
neutrophil function and clearance of potentially harmful inflammatory cells by
macrophages. However, in chronic inflammatory conditions, the rate of cell death
by apoptosis can exceed the macrophage clearance capacity leading to secondary
necrosis, resulting in release of harmful cellular contents and damage to the
surrounding tissues. There are many possible ways in which the rate and capacity of
macrophage clearance of apoptotic cells may be influenced, including soluble
mediators such as cytokines and glucocorticoid hormones or interactions with
extracellular matrix components. CD44 is a surface receptor, which has been
implicated in cellular adhesion to extracellular matrix proteins including hyaluronan.
CD44 has also been shown to augment macrophage phagocytosis of apoptotic
neutrophils after cross-linking surface receptors by a bivalent antibody. The aim of
this thesis was to characterise the mechanism underlying this augmentation further
and to investigate potential mechanisms responsible for the observed changes in
macrophage phagocytic capacity. Ligation ofCD44 by bivalent antibody was shown
to exert a prolonged effect upon augmentation of macrophage phagocytosis of
apoptotic neutrophils, suggesting that augmentation of macrophage phagocytosis by
cross-linking of CD44 was unlikely to be mediated by intra-cellular signalling and
might involve physical alterations to the CD44 receptor. However, analysis of the
surface expression and distribution of CD44 by immunofluorescence microscopy did
not support this hypothesis. To further characterise the mechanism of cross-linking
of CD44 on macrophage phagocytosis, cation depletion studies were carried out.
Data presented in this thesis demonstrates that augmentation of phagocytosis
following CD44 cross-linking involved two components. My data indicate that
CD44 cross-linking results in augmentation of macrophage phagocytosis via both a
cation dependent and cation independent component. Depletion of divalent cations
reduces the level of CD44 augmented phagocytosis but does not entirely block it.
Treatment of macrophages with a variety of inhibitors and antibodies allowed
identification of the molecule responsible for the cation dependent component -
CD32 (FcyRII). CD44 antibodies were shown to be acting as a bridge between
CD32 on the apoptotic neutrophil and CD44 on the macrophage. This highlighted
the importance of using F(ab')2 fragments instead of whole antibodies for functional
studies. To investigate potential signalling mechanisms involved in the divalent
cation-dependent effect resulting in CD44 augmented phagocytosis anti-CD44
F(ab')2 fragments were generated and conjugated to 6pm microspheres, which were
used to cross-link CD44 on the macrophage surface. Immunofluorescent microscopy
was then used to image changes in cellular distribution of signalling molecules in
response to CD44 cross-linking. The data presented in this thesis implicates
redistribution of ezrin, actin, PKC and Rac2 in the augmentation of macrophage
phagocytosis of apoptotic neutrophils following CD44 cross-linking. Western blot
and inhibition studies indicated that ERK did not play a role in CD44 augmented
phagocytosis. In summary, the studies presented in this thesis represent an analysis
of the cellular and molecular events associated with augmentation of phagocytosis of
apoptotic neutrophils. Whilst no gross alterations in CD44 distribution were seen,
these studies suggest that the irreversible nature of the augmentation reflects
redistribution of key cytoskeletal and signalling elements within the macrophage.
Together, these studies provide a firm foundation for future studies and highlight the
potential for modulation of phagocyte capacity for clearance of apoptotic cells in
treatment of inflammatory disease.
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1. The Inflammatory Response
Inflammation is a physiological response to infection or cellular injury. The primary
aim of an inflammatory response is to remove or isolate the infectious organism and
limit tissue damage. Once the infectious organism is removed, resolution of the
inflammatory response involves repairing any tissue damage and clearance of
unwanted leukocytes. Initiation of an acute inflammatory response is rapid and may
last for days or a few weeks. Cornelius Celsus in the first century AD described the
"cardinal signs" of inflammation as rubor (redness), calor (heat), dolor (pain) and
tumor (swelling), emphasising the importance of changes in the microcirculation
during inflammation. These complex changes involve a series of events such as
increased vascular permeability and blood flow, exudation of plasma proteins and
migration of leukocytes into the inflammatory site. Infiltrating leukocytes can clear
invading organisms while also contributing to tissue repair. They can also co¬
ordinate the inflammatory response by producing cytokines to promote or dampen
the response and influence progression to an adaptive immune response.
1.1 Initiation of inflammation
The initial stages of inflammation involve the acute-phase response and activation of
the complement, coagulation and kinin pathways.
The acute-phase response is initiated by inflammatory stimuli to alter the
concentration of specific plasma proteins (Gabay & Kushner, 1999). Release of pro¬
inflammatory cytokines such as tumour necrosis factor a (TNFa), interleukin-ip (IL-
lp) and interleukin-6 (IL-6) by tissue macrophages and other cells stimulates
hepatocytes to synthesise and secrete acute-phase proteins. Important acute-phase
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proteins include C-reactive protein (CRP) and Mannan-binding protein (MBP). C-
reactive protein binds to membrane phospholipids present in microbial membranes
and acts as an opsonin. It can also activate the classical complement pathway
(Mortensen, Osmand et al., 1976). Mannan-binding protein binds to mannose sugars
found on bacterial and fungal surfaces but not on mammalian cells (Ezekowitz &
Stahl, 1988). It activates the lectin pathway, which is similar to the classical
complement pathway (Ideda, Sannoh et al., 1987). MBP also acts as an opsonin,
flagging the opsonised particle for phagocytic uptake (Kuhlman, Joiner et al., 1989)
The complement pathway consists of a number of plasma proteins organised into two
distinct activation pathways; the classical and the alternative pathways. Antibody-
antigen complexes initiate the classical pathway, whereas bacteria, viruses, fungi and
some aggregates of immunoglobulin activate the alternative pathway (Lachmann &
Hughes-Jones, 1984). Both these pathways ultimately result in the formation of the
Membrane Attack Complex (MAC), which lyses infectious organisms by creating
pores in the organism's membrane (Muller-Eberhard, 1986). In addition to
producing the MAC, proteins of the complement cascade can also act as
chemoattractants (e.g. C3a and C5a) and opsonins (e.g. C3b). (Goldstein, Kaplan et
al., 1976; Orr, Varani et al., 1978)
Kinins such as bradykinin are important mediators in the inflammatory response.
They are liberated from precursor molecule (kininogens) by the action of several
proteases known as kininogenases. Kininogens are synthesised by the liver and are
released into the plasma. The kinins are potent vasoactive basic peptides and their
properties are wide ranging, including the ability to increase vascular permeability,
cause vasodilation, and the contraction of smooth muscle, and to act as co-factors in
the coagulation pathway (Regoli & Barabe, 1980). Initiation of the kinin pathway
occurs in response to the exposure of Hageman factor to negatively charged surfaces
during injury (Griffin, 1978). Hageman factor becomes activated and in turn
activates the kininogenase prekallikrein by converting it to kallikrein (Kaplan &
Austen, 1971). Kallikrein then breaks down kininogens to release bradykinin (Scott,
Silver et al., 1985).
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The coagulation pathway produces thrombin, which in addition to producing blood
clots, can also alter vascular permeability and generate chemoattractants. Activation
of the coagulation cascade occurs in response to tissue injury. Kallikrein, activated
by the kinin pathway cleaves Factor XII, which then activates Factor XI, a process
that is calcium dependent (Davie, Fujikawa et al., 1979). Activation of Factor X
occurs and leads to the formation of thrombin from prothrombin. Thrombin can then
cleave fibrinogen to generate fibrin and a blood clot.
Mediators from all three of these pathways can activate local macrophage
populations, leading to release of proinflammatory mediators such as TNFa and
chemoattractant molecules that promote leukocyte recruitment into a site of tissue
injury.
The first cell type recruited to a site of inflammation is the neutrophil granulocyte.
Neutrophils can be rapidly recruited from the blood in response to chemoattractant
molecules released from stromal cells, microorganisms or dying cells, such as MIP-2
and CXCR2 which have been shown to be released from apoptotic cells in peritoneal
inflammation (Iyoda & Kobayashi, 2004). Neutrophils initially adhere to the
endothelial wall through interactions between selectins and their ligands (e.g. Sialyl
lex, P-selectin, glycoprotein ligand-1) which results in "rolling" adhesion. If the
neutrophil becomes activated by chemoattractants (e.g. platelet activating factor, IL-
8, f-met-leu-phe, C5a) or bacterial products (e.g. lipopolysaccharide), then tighter
binding occurs and the cell begins to migrate in an integrin-dependent manner
between endothelial cells through modified tight junctions (diapedesis) (Parkos,
1997;Wagner & Roth, 2000). Once in the site of inflammation, the neutrophil exerts
its antimicrobial and cytotoxic effects by various mechanisms. Primarily, the
neutrophil phagocytoses invading micro-organisms, damaged cells and tissue debris.
However, the neutrophil also has the capacity to release granule contents and
generate reactive-oxygen metabolites that can result in tissue damage. As
inflammation progresses, circulating monocytes are actively recruited to continue the
inflammatory response and assist in tissue repair.
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1.2 Progression of the Inflammatory Response
Circulating monocytes and T lymphocytes are recruited to the site of injury in cases
of prolonged inflammation. They rapidly cross the endothelial barrier in a similar
manner to neutrophils using selectins, integrins and immunoglobulin superfamily
members to become tethered and diapedese (Albelda, Smith et al., 1994). Once the
monocyte leaves the circulation, it differentiates in a tissue specific manner to form a
tissue macrophage that has both phenotypic and functional properties. The
macrophage becomes activated in response to pro-inflammatory cytokines, bacterial
components and binding of immune complexes or opsonised particles resulting in an
increased ability to phagocytose and promoting the secretion of soluble mediators of
inflammation such as IFN-y, TNF-a, IL-1 and MCP-1 (Mosser, 2003). Macrophages
have also been shown to induce apoptosis in neutrophils and lymphocytes indicating
their importance in mediating the progression and ultimate resolution of
inflammation (Meszaros, Reichner et ah, 2000;Brown & Savill, 1999).
During inflammation, extensive tissue remodelling is mediated by the macrophage
through the production of matrix metalloproteinases (MMPs) both directly and
indirectly. Macrophages have been shown to up-regulate the activity ofMMPs with
gelatinase, caseinase and elastinase activity; in particular MMP-2, MMP-7, MMP-9
and MMP-12 (Song, Ouyang et al., 2000). Macrophages can also secrete
collagenases (MMP1 and MMP-13) in combination with a number of other enzymes
such as elastase and hyaluronidase (Nathan, 1987;Mariani, Sandefur et al., 1998),
which break down host tissues. Tissue remodelling is a dynamic process, which
removes damaged tissue and allows the immune system to remove any remaining
infectious particles. However, this process has to be tightly regulated to prevent
excessive tissue damage and lead to resolution of inflammation.
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1.3 Resolution of Inflammation
In most cases, acute inflammatory responses will resolve leaving little or no
permanent damage. During resolution of the inflammatory response, macrophages
play a vital role in clearance of apoptotic cells and tissue regeneration. Clearance of
apoptotic cells is essential to limit inflammation as many inflammatory cells, such as
neutrophils, are unable to exit the tissues and may then undergo secondary necrosis
leading to release of cellular contents and further host tissue damage (Savill, 1997).
Upon ingestion of apoptotic cells, macrophages become less responsive to pro¬
inflammatory stimuli e.g. LPS and begin to produce anti-inflammatory mediators
such as transforming growth factor-p (TGF-P), IL-10 and prostaglandin E2 (Fadok,
McDonald et al., 1998;Voll, Herrmann et al., 1997).
As acute inflammation begins to resolve, the process of wound repair begins. The
fibrin clot formed during the initiation of the inflammatory response becomes
replaced by granulation tissue. Macrophages at the site of inflammation produce
fibronectin, which is a chemoattractant for fibroblasts (Tsukamoto, Helsel et al.,
1981). Fibroblasts infiltrate the granulation tissue and act to reconstruct the
extracellular matrix through production of a wide range of extracellular matrix
proteins including collagen and fibronectin (Gabbiani, 2003). Macrophages also
play a role through secretion of growth factors and cytokines such as TGF-P,
fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF) that assist
with angiogenesis and tissue rebuilding (Wahl, Hunt et al., 1987;Wahl, Wong et al.,
1989).
2. Origins and development of the Neutrophil
Neutrophils are produced in the bone marrow and are the most predominant
leukocyte found in blood (Bainton, 1980). In the bone marrow, the neutrophil
undergoes several stages of development before becoming terminally differentiated
and released into the blood. Neutrophils originate from a stem cell pool developing
into a granulocyte precursor called a myeloblast, which is a relatively
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undifferentiated cell with a round nucleus and no granules. This stage is followed
by the promyelocyte and myelocyte stages, during which two types of granule
develop (Bainton, Ullyot et al., 1971). The first granule, the azurophil or primary
granule, forms during the promyelocyte stage and contains peroxidase. The second,
the specific or secondary granule, forms later during the myelocyte stage and is
peroxidase negative. The two final neutrophils precursors, the metamyelocyte and
band form are non-proliferating cells that eventually become mature neutrophils with
the characteristic multi-lobed nuclearmorphology.
2.1 Neutrophil Function
The main function of neutrophils is phagocytosis - ingesting and destroying target
micro-organisms and dead cells through Fey receptors and complement receptors
(Witko-Sarsat, Rieu et al., 2000). This process is thought to induce the neutrophil to
undergo programmed cell death or apoptosis, as described below, during which it
becomes unable to respond to external stimuli, causing downregulation of
chemotaxis, phagocytosis and degranulation (Hart, Ross et al., 2000). The neutrophil
contains cytoplasmic granules, which contain microbicidal proteins, proteases
including collagenase, gelatinase, proteases and plasma proteins that can inhibit the
growth of the invading micro-organism. Furthermore, the neutrophil can generate
reactive oxygen species (ROS) through NADPH oxidase action in the cell
membrane, which can also effectively kill micro-organisms (DeLeo, Allen et al.,
1999). The cell also generates and secretes pro-inflammatory cytokines, which act to
recruit further inflammatory cells (lymphocytes and monocytes) to the site (Lapinet,
Scapini et al., 2000).
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2.2 Neutrophil Apoptosis (programmed cell death)
Once neutrophils have been recruited to a site of inflammation, they do not migrate
to the lymph nodes like monocytes and lymphocytes, but die locally (Savill, 1994).
It was originally thought that neutrophils died by undergoing necrosis - cell death in
response to injury, which results in disruption of the plasma membrane and release of
intracellular contents (Hurley, 1983). However, it is now apparent that neutrophils
undergo a controlled form of cell death called apoptosis, which was first described
by Kerr and colleagues in 1972 (Kerr, Wyllie et ah, 1972). In contrast to necrosis,
apoptosis maintains cellular membrane integrity preventing release of intracellular
contents and limiting the potential for causing tissue damage. Phagocytes can then
recognise these apoptotic cells and clear them from the inflammatory site.
During apoptosis, cells undergo a series of characteristic morphological and
biochemical changes. These include cell shrinkage, membrane blebbing, chromatin
condensation, DNA fragmentation and formation of apoptotic bodies (Kerr, Wyllie,
& Currie, 1972;Wyllie, Kerr et al., 1980). The main effector proteins in apoptosis
are a family of proteolytic enzymes called cysteinyl aspartate-specific proteases
(caspases). Upon activation, the combined actions of caspases result in cellular
changes, which produce the apoptotic phenotype (Earnshaw, Martins et al., 1999).
Triggering of the apoptosis pathway occurs by a number of distinct pathways,
including interaction of a death receptor with its respective extracellular ligand.
Death receptors are cell-surface receptors belonging to the tumour necrosis factor
(TNF) receptor superfamily, which trigger apoptosis in response to ligand binding
(Nagata, 1997). Currently, six members of the death receptor family are known
including Fas (Apo-1 or CD95) and TNF-R1 (p55 and CD120a). Ligation of the
death receptor by their ligand i.e. Fas-L (CD95L) or TNFa promotes receptor
oligomerisation leading to recruitment of a number of adaptor proteins (Wallach,
Varfolomeev et al., 1999). Adaptor proteins contain domains such as the death
domain (DD), death-effector domain (DED) and the caspase activation and
recruitment domain (CARD), which allow them to link the receptor with initiator
caspases (caspase-8 and caspase-10) through the formation of the death induced
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signalling complex (DISC). The downstream signal of the DISC complex has
been classified into two types (Scaffidi, Fulda et al., 1998). In type I cells, large
amounts of caspase-8 are activated at the DISC as a result of their close proximity
and intrinsic proteolytic activity. This is followed by rapid activation of effector
caspases (e.g. caspase-3, caspase-6 and caspase-7) resulting in apoptosis. In type II
cells, DISC formation is greatly reduced and caspase activation occurs mainly
downstream of the mitochondria. This pathway involves the Bcl-2 family of
proteins, which can either be pro-apoptotic (e.g. Bax) or anti-apoptotic (e.g.Bcl-2).
Caspase-8 cleaves Bid, a pro-apoptotic member of the Bcl-2 family, to give
truncated-Bid (t-Bid). tBid translocates to the mitochondria and promotes release of
cytochrome c, apoptosis inducing factor (AIF) (Susin, Zamzami et al., 1996) and
second mitochondria-derived activator of caspases/direct IAP binding protein with
low PI (Smac/DIABLO)(Du, Fang et al., 2000;Verhagen, Ekert et al., 2000). Once
in the cytosol, cytochrome c binds to apoptosis-activating factor 1 (Apaf-1) and
procaspase-9 to form a complex called the apoptosome. Procaspase-9 becomes
active and triggers activation of caspase-3.
Engagement of these intracellular pathways effectively uncouples the apoptotic cell
from environmental stimuli and limits effector functions. In addition, there are
surface membrane alterations that may determine recognition and internalisation by
phagocytes. These changes will be considered in more detail in section 3.4.
3. The Mononuclear Phagocyte System
Macrophages represent only one part of a host-wide collection of cells, which are
termed the mononuclear phagocyte system. The mononuclear phagocyte system can
be defined as a population of cells derived from progenitor cells in the bone marrow,
which differentiate to form monocytes that circulate in the blood and then enter into
tissues where they become resident macrophages (van Furth & van Zwet, 1992).
Information on the bone marrow origin of macrophages was gained from studies
with chimeras (van Furth, Goud et al., 1982). Studies with labelled cells revealed
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that peritoneal macrophages, Kupffer cells, pulmonary macrophages and spleen
macrophages derive from circulating blood monocytes, indicating their common
lineage (Spector, Walters et ah, 1965;Crofton, Diesselhoff-den Dulk et ah, 1978;van
Furth & Diesselhoff-den Dulk, 1984). However, many of these studies based their
observations upon morphological similarities and expression of specific enzymes and
receptors, the validity of which is controversial (Hume, Ross et ah, 2002;McKnight
& Gordon, 1998). For example, the F4/80 antigen has been shown to be difficult to
detect upon certain populations ofmacrophage-like cell populations, such as alveolar
macrophages and macrophages of the lymphoid organs (Gordon, Crocker et ah,
1986). Moreover, Langerhans cells in the skin were originally thought to be tissue
macrophages as they express macrophage markers (Hoefsmit, Duijvestijn &
Kamperdijk, 1982.). However, they do not phagocytose and it is now thought that
they are a specialised type of dendritic cell, indicating an overlap between the

















Cells belonging to the mononuclear phagocyte system.
The phenotypic plasticity of macrophages can also make identifying members of the
mononuclear phagocyte system difficult. Resident macrophages adapt to their local
environment in order to perform specific functions (Gordon, 1995) and are
phenotypically different from recruited macrophages. However, some resident
macrophages, for example microglial cells, have been shown to undergo activation in




Macrophages are tissue resident phagocytic cells that form part of the mononuclear
phagocyte system (van Furth, Langevoort et ah, 1975). Macrophages are derived
from circulating monocytes and their characterisation is essential for investigation of
their development and function. There are numerous methods that allow this to be
carried out. One of the redundant methods for identification of monocytes was the
use of positive staining for non-specific esterase with acetate as substrate. The
presence of peroxidase positive granules can also be used to discriminate between
resident macrophages and exudate macrophages, which have migrated from the
circulation to a site of inflammation and have not lost their peroxidase activity by
degranulation (van Furth, Hirsch et al., 1970). With the development ofmonoclonal
antibodies against surface receptors and intracellular antigens the complexities of
monocyte-macrophage differentiation have been revealed. A number of broadly
expressed "markers" have been defined including such as F4/80 antigen on murine
cells, CD 14 on human monocytes and CD68 on human tissue macrophages (Austyn
& Gordon, 1981; Pulford, Sipos et al., 1990; Ugolini, Nunez et al., 1980). In
addition, differences in levels of expression of specific markers have been proposed
for monocytes differing in location and activation state. For example, in comparison
to nonactivated cells, activated peritoneal macrophages express more Mac-2 antigen
and activated alveolar macrophages express more CDllb/CD18 (CR3) (Nibbering,
Leijh et al., 1987).
Macrophages represent the terminally differentiated end stage of the mononuclear
phagocyte system. The development ofmononuclear phagocytes begins in the bone
marrow with the maturation of granulocyte/monocyte-colony-forming units into
monoblasts, promonocytes and finally, into monocytes (Gordon, Crocker, Morris,
Lee, Perry, & Hume, 1986). The production ofmonocytes in vivo is controlled by a
number of growth factors. IL- 3, granulocyte/macrophage colony stimulating factor
(GM-CSF) and macrophage colony stimulating factor (M-CSF) promote cell division
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by the monocyte precursors, whereas prostaglandin E (PGE) and interferon a and
P (IFNa/p) inhibit cell division (Sachs, 2005).
In the absence of tissue injury or infection, monocytes emigrate at a steady rate from
the bone marrow into the blood and then migrate into the tissues where they become
local tissue macrophages (Meuret & Hoffmann, 1973). However, production of
monocytes in the bone marrow increases during inflammation leading to an increased
number ofmonocytes in the blood. This has been shown to be a result of the action
of the monokine, factor increasing monocytopoiesis (FIM), which is produced by
macrophages at a site of inflammation. It then acts as a long range regulator to
promote production of monocytes by the bone marrow (Annema, Sluiter et al.,
1992). As circulating monocytes enter sites of inflammation they come into contact
with inflammatory mediators, which promote their maturation into macrophages with
potent secretory and endocytic capacity.
3.2 Macrophage morphology and physiology
The morphology ofmacrophages can be easily observed by allowing them to adhere
and spread during in vitro culture. The single kidney-shaped nucleus is surrounded
by abundant cytoplasm containing a complex cytoskeleton of actin filaments and
microtubules, which is responsible for the formation of ruffles and pseudopods.
Macrophages are extremely active metabolically and constantly pinocytose. It is
estimated that macrophages turn-over the equivalent of their entire plasma
membranes every 30 min (Steinman, Mellman et ah, 1983). In most cases these
pinosomes become primary lysosomes. The surface of the macrophage consists of a
wide variety of proteins including class I and class II molecules of the major
histocompatibility complex (MHC) and receptors for molecules such as
immunoglobulin, complement and specific bacterial components. These receptors
play an essential role in recognition and internalisation of infectious organisms.
Macrophages are also powerful secretory cells, which have been shown to produce
over 100 different molecules (Nathan, 1987). These include components of the
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complement cascade, coagulation factors, proteases, acid hydrolases, cytokines
and growth factors. Some of these, such as lysozyme are secreted constitutively;
however, most others are produced in response to occupancy of macrophage surface
receptors. Certain ligand-receptor interactions can result in macrophage activation
and triggering of the respiratory burst. The respiratory burst is generated by the
formation of an NADPH oxidase on phagosomal membranes and results in the
production of reactive oxygen compounds such as superoxide anions and through the
action of catalase and peroxidases, hydrogen peroxide and hydroxyl radicals (Forman
& Torres, 2002)
3.3 Macrophage function and phagocytosis
Macrophages are capable of a number of diverse functions including phagocytosis,
antigen presentation, cytokine and chemokine release and tissue repair and
remodelling. Elie Metchnikov first observed the process of phagocytosis in the late
nineteenth century (Cotran R.S., Kumar V. et al., 1989). Since then, there has been
much progress in the understanding of this process. Macrophages recognise micro¬
organisms and apoptotic cells through a variety of different cell surface receptors.
Engagement of specific receptors induces specific signalling cascades within the cell,
which controls subsequent responses. These receptors include toll-like receptors
(TLRs), complement receptors and immunoglobulin receptors (FcRs).
Toll-like receptors have evolved to recognise conserved products present on the
surface of bacteria, viruses and fungae (Janeway, Jr., 1992). These products are
termed pathogen-associated molecular patterns (PAMPs) and are unique to
microorganisms. PAMPs include molecules such as lipopolysaccharide (LPS),
peptidoglycan and lipoteichoic acids. In response to binding PAMPs, TLRs activate
a signalling pathway leading to activation ofNF-kB and MAP kinases (Li, Carpio et
al., 2001;Alexopoulou, Holt et al., 2001 ;Chu, Ostertag et al., 1999) and induction of
various genes that function in host defense (Thoma-Uszynski, Stenger et al., 2001).
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Complement receptors recognise opsonins produced by the complement pathway
such as C3b, iC3b and C4b. Opsonins bind to the surface of microorganisms and act
as a bridge between the microorganim and the phagocyte. Macrophages express
three receptors for opsonic fragments of complement - CR1 (CD35), CR3
(CD1 lb/CD18) and CR4 (CDllc/CD18) (Law, 1988). CR1 is a single chain
transmembrane molecule with an extracellular lectin-like ligand binding domain
(Ghiran, Barbashov et ah, 2000). It is unable to mediate internalisation of an
opsonised particle without additional signals; although ligation of CR1 has been
shown to enhance Fc-receptor mediated phagocytosis (Ghiran, Barbashov,
Klickstein, Tas, Jensenius, & Nicholson-Weller, 2000). CR3 and CR4 are integrins,
which consist of a common beta chain (CD 18) paired with a specific alpha chain
(CD1 lb or Cdl lc) (Ehlers, 2000). Internalisation of an opsonised microorganism by
CR3 requires additional signalling to increase the number of receptors at the cells
surface (Berger, O'Shea et ah, 1984;Sengelov, Kjeldsen et ah, 1993) and the affinity
of the receptors (Jones, Schofield et ah, 1998); which is then sufficient to trigger
phagocytosis. In addition to complement components, TNFa, LPS and fibronectin
have all been shown to stimulate phagocytosis through CR3 (Wright & Griffin, Jr.,
1985; Pommier, Inada et ah, 1983).
Microorganisms opsonised by immunoglobulin can be recognised by Fc receptors
present on the surface of macrophages (Ravetch & Bolland, 2001). The most widely
studied of these are the FcyRs which recognise the Fc portion of IgG antibodies.
FcyRs can be divided into two categories; receptors that contain immunoreceptor
tyrosine-based activating motif (ITAM) motifs in their intracellular domains that
activate phosphorylation cascades, and receptors that contain immunoreceptor
tyrosine-based inhibitory motif (ITIM) motifs, which recruit phosphatases to inhibit
signalling (Daeron, 1997). Activating receptors with high affinity (FcyRl/CD64)
and low affinity (FcyRIIA/CD32 and FcyRIIIA/CD16) for IgG undergo
phosphorylation in response to receptor clustering as a result of ligand binding
(Fitzer-Attas, Lowry et ah, 2000). Once activated the receptors recruit Syk, an SH2
domain containing kinase (Crowley, Costello et ah, 1997; Kiefer, Brumell et ah,
1998), which subsequently can recruit a number of adaptor molecules such as SLP-
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76 and BLNK (Bonilla, Fujita et al., 2000) that initiate pathways to promote
cytoskeletal alterations, pseudopod extension and engulfment of the opsonised
microorganism (May, Caron et ah, 2000;Lennartz, Yuen et ah, 1997;Kusner, Hall et
al., 1999). In contrast, FcyRIIB, the inhibitory receptor, regulates engulfment of
opsonised microorganisms via recruitment of the phosphatase SHIP that blocks
signalling through PI-3 kinase (Marshall, Booth et al., 2001). Therefore, the relative
expression of activating and inhibiting receptors determines the threshold for
phagocytosis and inflammatory responses to IgG opsonised particle.
In studies of the mechanisms of phagocytosis via different receptors, it has been
observed that uptake by complement receptors is very different to uptake by Fc
receptors. For CR-mediated phagocytosis, bound particles appear to sink into the
phagocytes surface, suggesting that formation of a phagocytic pit occurs (Kaplan,
1977). However, phagocytosis by Fc-receptors involves membrane "zippering" as
lamellipodia extend around the particle (Griffin, Jr., Bianco et al., 1975). These
differences can be accounted for by differential recruitment of cytoskeletal
components to phagosomes. During Fc-receptor mediated phagocytosis, recruitment
of Syk and enrichment of cytoskeletal proteins including actin, talin and paxillin
occurs near the phagosome membrane and phagocytosis can be entirely inhibited by
tyrosine kinase inhibitors (Allen & Aderem, 1996). In contrast, during CR-mediated
phagocytosis, cytoskeletal proteins formed discrete foci over the phagosome surface
and tyrosine kinase inhibition fails to prevent phagocytosis (Allen & Aderem, 1996).
Internalisation of micro-organisms by macrophages generally results in release of
pro-inflammatory cytokines and activation of antimicrobial mechanisms. Most
phagocytes including macrophages kill internalised micro-organisms through the
production of reactive superoxide ions produced by the formation of NADPH
oxidase on phagosomal membranes (DeLeo, Allen, Apicella, & Nauseef, 1999).
There are also a number of oxygen-independent proteins present in macrophage
granules to assist in microbial killing including lactoferrin and lysozyme.
Lactoferrin is an 80kDa iron binding protein which can inhibit growth of
microorganisms by sequestering iron required for microbial respiration (Arnold,
Russell et al., 1982). Lysozyme is a 14kDa cationic enzyme that hydrolyses
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glycosidic bonds between N-acetylglucosamine and N-acetylmuramic acid
residues in peptidoglycan, a component of bacterial cell walls (Laible & Germaine,
1985). Lysozyme is highly effective against many Gram-positive species but
appears to be ineffective against Gram-negative bacteria unless potentiated by co-
factors such as hydrogen peroxide and ascorbic acid (Ellison, III & Giehl, 1991).
3.4 Clearance of apoptotic cells by macrophages
There are a number of molecular receptors that have been suggested to contribute to
recognition of apoptotic cells by macrophages. Many of these receptors play a
critical role in innate immune responses including lectins (McGreal, Martinez-
Pomares et al., 2004), integrins (Savill, Hogg et al., 1992; Dransfield, Buckle et al.,
1990), scavenger receptors (Peiser, Mukhopadhyay et al., 2002), oxidised LDL
receptors (Miller, Viriyakosol et al., 2003), complement receptors (Carroll, 1998)
and the LPS receptor, CD 14 (Fenton & Golenbock, 1998). Interestingly, uptake of
bacterial pathogens via these receptors results in an inflammatory response and
stimulation of an adaptive immune response (Zhang, Broser et al., 1995; Aderem,
2003). However, uptake of apoptotic cells is generally considered to be non¬
inflammatory leading to dampening down of the immune response (Kurosaka,
Takahashi et al., 2003; Haslett, 1992).
One of the best characterised mechanisms for apoptotic cell recognition by
phagocytes is through the exposure of phosphatidylserine on the apoptotic cell. As
cells undergo apoptosis, they lose phospholipid asymmetry leading to exposure of
phosphatidylserine on the cell surface (Fadok, de Cathelineau et al., 2001). Indeed,
use of annexin V binding to exposed phosphatidylserine is one of the most
commonly used methods to detect the level of apoptosis within a cell population
(Zhang, Gurtu et al., 1997). This change has been shown to be required for
recognition and engulffnent to occur. Plasma membrane asymmetry is maintained in
2+
viable cells by an aminophospholipid translocase, which is thought to be a Mg -
dependent ATPase (Bevers, Comfurius et al., 1999). This ATPase transports any
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phospatidylserine, which may have reached the outer side back to the inner side of
the plasma membrane. However, during apoptosis there is activation of
"scramblase" proteins, which can move phospholipids across the membrane and
increase surface exposure of phosphatidylserine (Sims & Wiedmer, 2001).
Moreover, when apoptosis commences, the aminophospholipid translocase activity
becomes downregulated and oxidation of phosphatidylserine alters its ability to be
transported back to the inner membrane (Kagan, Fabisiak et al., 2000; Tyurina,
Shvedova et ah, 2000). These changes result in decreased transport of
phosphatidylserine from the outer to the inner plasma membrane.
The method of recognition of phosphatidylserine by macrophages is not yet
completely understood but a potential receptor for phosphatidylserine expressed on
the macrophage surface has been identified and cloned (Fadok, Bratton et ah, 2000).
However, there is some controversy regarding the nature of the proposed
phosphatidylserine receptor. Recent research investigating developmental defects in
phosphatidylserine receptor (PSR) knockout mice has yielded interesting, yet
conflicting results. Li and colleagues reported that PSR-deficient mice showed
abnormal development in the brain, lungs and eyes leading to death within hours of
birth (Li, Sarkisian et ah, 2003). They also indicated that PSR-deficient
macrophages did not clear apoptotic cells indicating the role of PSR in apoptotic cell
clearance. However, it is interesting to note that macrophage clearance was not
completely inhibited suggesting that the PSR is not essential for apoptotic cell
clearance. A further study investigating haematopoiesis in PSR-deficient animals
highlighted developmental defects in erythrocytes and T-lymphocytes (Kunisaki,
Masuko et ah, 2004). Finally, Bose and colleagues supported the observations that
ablation of PSR function resulted in impaired development of organs, however,
clearance of apoptotic cells was shown to be normal (Bose, Gruber et ah, 2004).
They also compared reactivity of cells from wild-type and knockout animals with
mAb 217, the antibody originally used to isolate the phosphatidylserine receptor.
They observed no difference in reactivity and any staining was restricted to the
membrane of fetal-liver macrophages. Therefore, it seems likely that the proposed
phosphatidylserine receptor encodes a protein that is essential during development
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but is not the primary phosphatidylserine receptor involved in apoptotic cell
clearance. This is supported by recent research suggesting that the psr gene encodes
a nuclear protein (Cikala, Alexandrova et ah, 2004; Cui, Qin et al., 2004).
Alternatively, it is possible that there is no specific receptor for phosphatidylserine
and that other bridging proteins interact with phosphatidylserine on the apoptotic
cell.
Other receptors have been suggested to recognise phosphatidylserine including
CD14, CD36 and the LDL-receptor related protein (CD91) (Henson, Bratton et ah,
2001; Savill, Dransfield et ah, 2002). Moreover, soluble substances can also interact
with PS such as thrombospondin (Savill, Hogg, Ren, & Haslett, 1992; Stern, Savill et
ah, 1996), Growth Arrest Specific Gene-6 (Gas-6) (Nakano, Ishimoto et ah, 1997),
Milk Fat Globule Factor-E8 (MFG-E8) (Couto, Taylor et ah, 1996) and Protein S
(Anderson, Maylock et ah, 2003). Both thrombospondin and MFG-E8 contain
aminophospholipid binding sites that bind PS and an RGD motif that binds avP3 and
avP5 integrins. Gas-6 and Protein-S interact directly with PS on the apoptotic cell
and Mer and Rse receptor tyrosine kinases on the phagocyte (Anderson, Maylock,
Williams, Paweletz, Shu, & Shacter, 2003; Scott, McMahon et ah, 2001).
A number of other surface changes on apoptotic cells, which promote recognition
and uptake by phagocytes, have been investigated. In humans, deficiency of Clq is
the foremost known genetic risk factor for systemic lupus erythematosis (SLE), a
human inflammatory condition characterised by circulating immune complexes and
autoantibodies in the blood (Navratil, Korb et ah, 1999). Clq-deficient mice develop
an SLE-like condition with immune complex deposition in the tissues and resulting
glomerulonephritis. Other complement components have also been implicated in the
process of apoptotic cell clearance. Complement binding to the apoptotic cell surface
would allow apoptotic cell recognition by macrophage complement receptors CR1
(CD35), CR3 (CD1 lb/CD18) and CR4 (CD1 lc/CD18). Antibody blockade of
complement receptors CR3 and CR4 has been shown to inhibit phagocytosis of
serum-exposed apoptotic cells (Mevorach, Zhou et ah, 1998; Mevorach, 2000).
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Antibodies and immune complexes are also potential candidates for opsonisation
of apoptotic cells. Patients with antiphospholipid syndrome (APLS) produce
antibodies against phospholipid-associated proteins, which can bind to PS. These
autoantibodies have been shown to bind apoptotic cells in vitro resulting in increase
in uptake by phagocytosis (Pittoni, Ravirajan et al., 2000; Balasubramanian, Chandra
et al., 1997). Recently, IgG containing immune complexes have been shown to
opsonise apoptotic neutrophils through FcyR interactions (Hart, Jackson et al., 2003).
Fc receptor-mediated phagocytosis is classically pro-inflammatory; raising the
possibility that opsonisation of apoptotic cells with IgG complexes may influence the
resolution of an inflammatory response by altering the balance of macrophage
cytokine production. However, it is possible that Fc receptor ligation in combination
apoptotic cell recognition molecules will engage specific signal transduction
pathways that act to down-regulate the pro-inflammatory responses normally
associated with FcyR ligation.
Other potential opsonins present within serum for apoptotic cells include pentraxins
and collectins. Pentraxins such as C-reactive protein (CRP) and serum amyloid
protein (SAP) are acute-phase proteins, which can bind chromatin, small nuclear
ribonucleoproteins and Clq (Volanakis & Wirtz, 1979). CRP can bind to late
apoptotic human lymphocytes, increasing the level of binding of Clq, factor B and
iC3b (Gershov, Kim et al., 2000). SAP has been reported to bind
phosphatidylethanolamine on apoptotic lymphoma cells (Familian, Zwart et al.,
2001). Collectins, mannan binding lectin (MBL) and surfactant protein A (SP-A) are
lectins which form structures similar to Clq and recognise high mannose
carbohydrates and other pathogen-associated molecular patterns (PAMPs).
In addition to the phosphatidylserine receptor, a number of receptors have been
reported to mediate their binding and uptake by macrophages and other phagocytic
cell types. The first to be investigated was the recognition of N-acetylglucosamine,
N-acetylgalactosamine, and galactose groups on apoptotic lymphocytes by an
uncharacterised macrophage lectin (Duvall, Wyllie et al., 1985). Subsequently, an
asialoglycoprotein receptor expressed on hepatocytes was shown to contribute to
recognition of apoptotic hepatocytes by their neighbours (Dini, Autuori et al., 1992).
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Moreover, an asialoglycoprotein receptor has been identified on macrophages,
which can possibly assist in uptake of apoptotic cells (Ii, Kurata et al., 1990).
Scavenger receptors and integrins have also been identified as contributing to the
recognition of apoptotic cells. In Drosophila, a member of the SR-B family,
Croquemort, has been shown to participate in removal of apoptotic cells (Franc,
Heitzler et ah, 1999). In human monocyte-derived macrophages, CD36 was found to
associate with the av|33 vitronectin receptor and mediate binding of apoptotic cells
via thrombospondin, a soluble molecule that acts as a bridge between the phagocyte
and the apoptotic cell. This interaction has also been suggested to be essential for PS
mediated uptake by human macrophages (Fadok, Warner et ah, 1998). Blockade of
CD36 resulted in eliminating uptake of apoptotic neutrophils by both PS stimulated
and unstimulated macrophages, indicating that CD36 plays an important role in
uptake of apoptotic neutrophils by human macrophages.
Recently, work by Hoebe and colleagues has shown that CD36 can act in
combination with Toll-like receptors 2 and 6 (TLR2/6) as a sensor of microbial
diacylglycerides (Hoebe, Georgel et ah, 2005). Since CD 14 and TLR4 act together
to mediate recognition of LPS (Poltorak, Ricciardi-Castagnoli et ah, 2000), this
presents an interesting possibility that there is a signalling "bridge" between the
response to apoptotic cells and the innate immune response to microorganisms.
The LPS receptor, CD 14 has also been suggested to be involved in uptake of
apoptotic cells (Devitt, Moffatt et ah, 1998; Devitt, Parker et ah, 2004). The
monoclonal antibody 61D3 was found to bind to the surface of human monocyte
derived macrophages and inhibited their ability to interact with apoptotic cells.
Identification of the epitope recognised by 61D3 implicated a region of the GPI-
linked plasma membrane receptor CD 14 that is closely associated with the LPS
binding region. However, unlike binding of LPS, CD14-mediated binding of
apoptotic cells did not result in release of inflammatory cytokines, suggesting that
CD14 has the potential to generate both pro- and anti- inflammatory signals. The
ligand of CD 14 has been suggested to be an altered form of ICAM-3 (Moffatt, Devitt
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et al., 1999b). ICAM-3 has been suggested to undergo a conformational change
associated with apoptosis that allows recognition by macrophage CD 14.
3.5 Regulation ofphagocytosis of apoptotic cells
If the rate of cell death by apoptosis is such that macrophage clearance capacity is
exceeded, apoptotic cells may become necrotic, resulting in release of harmful
cellular contents and damage to the surrounding tissue (figure 1.1). In support of this
suggestion, treatment of mice with anti-Fas antibody triggered a massive wave of
apoptosis in the liver, and the animals developed extensive hepatic necrosis and died
(Ogasawara, Watanabe-Fukunaga et al., 1993). Similarly, induction of apoptosis in
the rat lung led to pulmonary fibrosis (Hagimoto, Kuwano et al., 1997). It is likely
that in these situations that the hepatic and pulmonary macrophages respectively
were unable to clear the load of apoptotic cells with which they were faced. Similar
situations could arise if neutrophil apoptosis was to be deliberately induced as part of


















Neutrophil apoptosis andphagocytic clearance by macrophages in the resolution of inflammation.
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Future strategies for manipulation of inflammatory cell apoptosis in treatment of
disease may therefore have to include a way of concurrently augmenting the
clearance efficiency of local macrophages.
Macrophage phagocytic capacity in vitro may be influenced by soluble mediators
such as cytokines (Ren & Savill, 1995) and prostaglandins (Rossi, McCutcheon et
ah, 1998), or by glucocorticoid hormones (Giles et ah, 2000; Hart et ah, 2000; Liu,
Cousin et ah, 1999). In addition, interaction of surface adhesion molecules with
neighbouring cells and extracellular matrix components may profoundly influence
many aspects of cellular behaviour, including phagocytosis (Brown, 1986).
Some inflammatory mediators, including prostaglandins, signal through activation of
adenylate cyclase and elevation of intracellular cyclic AMP levels. Prostaglandins
can influence the immune response in a number of different ways, but prostaglandins
PGE2 and PGD2 are capable of inhibiting macrophage phagocytosis of apoptotic
neutrophils in vitro (Rossi, McCutcheon, Roy, Chilvers, Haslett, & Dransfield,
1998). Moreover, treatment of macrophages with a membrane permeable analogue
of cAMP also inhibited the uptake of apoptotic neutrophil (Rossi, McCutcheon, Roy,
Chilvers, Haslett, & Dransfield, 1998). Elevated levels of cAMP had no effect on
FcyR-mediated phagocytosis, indicating specificity for inhibiting apoptotic cell
uptake. Elevation of cAMP concomitantly induced phenotypic alterations in the
macrophage, including changes in the localisation of actin and talin into discrete
structures. Similar results have been observed when staining for vinculin, paxillin
and tyrosine phosphorylated proteins, suggesting that cAMP may uncouple adhesion
receptors from cytoplasmic cytoskeletal elements leading to observed morphological
alterations.
Corticosteroids are used widely in the treatment of inflammatory diseases and are
known to inhibit inflammatory cell recruitment and dampen cellular responsiveness.
They also have diverse effects on inflammatory cell apoptosis, promoting apoptosis
of thymocytes and eosinophils while inhibiting neutrophil apoptosis (Kato, Takeda et
ah, 1995). Treatment of human macrophages with glucocorticoids markedly
increases their capacity to phagocytose apoptotic neutrophils in vitro (Liu et al.,
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2000). The effect of glucocorticoids requires several hours of treatment and is
inhibited by the protein synthesis blocker cycloheximide (Giles, Ross et ah, 2001).
Also, phagocytic effects are not restricted to apoptotic target cells of the neutrophil
lineage. Human monocytes treated with the glucocorticoid dexamethasone in vitro
mature into a homogeneous population of macrophages with a typically smaller,
more rounded appearance than untreated cells. This is associated with reduced
expression ofpl30Cas (Giles, Ross, Rossi, Hotchin, Haslett, & Dransfield, 2001), an
adaptor molecule, which is predicted to bind to Crk/DOCK180 (ced-2/ced-5)
complexes that are important for cell adhesion. Disruption of these complexes in
combination with reduced phosphorylation and recruitment of paxillin and Pyk2 to
sites of adhesion may account for the changes in the cell morphology and phagocytic
capacity that accompany steroid hormone treatment (Giles, Ross, Rossi, Hotchin,
Haslett, & Dransfield, 2001). Despite the rounded appearance of dexamethasone-
treated cells they remain highly membrane active and can be observed rapidly
contracting and expanding cellular processes. Increased membrane protrusion may
be attributable to increased levels of active GTP-bound Rac in the dexamethasone
treated macrophages (Giles, Ross, Rossi, Hotchin, Haslett, & Dransfield, 2001).
Cytokines present at sites of inflammation have the potential to modulate cell
behaviour, including phagocytosis of a wide range of targets. A whole host of
cytokines including GM-CSF, TGF-(31, IFNy, IL-1 (3 and TNFa have been shown to
increase macrophage uptake of apoptotic neutrophils after four hours' incubation
(Ren & Savill, 1995). GM-CSF, IFNy, IL-1 P and TNFa all play important roles in
the initiation and amplification of an immune response. Moreover, they are present
at sites of inflammation where monocytes mature into macrophages. Therefore,
these cytokines may assist in preparing macrophages to clear senescent neutrophils
once they undergo apoptosis.
The adhesive state of a macrophage can modulate phagocytic potential. Adhesion of
macrophages to fibronectin, vitronectin or collagen VI increased the proportion of
macrophages that ingested apoptotic neutrophils (McCutcheon, Hart et al., 1998). It
is possible that the binding of a specific repertoire ofmacrophage adhesion receptors
can influence the potential for phagocytosis of apoptotic neutrophils. Thus,
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macrophage production and deposition of matrix molecules in vitro may play a
role in regulating observed levels of phagocytosis of apoptotic cells in experimental
systems. Macrophage adhesion to fibronectin may involve CD44, which can be
ligated via heparin binding sites. Heparin completely inhibited fibronectin
augmentation of macrophage phagocytosis (McCutcheon, Hart, Canning, Ross,
Humphries, & Dransfield, 1998). Despite this, treatment of macrophages with a
proteolytic fragment of fibronectin, which contained the major heparin binding sites,
was unable to augment phagocytosis. This observation suggests that if fibronectin is
a ligand for CD44 in this system, generation of a signal for augmented phagocytosis
may require binding to additional receptors.
4. Structure and function of CD44
The CD44 gene in humans consists of 50-60 kilobase pairs located on the short arm
of chromosome 11. The gene is comprised of 20 exons, 10 of which undergo
variable splicing, giving rise to changes in the extracellular, membrane proximal
region of the CD44 protein (Screaton, Bell et al., 1992; Cooper & Dougherty, 1995)
(figure 1.2). The most prevalent isoform of CD44, termed CD44s ("standard")
ligand binding
domain V1 -10 variant exons PO^n^tifs
O . Q
to
extracellular domains TM intra-cellular
domains
FIGURE 1.2
Schematic representation of the CD44 gene.
The CD44 gene in humans consists of 20 exons, including 10 variantly spliced exons. It is located on
the short arm of chromosome 11.
TM - transmembrane domain.
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contains no additionally spliced exons. CD44s consists of a single chain type I
transmembrane protein containing 341 amino acids, which due to extensive post-
translational glycosylation has a molecular weight of 80-100kD on SDS-PAGE
(Camp, Kraus et al., 1991). The expression of these variant isoforms in combination
with differential glycosylation alters the range of potential ligands that cells might
respond to (Katoh, Zheng et al., 1995; Lesley, English et al., 1995).
The CD44 molecule was first discovered as an antigen that was recognised by a
monoclonal antibody against human leukocytes (Picker, Nakache et al., 1989).
Further studies indicated that antibodies which were thought to be against three
separate distinct antigens were recognising epitopes common to a group of
polymorphic proteins (Picker, Nakache, & Butcher, 1989). The Elermes lymphocyte











CD44 consists of a large extracellular ligand-binding domain, an alternatively spliced membrane
proximal domain, a highly conserved transmembrane sequence, and a short cytoplasmic tail
containing phosphorylation sites (green circles). CD44 undergoes extensive glycosylation
indicated by the blue (N-glycosylation) and red (O-glycosylation) circles.
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endothelial cells, which line post-capillary venules in lymphoid tissue (Jalkanen,
Reichert et ah, 1986). Expression of Pgp-1, a polymorphic murine glycoprotein, was
shown to be up-regulated on prothymocytes and activated T lymphocytes.
Antibodies against the CDw44 cluster recognised a widely distributed human
glycoprotein related to the Lutherian blood group antigen that was a marker for
medullary thymocytes. The discovery that these proteins were identical was
followed by expression cloning of CD44, which revealed that the amino terminal
domain of the protein shared homology with cartilage link proteins (Goldstein, Zhou
et al., 1989; Stamenkovic, Amiot et al., 1989). The formation of the extracellular
matrix as well as many other aspects of cell behaviour relies upon interactions
between hyaluronan and hyaluronan-binding proteins (Knudson & Knudson, 1993).
In cartilage, link proteins stabilise aggregates of proteoglycan core protein and the
linear sugar hyaluronan by binding either the proteoglycan monomer or hyaluronan.
These interactions are mediated by a common protein domain called the link module.
The link module consists of approximately 100 amino acids and contains four
disulphide-bonded cysteine residues. Link modules are present in matrix proteins
such as aggrecan, versican and the arthritis-associated protein TNF-stimulated gene 6
(TSG-6) (Day & Prestwich, 2002). Structural analysis of the link domain has shown
it to be approximately 100 residues in length, consisting of two alpha helices and two
anti-parallel beta sheets, stabilised by two disulphide bridges and bearing structural
similarity to C-type lectins(Blundell, Mahoney et ah, 2003; Kohda, Morton et ah,
1996).
Evidence has suggested that the link domain of CD44 is more complex, involving
sequences from outwith the link domain. Constructs comprising of only the link
domain of CD44 expressed in E.coli have been shown to fail to refold and are
functionally inactive (Banerji, Day et ah, 1998). Studies using site-directed
mutagenesis suggest that basic amino acid residues flanking the link domain
participate in binding ofHA (Peach, Hollenbaugh et ah, 1993). Recently, elucidation
of the 3D crystal structure of the HA binding domain of CD44 by X-ray
crystallography and NMR spectroscopy has provided new insights into the function
and regulation of CD44 (Teriete, Baneiji et ah, 2004). The CD44 HA binding
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domain was shown to contain a link domain similar to that in TSG-6, however, in
the flanking regions an additional four beta strands contribute to the binding domain,
forming an additional "structural lobe" in close contact with the link domain.
Interestingly, this enlarged binding domain allows for regulation of ligand binding in
response to proinflammatory cytokines and other factors which can produce changes
in receptor N-glycosylation.
CD44 is expressed by many cell types, including leukocytes, fibroblasts,
erythrocytes, endothelial and epithelial cells and a variety of tumour cells (Lesley,
Hyman et ah, 1993). CD44 has broad ligand specificity and has been proposed to
bind the ECM molecules hyaluronan (Aruffo, Stamenkovic et al., 1990;Culty,
Miyake et al., 1990), fibronectin (Jalkanen & Jalkanen, 1992), collagen (Faassen,
Schrager et al., 1992), and fibrin (Henke, Roongta et al., 1996;Svee, White et al.,
1996). In addition, CD44 has also been shown to bind to the extracellular
phosphoprotein osteopontin (Weber, Ashkar et al., 1996), CD44 molecules on
neighbouring cells (Droll, Dougherty et al., 1995), the proteoglycan serglycin present
in lymphocyte and mast cell granules (Toyama-Sorimachi, Sorimachi et al., 1995)
and metalloproteinases (Isacke & Yarwood, 2002). Interactions between CD44 and
hyaluronan is thought to be important in a number of cell-adhesion related functions
including cell adhesion and migration (DeGrendele, Estess et al., 1996;Culty,
Miyake, Kincade, Sikorski, Butcher, Underhill, & Silorski, 1990;Milstone, Hough-
Monroe et al., 1994), chemokine and cytokine production (McKee, Penno et al.,
1996;Rameshwar, Chang et al., 1996;Zembala, Siedlar et al., 1994), lymphocyte
proliferation (Pierres, Lipcey et al., 1992) and tumour formation and metastasis
(Bartolazzi, Jackson et al., 1995;Price, Coombe et al., 1996).
The function of CD44 isoforms has become of interest due to their role in cell
migration, especially in metastasis and invasion of cancer cells. CD44 is expressed
as a number of splice variants and one splice variant CD44v4-7 is involved in the
metastatic spread of tumour cells (Gunthert, Hofmann et al., 1991). The expression
of these splice variants have been proposed as one way of diagnosing and indicating
the prognosis of human tumours. However, the relationship between CD44
expression and metastatic potential may be more complex. The expression of variant
38
isoforms of CD44 in colorectal carcinomas indicates poor prognosis (Wielenga,
Heider et al., 1993). In contrast, in neuroblastomas the absence of any CD44
expression signifies metastatic capacity and poor prognosis (Shtivelman & Bishop,
1991). In these cases, it is not the CD44 itself that is mutated but genes controlling
the expression of CD44. Alternative splicing is controlled by the Ras-MAP kinase
cascade, which are subject to mutation in many cancers (Hofmann, Rudy et al.,
1993).
FIGURE 1.4
A modelfor CD44 specific signallingpathways upon hyaluronan binding.
CD44-Hyaluronan interactions promote Src phosphorylation leading to recruitment of Vav2 and
Tiaml, which in turn activate RhoA and Racl. Binding of hyaluronan also promotes interaction of
CD44 with cytoskeletal proteins such as ankyrin and ERM proteins. Activation of these pathways
can influence macrophage function in terms of adhesion, proliferation/growth, migration,
phagocytosis and tumour cell migration.
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Hyaluronic acid (HA) is an unbranched, non-sulphated glycosaminoglycan that
consists of repeating disaccharide units ofN-acetyl-D-glucosamine and D-glucuronic
acid (Laurent & Hellstrom, 1992). It can be found as a high molecular weight (500-
5000kD) polysaccharide at high concentrations in connective tissue, cartilage,
synovial fluid, vitreous humor and umbilical cord (Laurent & Hellstrom, 1992;Toole,
2001). HA binds to a number of receptors, including CD44 (Aruffo, Stamenkovic,
Melnick, Underhill, & Seed, 1990), receptor for HA-mediated motility (RHAMM)
(Savani, Cao et al., 2001;Hardwick, Hoare et al., 1992) and lymphatic vessel
endothelial receptor (LYVE-1) (Banerji, Ni et al., 1999).
Binding of HA to CD44 has been shown to result in altered tyrosine kinase activity
within cells (figure 1.4). The cytoplasmic domain of CD44 binds to Src kinase at a
single site with high affinity (Bourguignon, Zhu et al., 2001a). HA binding to CD44
stimulates Src kinase activity resulting in tyrosine phosphorylation of cortactin, a
cytoskeletal protein which can cross-link filamentous actin (Bourguignon, Zhu,
Shao, & Chen, 2001a). The Src kinases Lck and Fyn have been shown to interact
with CD44 in lipid rafts present in the cell membrane of human peripheral blood
lymphocytes (Bourguignon, Zhu et al., 1999). In tumour cells, binding of HA to
HER2CD44 has been shown to stimulate pi85 tyrosine kinase activity leading to
increased cell growth (Bourguignon, Zhu et al., 1997). Rho GTPases have been
found to participate in the interaction between cytoskeletal proteins and CD44.
Specifically, RhoA has been shown to be linked to a specific CD44 isoform in breast
cancer cells (Oliferenko, Kaverina et al., 2000). When this isoform is complexed
with RhoA, RhoA stimulates Rho kinase (ROK) leading to increased membrane-
cytoskeleton interactions and tumour cell migration during the progression of breast
cancers (Oliferenko, Kaverina, Small, & Huber, 2000). Binding ofHA to CD44 also
results in activation of Racl signalling, which can regulate actin assembly
influencing membrane ruffling, formation of filopodia, cell motility and cell
transformation (Bretscher, 1999;Bourguignon, Zhu et al., 2000). The cytoplasmic
domain of CD44 has been proposed to bind guanine nucleotide exchange factors
such as Tiaml and Vav2, which can interact with Racl leading to hyaluronan
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mediated tumour cell migration (Bourguignon, Zhu, Shao, & Chen,
2000;Bourguignon, Zhu et ah, 2001b).
HA binding to CD44 may also result in the cytoplasmic domain interacting with the
cytoskeleton membrane linker proteins, ezrin/radixin/moesin (ERM) (Bourguignon,
Zhu, Shao, & Chen, 2000). Moreover, the cytoplasmic domain of CD44 can also
interact with ankyrin, a membrane-associated cytoskeletal protein. Overexpression
of ankyrin promotes hyaluronan-dependent and CD44-specific tumour cell
migration, suggesting that CD44 - ankyrin interactions are required for cytoskeletal
changes during hyaluronan signalling (Bourguignon, Zhu, Shao, & Chen, 2000).
Studies have also shown that a soluble form ofCD44 (sCD44) is detectable in serum,
lymph, arthritic synovial fluid and bronchoalveolar lavage (Katoh, McCarthy et al.,
1994;Katoh, Taniguchi et al., 1999;Shi, Dennis et al., 2001). Increased levels of
sCD44 are often present in malignant disease and inflammatory conditions. These
findings suggest that CD44 levels may be a potential indicator for tumour growth,
metastasis and inflammation. An alternatively spliced form of CD44, lacking the
transmembrane and cytoplasmic domains has been described, providing a
mechanism for de novo synthesis of sCD44 (Yu & Toole, 1996). However, the
major mechanism for production of sCD44 is proteolytic cleavage of cell surface
CD44 (Okamoto, Kawano et al., 1999). CD44 has been shown to be constitutively
released from cells. Release can be promoted by phorbol esters, the calcium
ionophore, ionomycin (DeGrendele, Kosfiszer et al., 1997), cytokines (Ristamaki,
Joensuu et al., 1997) and various proteinases (Cichy, Bals et al., 2002;Lazaar,
Plotnick et al., 2002). Cytoskeletal rearrangement occurs concurrently with CD44
shedding and pharmacological disruption of actin assembly reduces CD44 shedding.
Activation ofRho family GTPases, which regulate actin filament assembly, enhances
CD44 cleavage (Shi, Dennis, Peschon, Chandrasekaran, & Mikecz, 2001) and Ras
has also been shown to induce shedding of CD44, suggesting that both Ras and Rho
GTPases control CD44 shedding through their effects upon the actin cytoskeleton.
Results from pharmacological inhibition studies of endogenous metalloproteinases
and serine proteinases have suggested that they can contribute to CD44 shedding
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(Okamoto, Kawano, Tsuiki, Sasaki, Nakao, Matsumoto, Suga, Ando, Nakajima, &
Saya, 1999). Although, the ADAM (a disintegrin and metalloprotease) family of
enzymes may contribute to CD44 receptor shedding, TACE (TNFa converting
enzyme) has been shown not to be involved (Shi, Dennis, Peschon, Chandrasekaran,
& Mikecz, 2001). Membrane type 1 and membrane type 3 metalloproteinases (MT1-
MMP and MT3-MMP) have been shown to play a role in CD44 processing and co-
expression of MT1-MMP and MT3-MMP in human breast carcinoma cells was
found to result in shedding ofCD44 (Kajita, Itoh et ah, 2001)
Release of CD44 from the cell surface can possibly have a number of effects. It is
likely that sCD44 can compete with cell surface CD44 for ligand binding. sCD44
has been shown to disrupt CD44-HA interactions resulting in apoptosis and
inhibition of tumour cell metastasis (Yu, Toole et al., 1997;Yu, Woessner, Jr. et al.,
2002). Cleavage of CD44 may also assist in preventing cell - cell or cell -
extracellular matrix adhesion. It could also regulate the migratory capacity of the
cell, especially in tumour cells.
4.2 CD44 in inflammation and disease
Several different observations have recently implicated CD44 in the regulation of the
inflammatory response. Freshly isolated peripheral blood monocytes have been
shown to express CD44S strongly (Mackay, Terpe et ah, 1994), and differentiation
of monocytes into macrophages during in vitro culture is associated with increased
expression of variant isoforms while CD44S expression persists at high levels (Culty,
O'Mara et ah, 1994;Levesque & Haynes, 1996). Elevated local concentrations of
CD44 ligands (such as hyaluronan and fibronectin) that follow tissue injury are likely
to be important mediators of macrophage function as the inflammatory response
progresses. Expression of the variant isoforms (CD44v6 and CD44v9) by monocyte-
like THP-1 cells can be up-regulated following exposure to the inflammatory
cytokines TNF-a or IFN-y (Mackay, Terpe, Stauder, Marston, Stark, & Gunthert,
1994), and macrophage expression of some CD44 isoforms is increased at sites of
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chronic inflammation (Levesque & Haynes, 1996). In vivo, systemic
administration of CD44 monoclonal antibodies reduced the severity of joint
inflammation in mice with experimental arthritis (Mikecz, Brennan et ah,
1995;Verdrengh, Holmdahl et ah, 1995;Verdrengh, Holmdahl, & Tarkowski, 1995).
Recent studies involving CD44 "knockout" mice have provided a more direct
evidence for the involvement of CD44 in inflammation. Teder et ah demonstrated
that CD44-deficient mice exhibited unremitting and often fatal inflammation
following bleomycin-induced lung injury compared with wild type animals (Teder,
Vandivier et ah, 2002). The increased susceptibility to severe pneumonitis could be
largely reversed by repopulating the bone marrow of the CD44-deficient mice with
CD44+ wild type cells, demonstrating a critical role for CD44 expressed by
macrophages or other haematopoietic cells in the resolution of lung inflammation.
4.3 CD44 and clearance of apoptotic neutrophils
Ligation of CD44 on the surface of human macrophages has been shown to increase
the capacity for phagocytosis of apoptotic neutrophils (Hart, Dougherty et ah, 1997).
Augmentation of phagocytosis required cross-linking of CD44 on the macrophage
surface, as ligation of CD44 using Fab' fragments resulted in no increase in
phagocytosis. Moreover, CD44 cross-linking has no effect upon phagocytosis of
fresh neutrophils, apoptotic lymphocytes, IgG opsonised erythrocytes and zymosan,
indicating that this augmentation is specific for apoptotic neutrophils. Moreover, the
molecular mechanism of CD44 augmented phagocytosis has been shown to be




The aim of this thesis is to investigate potential molecular mechanisms for
augmentated macrophage phagocytosis of apoptotic neutrophils, following cross-
linking of CD44. Initially, CD44 augmented phagocytosis was characterised using
flow cytometric phagocytosis assays, time-lapse microscopy and antibody/ligand
inhibitor studies. Next, surface expression ofCD44 on the macrophage was analysed
using immunofluorescence and con-focal microscopy. Finally, the intracellular





All cell culture materials were from Invitrogen (Paisley, UK) and other reagents were
from Sigma (Poole, UK) unless otherwise stated. Antibodies used and their suppliers
are detailed in table 2.1. All monoclonal antibodies (mAb) were used at saturating
concentrations as determined by indirect immunofluorescence techniques and flow
cytometric analysis (FACS Calibur, Becton-Dickinson, Oxford, UK).
Preparation of CD44 F(ab')2 antibody fragments.
CD44 mAb (5A4) was purified from hybridoma culture supernatant using Protein A
affinity chromatography as described (Ey, Prowse et al., 1978). Hybridoma culture
supernatant was passed through a column of protein A Sepharose microspheres,
which was then washed with 0.1M phosphate buffer (pH8.0). To elute the antibody
from the column, 0.1M citrate buffer pH4.0 was used. The optical density of each
fraction was measured and the fractions with the highest protein content pooled for
pepsin digest. Purified antibody underwent pepsin digestion (1% wt/wt) to generate
F(ab')2 fragments, for 5-13 hours depending on the antibody concentration. The
digest was terminated by raising the pH of the sample to 8 with 1M Tris (pH9.0).
Residual intact antibody was removed by three rounds of depletion using protein A
agarose affinity resin (Sigma, Poole, UK) and the resulting F(ab')2 fragments were
analysed using SDS-PAGE under non-reducing conditions and visualised using
GelCode Blue (Pierce), according to manufacturer's instructions, to confirm purity.
Indirect immunofluorescence analysis together with flow cytometry was used to
confirm that preparation of antibody fragments did not compromise binding and that
antibody fragments were used at saturating concentrations in other assays.
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Antibody Source
5A4 (pan-CD44; supernatant) Dr Dougherty, San Francisco, USA
C-11 (Rac2), rabbit polyclonal Santa Cruz Biotechnology Inc
IV3 (CD32), mouse lgG2b Medarex Inc, NJ, USA
DFT-1 (CD43), mouse lgG1 Serotec, Oxford, UK
CD106 (VCAM), mouse lgG1 Caltag Laboratories, CA, USA
panPKC, mouse lgG2a BD Pharmingen
Goat anti-mouse IgG (Fc specific) Sigma-Aldrich
Biotinylated goat anti-mouse Ig Amersham Biosciences, St Albans, UK
ezrin, mouse lgG1 BD Pharmingen
p44/42 MAPK, rabbit polyclonal Cell Signalling Technology
Phospho-p44/42 MAPK, rabbit polyclonal Cell Signalling Technology
IVC7 (CD36), mouse lgG1 CLB, Amsterdam
61D3 (CD14, ascites), mouse lgG1 Dr Devitt, Edinburgh, UK
52U (ascites control), mouse lgG1 Dr Devitt, Edinburgh, UK
talin, mouse lgG1 Serotec, Oxford, UK
vinculin, mouse lgG1 Serotec, Oxford, UK
HRP-conjugated goat anti-rabbit Ig Dako Cytomation
HRP-conjugated goat anti-mouse ig Dako Cytomation
TABLE 2.1
Antibodies used in this thesis
Cell Isolation
Mononuclear cells and neutrophils were isolated from human peripheral blood by
dextran sedimentation and discontinuous Percoll™ (Amersham Pharmacia, St.
Albans, UK) gradient centrifugation as described (Dransfield, Buckle et al., 1994).
After removal of platelet-rich plasma by centrifugation at 220g, erythrocytes were
sedimented using 6% Dextran in 0.9% NaCl (Amersham Pharmacia, 2.5ml/10ml cell
pellet, made up to 50ml using saline) for 20min at room temperature. The leukocyte
rich upper layer was then removed and centrifuged at 220g for 6 minutes. The
resulting cell pellet was resuspended in 55% Percoll (90% in PBS without
Ca2+/Mg2+) and layered gently onto a gradient of 68% and 81% Percoll. After
centrifugation at 220g for 6 minutes, mononuclear cells and neutrophils were
harvested (mononuclear cells from the 55/68 interface and neutrophils from the
68/81 interface), washed and counted. Mononuclear cells were suspended at 4 x
106/ml in Iscove's Modified Dulbecco's Medium (Gibco Brl), supplemented with
50U/ml Penicillin and 50U/ml Streptomycin (Gibco), and allowed to adhere to cell
culture plates (Costar, Corning Inc, NY, USA) during incubation at 37°C for 1 hour.
Non-adherent cells (predominantly lymphocytes) were removed and adherent cells
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2+ 2+washed three times in Hanks balanced salt solution without Ca /Mg (HBSS).
Adherent monocytes (approximately 90% CD 14+) were then cultured in IMDM
containing 10% autologous serum for 5 to 7 days. For microscopy based
experiments, monocytes were cultured adherent to 13mm glass coverslips in 24 well
plates.
For serum free experiments, monocytes were cultured in Macrophage SFM-Medium
(Gibco Brl, supplemented with 50U/ml penicillin and 50U/ml streptomycin)
supplemented with 250U/ml GM-CSF (R&D) for three days, washed with HBSS
2d- 2+without Ca /Mg and cultured for a further two days in IMDM.
Neutrophils were incubated at 2 x 10 /ml with 22pM CM-carboxyfluorescein
diacetate (CFDA, Molecular Probes, Oregon, USA) at 37°C for 15 minutes. Labelled
neutrophils were then cultured at 4 x 106/ml in IMDM with 10% autologous serum
for 24 hours during which time they underwent spontaneous apoptosis (Savill,
Wyllie et al., 1989). Apoptosis was assessed by microscopic inspection of
cytocentrifuge preparations that has been stained with Diff-Quik™ (Baxter
Healthcare, Glasgow, UK) as per manufacturer's protocol.
Preparation of human autologous serum
Platelet-rich plasma (PRP) was separated from human peripheral blood by
centrifugation at 350g for 20 minutes. To prepare serum, 10ml PRP was incubated
with 220pl of 1M CaCl2 in glass tubes for 30min at 37°C.
Assessment of macrophage phagocytosis by flow cytometry
Monocyte-derived macrophages were washed with HBSS without Ca2+/Mg2+ and
pre-incubated with IMDM alone or CD44 antibody 5A4 (supernatant; diluted 1:5 in
IMDM) for 15 minutes at 37°C. Excess mAb was removed and monocyte-derived
macrophages washed with HBSS without Ca2+/Mg2+ prior to adding 2 x 106 CM-
CFDA-labelled apoptotic neutrophils in 0.5ml of either IMDM or (25mM and pH
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7.0) Hepes Buffered Saline (divalent cation-free) to each well for 60 minutes at
37°C. At the end of the assay, a solution of 0.25%Trypsin/lmM EDTA was added to
each well and the cells incubated at 37°C for 15 minutes to detach all monocyte-
derived macrophages and remove non-internalised neutrophils. After 15 minutes
incubation on ice, the proportion of macrophages that exhibited increased
fluorescence (corresponding to phagocytosis of fluorescently labelled apoptotic
neutrophils) was determined by flow cytometry using a FACSCaliber analyser with
post-acquisition data analysis performed using CellQuest software (Becton-
Dickinson).
In the cation depletion phagocytosis assay, 2 x 106 CM-CFDA-labelled apoptotic
neutrophils in 25mM Hepes-buffered Saline supplemented with 1 mM calcium
chloride, ImM magnesium chloride or 250pM manganese chloride were used.
In the CD32 inhibition studies, either macrophages or apoptotic neutrophils were
incubated with lOpg/ml IV3 mAb for 15min at 37°C, prior to carrying out the
phagocytosis assay as described above.
Assessment of macrophage phagocytosis by plate assay
5 day cultured monocyte-derived macrophages were gently washed with HBSS
2ft" ?+without Ca /Mg . The media was then replaced with 1ml of unlabelled overnight
"aged" neutrophils and the plate incubated at 37°C for 1 hour. The cells were then
9+ 9+
washed three times with PBS without Ca /Mg to remove all bound, non-ingested
neutrophils. The cells were then fixed in 2.5 % gluteraldehyde for 20 minutes at
room temperature. The cells were then washed as before to remove the fixative. The
neutrophils were then stained for myeloperoxidase activity with O.lmg/ml
dimethoxybenzidene and 0.03% (v/v) hydrogen peroxidase in PBS for 20 minutes.
The effects of antibody/ligand inhibitors upon phagocytosis
2~f 2+
Human monocyte-derived macrophages were washed with HBSS without Ca /Mg
and incubated with mAb 5A4 (1:5 in IMDM) for 15min at 37°C. Unbound antibody
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was washed off and the cells treated either with lmg/ml fucoidan (Sigma, Poole,
UK), 50U/ml heparin (provided by Dr M. McElroy, Department of Pathology,
University of Edinburgh, UK), 10pg/ml IV3 (CD32; Medarex, Annandale, NJ,
USA), lpg/ml IVC7 (anti-CD36; CLB, Amsterdam), lmg/ml 61D3 (anti-CD14
provided by Dr A. Devitt, Centre for Inflammation Research, University of
Edinburgh, UK), lmg/ml 52U (IgGl ascites control) or IMDM alone, for 15min at
37°C. The cells were then washed with HBSS without Ca2+/Mg2+ and 2 xlO6 aged
neutrophils labelled with CM-Green in 0.5ml HBS were added to each well. After
incubation for 60min at 37°C the medium was removed and 0.25%Trypsin/lmM
EDTA added to each well. The cells were incubated for 15min at 37°C and then on
ice for a further 15min. The percentage of macrophage phagocytosis was then
assessed using the flow cytometric assay described above.
Preparation of macrophage lysates
Freshly isolated human monocytes were cultured adherent to six well culture plates
(Costar, Corning Inc) for the time indicated in individual experiments. Mature
2~b 2~b
macrophages were washed with HBSS without Ca /Mg , incubated with either 5A4
or a control antibody diluted in IMDM at 37°C for 15min, and then washed again.
For western blotting, macrophages were lysed with 200pl/well 140mM NaCl/20mM
Tris pH 7.6 containing 1% Triton X-100, protease inhibitor cocktail (Sigma-Aldrich)
and phosphatase inhibitors (ImM sodium orthovanadate, 20mM glycerophosphate).
The lysates were incubated on ice for 20min, the macrophage monolayer scraped
with a plastic cell scraper and the lysates aspirated into 1.5ml Eppendorf centrifuge
tubes. To remove detergent-insoluble material, the samples underwent centrifugation
at lOOOOg for 15min at 4°C, the supernatants were removed and stored at -80°C prior
to use.
Western blotting for p44/p42 MAPK (Erk1/2) activity
Macrophage lysates were run on a non-reducing 12% SDS-polyacrylamide gel. The
proteins were blotted (80v for 1 hour) onto a nitrocellulose membrane (Amersham
49
Pharmacia), which was then blocked for 1 hour in PBS containing 0.1% Tween-
20. The membrane was incubated overnight with either 1:1000 rabbit anti-human
p44/42 MAPK in Tris buffered saline with 0.1% Tween-20 and 5% nonfat dry milk
or 1:1000 goat anti-human phospho-p44/42 MAPK in TBS with 0.1% Tween-20.
The membrane was then washed with TBS/Tween and probed for 1 hour with either
1:2500 HRP-conjugated goat anti-rabbit immunoglobulin (Dako) in TBS/Tween to
detect whole ERK or 1:2500 HRP-conjugated goat anti-mouse immunoglobulin
(Dako) in TBS/Tween to detect phosphorylated ERK. The blot was washed with
TBS/Tween and developed using ECL+ (Amersham Biosciences) according to
manufacturer's instructions (Kodak Biomax Light Film, Sigma-Aldrich).
Inhibition of p44/42 MAPK (Erk1/2)
To inhibit activation of p44/42 MAPK, macrophages were washed and pre-treated
with 50pM PD98059 (Calbiochem) in IMDM for 15min at 37°C prior to making
lysates or using them in phagocytosis and migration assays.
Time-lapse microscopy migration assay
4xl06/ml freshly isolated human monocytes were adhered to slide flasks (Nunc) for 1
hour, washed with HBSS without Ca2+/Mg2+, and cultured in IMDM with 10%
autologous serum for 5 days at 37°C. Macrophages were washed as before,
incubated with either whole 5A4, 5A4 F(ab')2 fragments or IMDM alone for 15min
at 37°C, washed and incubated in IMDM with 10% autologous serum for the
duration of the experiment. Macrophage monolayers were wounded using a pastette.
The migration ofmacrophages back into the wound was examined by phase-contrast
microscopy with an image captured every 5 minutes for 20 hours. The resulting
images were played back at 6 frames/second and made into movies using
QuickTime™ Player.
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Data was analysed by overlaying the initial image at time 0 with an acetate sheet
in order to define the "wound". Subsequent images were then examined and the
number of cells within the wound recorded.
Immunofluorescence microscopy of CD44 surface expression
Human monocyte-derived macrophages, grown adherent to 13 mmcoverslips, were
washed gently with HBSS without Ca2+/Mg2+, and incubated with human heat-
inactivated serum (heat-inactivated at 65 °C for lOmin, 1:10 in IMDM,) for lOmin at
37°C. After washing as before, macrophages were incubated with 5A4 (1:5 in
IMDM) for 15min at 37°C. Macrophages were fixed with PBS without Ca2+/Mg2+
containing 3% paraformaldehyde for 20min at room temperature, washed and
permeabilised with 0.1% Triton X-100 in PBS without Ca2+/Mg2+ for 4min at room
temperature. Macrophages were washed and stained with goat anti-mouse Alexa 488
(1:200; Molecular Probes, Oregon, USA) for 30min on ice in the dark. Coverslips
were washed as before and mounted on microscope slides with Movial mounting
medium.
For the CD44 expression time-course experiments, macrophages were incubated for
differing lengths of time, after stimulation with 5A4 antibody, at both 4°C and 37°C
before washing and fixing.
Antibody biotinylation
5A4 F(ab')2 fragments or goat anti-mouse immunoglobulin (Fc specific, Sigma-
Aldrich) was dialysed into PBS without Ca2+/Mg2+ overnight. Biotinylation was




Dot blotting was used to assess if biotinylation of 5A4 F(ab)2 fragments had been
successful. 3pl dots of antibody at lmg/ml or PBS were applied to a nitrocellulose
membrane with a pipette tip and allowed to dry. The membrane was blocked for
30min in PBS/0.1% Tween-20 at room temperature and incubated with HRP-
conjugated goat anti-mouse immunoglobulin (1:3000 in PBS/0.1% Tween-20) for
30min. The membrane was washed with PBS/0.1% Tween-20 and the blot
developed using 0.lmg/ml 3,3-Diaminobenzidine (DAB; Sigma-Aldrich) and 0.05%
H202.
Preparation of antibody conjugated microspheres
Streptavidin-conjugated latex microspheres (6pm; Polysciences Inc, PA, USA) at
1x10 /ml were incubated with either biotinylated 5A4 F(ab')2 fragments, anti-CD106
(VCAM) F(ab')2 fragments or IgGl control (all at lmg/ml) for 30min at 37°C with
constant mixing. The antibody conjugated microspheres were washed, centrifuged
and the resulting supernatant discarded twice to remove any residual, unbound
antibody.
Analysis of microsphere binding by flow cytometry
Monocyte-derived macrophages were washed, incubated with 5mM EDTA, 0.1%
BSA in PBS without Ca2+/Mg2+ for 30min on ice. Macrophages were then removed
from culture plates by vigorous washing and resuspended at lxl07/ml in flow buffer
(0.2% BSA, 0.1% sodium azide in PBS without Ca2+/Mg2+). To block non-specific
binding, macrophages were incubated with normal rabbit immunoglobulin (1:10,
Dako) for 5min on ice. 6pm fluorescent microspheres conjugated to either 5A4
F(ab')2 fragments or IgGl control were incubated with macrophages at a ratio of 10
microspheres to every macrophage for 30min at 37°C. The level of microsphere
binding to macrophages was assessed using an Epics Coulter analyser with Expo 32
software (Beckman Coulter).
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Analysis of microsphere binding by phase-contrast microscopy
Antibody conjugated microspheres were prepared as described above. Macrophages
2~b 2"badherent to glass cover-slips were washed with PBS without Ca /Mg , and
incubated with IMDM containing 1:10 human heat-inactivated serum to block non¬
specific microsphere binding. 500pl of microspheres either alone or conjugated to
5A4 F(ab')2 fragments or IgGl negative control were incubated with macrophages
for 30min at 37°C. After washing to remove unbound microspheres, the cover-slips
were mounted on microscope slides using Movial mounting medium. The slides
were then analysed and photographed using a Zeiss Axiovert 5100 fluorescent
microscope and OpenLab 3.0 software.
Preparation of Fc specific goat anti-mouse immunoglobulin secondary
antibody
lOOpl of 2.5mg/ml biotinylated goat-anti mouse immunoglobulin (Fc specific) and
lOOpl of lmg/ml streptavidin-conjugated Alexa Fluor 488 were incubated for 15min
at 37°C with constant mixing. The resulting conjugate was used at 1:150.
Imaging cytoskeletal changes and signalling events after CD44
antibody binding
Macrophages grown adherent to cover-slips were washed with PBS without
2_j_ O-pCa /Mg and incubated with IMDM containing human heat-inactivated serum
(1:10). 50pl of microspheres conjugated to either VCAM-1 F(ab')2 fragments or
5A4 F(ab')2 fragments were incubated with the macrophages for 30min at room
temperature. After washing, the macrophages were fixed in PBS without Ca2+/Mg2+
containing 0.1% paraformaldehyde for 20min at room temperature. The
macrophages were then washed and used immediately or kept at 4°C for later use.
Fixed macrophages were permeabilised with 0.1% Triton X-100 in PBS without
Ca2+/Mg2+ for 4min at room temperature, washed and incubated with rhodamine
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phalloidin (1:500) or phalloidin-alexa fluor 488 (1:200; Molecular Probes) or
antibodies against either ezrin (1:50; mouse anti-human; BD Pharmingen, ), Rac2
(1:50; rabbit anti-human; Santa Cruz Biotechnology Inc), panPKC (1:50; mouse anti-
human mAb), vinculin (1:50; Serotec), talin (1:50; Serotec) or mouse IgGl negative
control (1:50; Dako) for 30min on ice. Macrophages were washed and incubated
with the appropriate secondary antibody for 30min on ice - goat anti-rabbit
immunoglobulin Alexa fluor 488 (1:200; Molecular Probes) for Rac2 primary and
goat anti-mouse immunoglobulin Fc specific Alexa fluor 488 (1:200; Molecular
Probes) for all others. Macrophages were washed and the cover-slips mounted on
microscope slides with Movial mounting medium. Macrophages stained for actin
required no secondary and were just washed and mounted on microscope slides after
primary antibody staining.
Statistical Analysis
Statistical analysis of flow cytometry results was carried out using GraphPad
InStat™ software. To compare samples the Student-Newman-Keuls Multiple




PHAGOCYTOSIS OF APOPTOTIC NEUTROPHILS
INTRODUCTION
Apoptosis of neutrophils and their subsequent phagocytic clearance by macrophages
represents an essential process in the resolution of inflammation. However, if the
rate of apoptosis within the inflamed tissue becomes so high that the capacity for
phagocytic clearance becomes overwhelmed, apoptotic cells eventually undergo
secondary necrosis, resulting in the release of cytotoxic cellular contents and damage
to the surrounding tissue (Haslett, Savill et ah, 1994). It has been shown that
inadequate clearance of apoptotic cells and the resulting neutrophil-mediated tissue
damage can contribute to exacerbation of the inflammatory response and lead to
chronic inflammatory diseases. For example, mice exposed to anti-Fas antibodies
have been shown to develop pulmonary fibrosis due to Fas - Fas ligand interactions
leading to apoptosis of bronchial and alveolar epithelial cells (Hagimoto, Kuwano,
Miyazaki, Kunitake, Fujita, Kawasaki, Kaneko, & Hara, 1997). Moreover, lung
tissue from patients with fibrosing lung disease showed upregulation of Fas ligand
expression in comparison to normal lung tissue (Kuwano, Hagimoto et ah, 1999).
Similar observations have been recorded from patients who have ulcerative colitis
(Yukawa, Iizuka et ah, 2002). Colonic mucosal specimens from patients with
ulcerative colitis also had elevated levels of Fas ligand expression (Ueyama,
Kiyohara et ah, 1998). Moreover, neutrophils from patients with inflammatory
bowel diseases have been found to undergo apoptosis more slowly than neutrophils
from other patients (Brannigan, O'Connell et ah, 2000) suggesting that the whole
machinery of apoptosis and subsequent clearance is disrupted in these patients. The
fibrosis and tissue injury observed in these experimental studies possibly resulted
from the failure of tissue phagocytes to clear the level of apoptotic cells present
within the tissues. Therefore, by understanding the physiological mechanisms that
regulate phagocytic clearance capacity for apoptotic cells, it may be possible to
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augment phagocyte capacity for clearance of apoptotic cells and prevent tissue
load of apoptotic cells becoming excessive. Furthermore, induction of inflammatory
cell apoptosis combined with enhancement of macrophage clearance of apoptotic
cells may represent an effective therapeutic strategy for the treatment of human
inflammatory disease.
The phagocytic capacity of a macrophage can be influenced by soluble mediators
such as cytokines (Ren & Savill, 1995), prostaglandins (Rossi, McCutcheon, Roy,
Chilvers, Haslett, & Dransfield, 1998), and steroid hormones (LIU, 1999 170 /id).
Moreover, cellular interactions with the ECM can modulate many aspects of cell
behaviour, through ligation of adhesion receptors and transduction of an intracellular
signal (Brown, 1986). Adhesion ofmacrophages to the ECM component fibronectin
has been shown to significantly augment their capacity for phagocytosis of apoptotic
neutrophils (McCutcheon, Hart, Canning, Ross, Humphries, & Dransfield, 1998). In
view of the finding that Pi integrins only partially accounted for observed
augmentation, we examined the role ofCD44 was examined, as this receptor has also
been reported to recognise fibronectin (Jalkanen & Jalkanen, 1992). Ligation of
CD44 on the macrophage surface using antibodies was found to strongly promote the
capacity for phagocytosis of apoptotic neutrophils (Hart, Dougherty, Haslett, &
Dransfield, 1997).
CD44 augmented phagocytosis was found to be specific for apoptotic neutrophils as
CD44 ligation has no effect upon phagocytosis of fresh neutrophils, apoptotic
lymphocytes, IgG opsonised erythrocytes and zymosan. This observation suggests
that CD44 augmented phagocytosis could potentially represent a specific mechanism
for promotion of clearance of apoptotic neutrophils during inflammation. The
molecular basis for CD44 augmented phagocytosis of apoptotic neutrophils was
suggested to be distinct, being independent of integrin ligation, CD36, CD 14,
scavenger receptors or the PS receptor.
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This chapter describes experimental approaches to further characterise the
mechanism of antibody-mediated CD44 ligation on macrophage phagocytosis of
apoptotic neutrophils.
RESULTS & DISCUSSION
Time-course of CD44 augmented phagocytosis.
I sought to determine whether CD44 antibody treatment of monocyte-derived
macrophages initiated intracellular signals that resulted in augmented phagocytosis
through indirect clustering of associated signalling molecules. Alternatively, CD44
antibody might cause membrane receptor redistribution, altered mobility of receptors
in the plasma membrane, or "patching" of receptors to reveal pro-phagocytic
receptors that are normally hidden by receptors such as CD44, which would be
predicted to adopt an extended conformation.
By examining the duration of the increase in phagocytosis promoted by CD44
antibody, I hoped to gain insight to the nature of the mechanism of the response. A
signalling response would generally be predicted to be very rapid. For example the
activation of Rac2 in human neutrophils in response to f-Met-Leu-Phe (fMLP) and
Leukotriene-B4 (LTB4) is both rapid and transient (Akasaki, Koga et al., 1999).
However, signalling events may result in transcriptional activation that results in
expression of new proteins, which result in acquisition of a more phagocytic
phenotype. Responses which involve redistribution of molecules within the cell
membrane might be expected to be slower and longer-lived. First, I investigated
CD44 antibody mediated augmentation of phagocytosis of apoptotic neutrophils over
time, monocyte-derived macrophages were treated with 5A4 for 15min and
incubated with fluorescently labelled apoptotic neutrophils for 30, 60, 90 and 120
min. These experiments aimed to test whether CD44 mAb treatment simply acted to
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The effect ofCD44 stimulation on macrophage phagocytosis of apoptotic neutrophils over 120
minutes.
a. Macrophages were incubated with IMDM alone (black bars) or 5A4 (anti-CD44, grey bars) for
15min, washed, and incubated with a suspension of aged neutrophils for the length of time
indicated. After Trypsin/EDTA treatment, the percentage of macrophages that had undergone
phagocytosis was analysed using a flow cytometric assay. (n=3, P<0.05)
b. Comparison of untreated and CD44 treated macrophages after 60 minutes incubation with
apoptotic neutrophils using flow cytometric and microscopic analysis. Black circle indicates a
non-injested neutrophil. Black arrow indicates phagocytosis.
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the proportion of fluorescent (phagocytic) macrophages was analysed by flow
cytometry (figure 3.1).
These experiments revealed that for untreated macrophages, phagocytosis was
essentially maximal after 1 hour (figure 3.1). Although there was a trend to higher
proportions of phagocytic macrophages at longer time points, these failed to reach
significance. Interestingly, CD44 mAb treatment augmented phagocytosis at all time
points examined, with greatest effect observed at 60 minutes. This observation
suggested that CD44 mAb treatment "enabled" a previously unresponsive population
of macrophages for apoptotic cell phagocytosis, since untreated macrophage
phagocytosis failed to approach the levels seen following CD44 treatment even with
prolonged assay times (120min still less than 30min CD44). To be certain that I was
examining optimal effects of CD44 mAb treatment, I therefore studied 60 minute
time points in subsequent experiments.
Time-course of CD44 cross-linking effect
Previous studies had shown that cross-linking of CD44 was essential for augmented
phagocytosis. Ligation ofCD44 with whole antibody and F(ab')2 fragments resulted
in augmentation of macrophage phagocytosis of apoptotic neutrophils, whereas
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Schematic representation of the CD44 cross-linking experiments
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stimulation with Fab' fragments failed to augment macrophage phagocytosis at all
(Hart, Dougherty, Haslett, & Dransfield, 1997). I therefore decided to investigate
how long this cross-linking effect persisted in terms of its effects on the levels of
apoptotic cell phagocytosis. To determine how long the augmentation of
macrophage phagocytosis lasts after CD44 mAb mediated cross linking,
macrophages were incubated with CD44 mAb 5A4 for 15min, the antibody washed
off and the macrophages incubated for a further Ohr, lhr, 2hr and 4hr before addition
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FIGURE 3.3
The effect of cross-linking CD44 for varying lengths of time on macrophage phagocytosis of
apoptotic neutrophils.
Macrophages were incubated with either IMDM alone (black bars) or 5A4 (grey bars) for 15min,
washed,and incubated for the length of time indicated above, before incubation with a suspension
of aged neutrophils for 60min. After treatment with trypsin/EDTA, the percentage ofmacrophage
phagocytosis was determined using a flow cytometric assay. (n=3, P<0.01)
Surprisingly, CD44 mAb treated monocyte derived macrophages exhibited
augmented phagocytosis of apoptotic neutrophils even after several hours, suggesting
that the effects of CD44 mAb cross-linking were not transient (figure 3.3a). In this
regard, the effect of CD44 mAb contrasted chemokine induced activation of
intercellular adhesion (e.g. neutrophil/endothelial cell interaction or T cell/antigen
presenting cell), which has been shown to be transient (Chan Hyduk & Cybulsky,
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2003). Thus, the effects of CD44 mAb may not be readily reversed and this
contrasts with many other signalling events which exhibit reversibility.
To further explore this observation, I decided to investigate the cross-linking effect
of CD44 over a longer period of time. Macrophages were treated with 5A4 for 15
min as before and incubated for Ohr, lhr, 20hr and 24hr before assessing
phagocytosis of apoptotic neutrophils. Cross-linking of CD44 resulted in augmented
phagocytosis for up to 24 hours after mAb addition and thus potentially may be
irreversible (figure 3.3b). Furthermore, it is notable that the percentage of
phagocytosis in CD44 mAb treated macrophages does not significantly differ from
that observed within 1 hour of phagocytosis, indicating that whatever the mechanism
which underlies augmentation of phagocytosis by CD44 mAb it continues to
influence the treated macrophages behaviour for a considerably longer time.
These results suggest that CD44 mAb binding to the macrophage leads to a long
lasting change in macrophage phagocytic function. These data may indicate that a
signalling event within the cell is unlikely to mediate the observed effect, unless
CD44 cross-linking is associated with an essentially irreversible change in regulatory
pathways.
CD44-augmented phagocytosis in divalent cation deplete conditions
Previous experiments using blocking antibodies and competitive ligands had failed to
identify a molecular basis for the observed augmentation of phagocytosis following
CD44 mAb treatment of monocyte derived macrophages. Since a number a
important cell-cell adhesion molecules are dependent upon divalent cations for
function (including integrins and C-type lectin receptors), removal of these divalent
cations provides a means to discriminate possible receptor pathways involved in
CD44 augmentation of macrophage phagocytosis of apoptotic neutrophils. To
investigate the effect of cation depletion upon CD44-augmented phagocytosis,
macrophages were co-incubated with apoptotic neutrophils in Hepes buffered saline
(HBS) or HBS supplemented with calcium, magnesium or manganese. The
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percentage of macrophage phagocytosis for both unstimulated and CD44




The effect of cation depletion upon CD44 augmented macrophage phagocytosis of apoptotic
neutrophils.
Macrophages were incubated with either IMDM alone (black bars) or 5A4 (grey bars), washed
and then incubated with a suspension of aged neutrophils in HBS alone or supplemented with the
cation indicated above for 60min. After treatment with trypsin/EDTA, the percentage of
macrophage phagocytosis was determined using a flow cytometric assay. (n=3)
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For untreated macrophages, cation depletion almost eliminated baseline
phagocytosis in comparison to phagocytosis in IMDM. Addition of different
divalent cations failed to restore phagocytosis to control levels suggesting that
multiple cations are required for phagocytosis. However, CD44 stimulation
consistently resulted in augmentation of phagocytosis in a divalent cation deplete
environment, although this augmentation was not as great as that observed in
divalent cation replete conditions. Furthermore, supplementing HBS with either
calcium or magnesium resulted in a higher level of augmentation. Thus, CD44-
augmented phagocytosis of apoptotic neutrophils may be partially dependent upon
divalent cations. The results from these experiments were surprising in several ways.
9+ 9+
First, the addition of either Ca or Mg alone failed to restore phagocytosis in
untreated cells, raising the possibility that other media constituents in IMDM were
necessary for phagocytosis, for example glucose. This possibility could be tested
using media selectively depleted of divalent cations using special chelating resins.
9+
Second, the failure of Mn to restore phagocytosis is interesting since using
2_|_
microscopy based assays, 2 independent groups have observe augmentation by Mn
2+
(Dransfield and Savill, unpublished data). One possible explanation is that Mn
2"F
promoted adhesion and phagocytosis. Since Mn strongly promotes integrin
activation this observation makes it unlikely that integrins contribute to the
phagocytic process. The data also strongly suggest that a major component of the
effect of CD44 mAb treatment is distinct from that observed in untreated cells in that
it is observed in HBS without divalent cations.
Antibody/Ligand panel
Depletion of divalent cations dramatically reduces the effect of CD44 upon
augmentation of phagocytosis (15-20% phagocytosis as opposed to 40-50%
phagocytosis). It also reduces basal phagocytosis to around 2% giving an ideal
system where the divalent cation independent component of CD44 augmentation can
be investigated. In order to characterise the divalent cation independent component
of CD44-augmentated phagocytosis, I treated macrophages with a number of known
inhibitors of divalent cation independent cellular interactions. The polysaccharide
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fucoidan is found in some species of Pheaeophycaea (brown seaweed), and has been
shown to act as an antagonist of the macrophage scavenger receptor in macrophage
cell lines THP-1, J774, RAW264.7 and murine peritoneal macrophages(Hsu, Hajjar
et ah, 1998; Kim, Ordija et ah, 2003; Falcone, Rossi et ah, 2001). Moreover,
fucoidan can also to bind to CD 14 resulting in signal transduction and cytokine
release by the macrophage (Kim, Ordija, & Freeman, 2003). Heparin in high
concentrations can influence the rate of macrophage phagocytosis (Savill, Wyllie,
Henson, Walport, Henson, & Haslett, 1989; McCutcheon, Hart, Canning, Ross,
Humphries, & Dransfield, 1998; Akbar, Savill et ah, 1994). Anti-CD36 antibodies
act as a blockade of the thrombospondin receptor, which along with integrins have
been reported to assist in clearance of apoptotic cells (Savill, Hogg, Ren, & Haslett,
1992). Blockade ofCD14 prevents it binding to ICAM3, which has also been shown
to trigger uptake of apoptotic cells (Devitt, Moffatt, Raykundalia, Capra, Simmons,
& Gregory, 1998; Moffatt, Devitt et ah, 1999a). Anti-CD32 antibodies will block any
FcyRII receptor interactions and were initially included as a negative control, since
FcR interactions were thought to be unlikely to be involved in apoptotic cell
clearance.
30 ~i * * * * * *
FIGURE 3.5
The effect ofa variety ofantibodies & ligands on CD44 augmentedmacrophage phagocytosis of
apoptotic neutrophils.
Macrophages were incubated with either IMDM alone (black bars) or 5A4 (grey bars) for 15min,
washed and then incubated with the antibody/ligand indicated above for a further 15min. After
washing, macrophages were incubated with a suspension of aged neutrophils in HBS for 60min
before trypsin/EDTA treatment. Analysis ofmacrophage phagocytosis was then carried out using
a flow cytometric assay. (n=3, P<0.01)
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Pre-treatment with fucoidan, heparin, anti-CD36 antibodies, anti-CD 14 antibodies
or an IgGl control mAb prior to incubation with apoptotic neutrophils for 60 minutes
at 37°C under divalent cation-free conditions failed to inhibit the CD44 augmented
phagocytosis (figure 3.5). Surprisingly, treatment with an anti-CD32 antibody (IV3)
resulted in inhibition of CD44-augmented phagocytosis in the absence of divalent
cations. This finding suggests that CD32 (FcyRII) is responsible for the divalent
cation independent component of CD44-augmented phagocytosis.
Inhibition of CD32 on macrophages and neutrophils
CD32 is present upon both macrophages and neutrophils, therefore it was important
to ascertain which was responsible for the observed inhibition of CD44-
augmentation. Initially we thought that FcyR on macrophages were likely to be
important since apoptotic neutrophils lose FcyRIII (CD16) and show a moderate
down-regulation of FcyRII (Hart, Ross, Ross, Haslett, & Dransfield, 2000). Again,
we were surprised to find that pre-incubation of macrophages with CD32 mAb IV3
had no inhibitory effect on CD44-augmented phagocytosis in divalent cation-free
40
No Pre-lncubation Macrophages Pre-lncubated Neutrophils Pre-lncubated
with anti-CD32 antibodies with anti-CD32 antibodies
FIGURE 3.6
The effect of pre-treating macrophages or neutrophils with anti-CD32 antibodies on CD44
augmentedphagocytosis ofapoptotic neutrophils.
Macrophages or aged neutrophils were pre-incubated with anti-CD32 antibodies for 15min,
washed and resuspended in IMDM. Macrophages were then incubated with IMDM alone (black
bars) or 5A4 (grey bars) for 15min, washed and incubated with a suspension or aged neutrophils in
HBS for 60min. Phagocytosis was stopped by addition of Trypsin/EDTA. The percentage of
phagocytosis was determined using a flow cytometric assay. (n=3)
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conditions (figure 3.6). This data suggests that macrophage FcyRII was not
mediating the divalent cation-independent CD44-augmented phagocytosis.
In contrast, pre-incubation of apoptotic neutrophils with IV3, prior to use in
phagocytosis assays, resulted in a major reduction ofCD44-augmented phagocytosis.
Thus, CD32 mAb blocks around 50% of the CD44-augmentation observed in the
absence of divalent cations. Consequently, these data suggest that CD32 is the
molecule responsible for the divalent cation independent component of CD44-
augmented phagocytosis. One possible mechanism for this would be the binding of
the 5A4 antibody to CD44 molecules on the macrophage surface and the Fc portion
binding to CD32 expressed on the apoptotic neutrophil (figure 3.7). Thus, the CD32
mAb may act as a "bridge" between the macrophage and the apoptotic neutrophil and
this tethering event then facilitates uptake of the neutrophil.
Neutrophils have been shown to express both CD16 (FcyRIIA) and CD32 (FcyRIIIB)
upon their cell surface. As previously mentioned, during apoptosis the expression of
these FcyRs is altered. CD 16 expression is markedly downregulated (Dransfield,
Buckle, Savill, McDowall, Haslett, & Hogg, 1994) and CD32 expression is down-
regulated (Hart, Ross, Ross, Haslett, & Dransfield, 2000). It was believed that down-
regulation of surface receptors associated with apoptosis resulted in functional down-
regulation of neutrophil function, acting to "isolate" them from potentially pro¬




Tethering the apoptotic neutrophil to the macrophage via CD44/5A4/CD32 interactions
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However, recent data suggests that apoptotic neutrophils may undergo an
apoptosis-associated change in FcyR function resulting in the apoptotic neutrophil
acquiring the ability to bind antibody-antigen complexes. (Hart et al, 2003). In this
situation, the apoptotic neutrophil becomes opsonised by immune complexes and
potentially flagged for clearance via alternative pathways.
Together these data support my hypothesis that neutrophil CD32 is responsible for
the divalent cation-independent component ofCD44 augmented phagocytosis.
Generation of anti-CD44 F(ab')2 fragments
To verify this hypothesis, I made anti-CD44 F(ab')2 fragments to allow the role of
CD32 in CD44-augmented phagocytosis to be confirmed. If my hypothesis was
correct, then the anti-CD44 F(ab')2 fragments would be a useful tool to explore the
divalent cation dependent component of CD44-augmented phagocytosis. I therefore





5A4 p5A4 pre post
FIGURE 3.8
SDS-PAGE analysis ofpepsin digestion of5A4 antibody
Anti-CD44 antibody (5A4) was purified using protein A affinity chromatography (p5A4).
Antibody was then eluted from the column and underwent pepsin digestion (pre - pre-digest, post
— post-digest). Residual intact antibody was removed using protein A agarose affinity resin.
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ammonium sulphate purification and protein A affinity chromatography. The
isolated antibody was pepsin digested and any remaining whole antibody fragments
removed by affinity chromatography on protein A sepharose. The resulting anti-
CD44 F(ab')2 fragments were analysed for purity (figure 3.8) and tested for their
binding ability at varying concentrations, (figure 3.9)
FIGURE 3.9
Analysis ofanti-CD44 F(ab ')2 fragmentsfor binding
Macrophages were incubated with different concentrations of anti-CD44 F(ab')2 fragments for
30min on ice. After thorough washing, the macrophages were incubated with goat anti-mouse FITC
for 30 min on ice, washed thoroughly and antibody binding analysed using flow cytometry.
Effect of anti-CD44 F(ab')2 fragments on macrophage phagocytosis
To examine the role of CD32 in CD44-augmented macrophage phagocytosis, anti-
CD44 F(ab')2 fragments were used in phagocytosis assays in both divalent cation
deplete and divalent cation replete conditions.
Pre-treatment of macrophages with anti-CD44 F(ab')2 fragments prior to co-
incubation with apoptotic neutrophils in IMDM (cations present) resulted in
augmentation of phagocytosis, in comparison to untreated macrophages (figure
3.10a). The augmentation with F(ab')2 was lower than that observed using whole
antibody against CD44, supporting a contribution for the Fc portion of the antibody
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in binding to CD32. Moreover, the observed augmentation by anti-CD44 F(ab')2
fragments was very slight at 30min but had greatly increased by 60min, suggesting
that CD32 mediated tethering may make a major contribution to apoptotic cell
tethering, whereas CD44 cross-linking has a more delayed effect.
Macrophages pre-treated with anti-CD44 F(ab')2 fragments before being allowed to
interact with apoptotic neutrophils in HBS (cation deplete) had levels of
phagocytosis similar to those of untreated macrophages (figure 3.10b). These data
further suggest that my hypothesis that CD32 binding was responsible for the
observed cation independent component of CD44-augmented phagocytosis.
Taken together, these data clearly indicate that CD32 assists in CD44-augmented
phagocytosis through tethering the macrophage to the apoptotic neutrophil.
However, CD44 antibody binding does augment phagocytosis independently of
CD32 as indicated by the observed augmentation by CD44 F(ab')2 in divalent cation
replete conditions. It is this divalent cation dependent augmentation that likely
represents the true effect of CD44 receptor ligation. Further examination of the
molecular mechanism would therefore require studies with anti-CD44 F(ab')2
antibody. Furthermore, these experiments also highlight the importance of taking the












Phagocytosis of apoptotic neutrophils by macrophages pre-incubated with anti-CD44 F(ab')2
fragments in either IMDM or HBS.
Macrophages were incubated with either IMDM alone (black bars), whole 5A4 antibody (light
grey bars) or anti-CD44 F(ab')2 fragments (dark grey bars) for 15 min, washed and then incubated
with a suspension of aged neutrophils in either IMDM (a.) or HBS (b.) for a further 60 min. After
treatment with trypsin/EDTA, the percentage of macrophage phagocytosis was determined using a
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FIGURE3.il
Phagocytosis of apoptotic neutrophils by macrophages pre-treated with anti-CD43 antibody.
Macrophages were pre-incubated with either CD44 mAb, CD43 mAb or a combination of both, or
untreated control for 15 minutes, washed and then incubated with apoptotic neutrophils in the
absence of divalent cations for 60 minutes. Macrophage phagocytosis of apoptotic neutrophils in
duplicate samples was then determined by flow cytometry. Results are shown as mean ± SEM of
six independent experiments.
CD43 and macrophage phagocytosis
One important prediction from the above experiments is that any antibody, which
binds to a molecule expressed at high levels on the macrophage surface should have
the potential to augment phagocytosis in cation-depleted conditions. To investigate
this possibility, I used an antibody against CD43, which has similar levels of
expression to CD44, to see if phagocytosis could be augmented through binding to
CD32.
Somewhat surprisingly, Pre-treatment of macrophages with an anti-CD43 antibody
in divalent cation-free conditions failed to augment phagocytosis (figure 3.11).
Moreover, there was no observed change in the effect of CD44 stimulation in the
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presence of an anti-CD43 antibody. This observation contradicts my proposed
mechanism for apoptotic cell tethering via CD32 and the reasons for this have not yet
been clarified. It is possible that tethering of the apoptotic neutrophil to the
macrophage does occur through CD43/CD32 interactions, when the anti-CD43
antibody is present, but that this does not result in phagocytosis. In contrast, with
CD44 mAb binding to macrophages I have demonstrated that there is a pro-
phagocytic signal via the F(ab')2 portion of antibody. Thus, there is potentially a
signal as well as tethering leading to phagocytosis, similar to the proposed "tether
and tickle" model (figure 3.12). Tethering of an apoptotic cell to the macrophage
may represent an independent process from phagocytosis and does not necessarily
lead to phagocytosis. The flow cytometric assay used to measure levels of
phagocytosis discriminates tethering from phagocytosis, as the majority of apoptotic
neutrophils bound to the macrophages surface are removed by washing and
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FIGURE 3.13
Macrophagephagocytosis ofapoptotic neutrophils in serum-free conditions.
Macrophages, grown in serum-free conditions, were incubated with either IMDM (black bars) or
5A4 (grey bars) for 15min, washed and incubated with a suspension of aged neutrophils for
60min. After treatment with trypsin/EDTA, the percentage of macrophage phagocytosis
population when samples were sorted (Jersmann, Ross et al., 2003). Whilst, this is
useful when a true indication of levels of phagocytosis is required, it is not useful
when trying to quantify levels of tethering. Therefore, it would be necessary to
develop a modified technique to assess the levels of tethering of apoptotic
neutrophils to macrophages treated with either CD44 or CD43 mAb. It might also be
useful to carry out a plate phagocytosis assay to allow visual quantification of bound
in comparision to ingested apoptotic neutrophils. It may also be possible to not use
trypsin/EDTA to detach neutrophils and instead quench fluorescence of surface
bound neutrophils with trypan blue. Alternatively, binding of particles could be
assessed by staining them with an anti-neutrophil antibody i.e. CD14. CD15 mAb
would only stain neutrophils tethered to the macrophage and not those which have
been ingested, allowing discrimination between tethering and phagocytosis.
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CD44-augmented phagocytosis in serum-free conditions
Serum components have been shown to play a role in facilitating phagocytosis of
apoptotic cells. One of the most prominent serum components implicated in the
uptake of apoptotic cells are the proteins of the complement cascade. Mice deficient
in the complement protein Clq have been shown to have a defect in clearance of
apoptotic cells, which can then be observed in the kidney (Botto, 1998). This failure
in clearance may contribute to the development of auto-antibodies associated with
Clq deficiency.
It is possible that a variety of potential opsonins present in serum could assist in
CD44-augmented phagocytosis by acting as a bridge between CD44 and a receptor
on the apoptotic neutrophils surface, as this is the case for many phagocyte receptors.
In fact, very few phagocyte receptors implicated in apoptotic cell clearance have
been shown to interact directly with the apoptotic cell surface. Although, the flow
cytometric phagocytosis assay is carried out in serum-free conditions both
monocytes and neutrophils are cultured in the presence of 10% human autologous
serum. Therefore, it is possible that both the macrophages and the apoptotic
neutrophils will have been opsonised with serum components bound to their
surfaces. To investigate the possible effect that serum may be having upon the
macrophage response to CD44, macrophages were grown in serum-free conditions
before being co-incubated with apoptotic neutrophils (also cultured using serum-free
media).
Macrophages cultured in serum-free conditions had a lower level of control
phagocytosis overall (figure 3.13). CD44 treatment of macrophages still increased
phagocytosis of apoptotic neutrophils but not to as great an extent as those cultured
in the presence of autologous serum. This raises the possibility that serum
components are required for CD44-augmentation. These serum components are
possibly essential for the maturation ofmonocytes into macrophages that are capable
of phagocytosing. For example, GM-CSF is added to serum-free medium to assist in
producing mature macrophages. However, GM-CSF may not be sufficient to allow
the maturation pathway to be completed. It has been shown that it is macrophage
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colony stimulating factor (M-CSF) that is essential to complete monocyte
maturation into macrophages, and that addition of GM-CSF is not as effective
(Brugger, Kreutz et ah, 1991). Examination of the morphology of macrophages
grown in serum-free conditions also seem to support this, as they were smaller and
had a more spindly appearance than macrophages grown in the presence of
autologous serum.
To investigate the effects of differentiation further I would assess the capacity for
CD44 mAb to augment phagocytosis at different stages of macrophage culture,
comparing monocytes and monocyte-derived macrophages cultured in serum-free
media in the presence of different cytokines known to influence macrophage
differentiation and induce different phenotypes e.g. IFN-y, IL-4, IL-10 and GM-CSF.
CD44 stimulation and macrophage migration
In view of the close relationship between adhesion, migration and phagocytosis in
terms of regulatory mechanisms and proteins involved in cytoskeletal reorganisation
(e.g. Rac, DOCK180 and crk), I sought to characterise whether CD44 influenced
macrophage migration. In addition, it is possible that there may be an indirect
association of cell motility with phagocytosis through the increased likelihood of
macrophages making contact with apoptotic cells during the assay.
To investigate the association between phagocytic capacity and migration,
macrophage monolayers were "wounded" with a pastette and the subsequent
movement of macrophages into the "wound" was monitored using time lapse video
microscopy over 20 hours. This system allowed the investigation of the effects of
CD44 mAb binding to monolayers of cells under conditions similar to those used in
the phagocytosis assay.
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Surprisingly, pre-treatment ofmacrophages with CD44 mAb resulted in a reduced
level of macrophage migration into the wound, in comparison with un-treated
macrophages (figure 3.14). This observation suggests that stimulation of CD44
reduces macrophage capacity for migration. Alternatively, the anti-CD44 antibody
may be blocking interactions between the macrophage CD44 and another molecule
that is needed to facilitate migration. Macrophage migration is an incredibly
complex and highly co-ordinated process. In order to investigate it further, it could
be broken down into stages. The first stage involves extension of the plasma
membrane forwards at the leading edge of the cell. This protrusion is stabilised by
recruitment of signalling molecules and cytoskeletal proteins to form an adhesion.
These adhesions are the attachments that drive the cell forward. The final stage
consists of release of adhesions and retraction of the trailing edge of the cell.
Over 50 proteins have been found in adhesions (Zamir & Geiger, 2001). As it is
these small adhesions that have been shown to drive migrating cells (Beningo,
Dembo et al., 2001;01iver, Dembo et al., 1999) then it would be useful to investigate
Time
FIGURE 3.14
The effect ofCD44 stimulation on macrophage migration.
Macrophages were incubated with either IMDM alone (black line) or 5A4 (grey line) for 15min,
washed and the monolayer wounded using a pastette. Migration was recorded over a 20 hour
period. (n=3)
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differences in these structures between untreated and CD44 stimulated
macrophages. An ideal strategy for this would be to carry out a protein array and
protein expression profiling to highlight differences in protein expression between
untreated and CD44 treated macrophages.
There are also a number of microscope-based techniques, which could be used to
study molecular interactions during migration. Fluorescence Ratio Imaging (FRI) is
one such technique, which can be used to examine co-localisation of signalling
molecules and relative changes in protein concentration (Zamir, Katz et al., 1999;
Kam & Boxer, 2001). The recent development of Traction Force Microscopy
provides a mechanism to compare forces exerted by a moving cell (Dembo, Oliver et
al., 1996). The technique involves plating cells onto a gel with marker microspheres
embedded into it. The displacement of these microspheres, as the cell moves, can be
translated into a traction stress map. The traction forces in both untreated and CD44
treated macrophages could be analysed for any differences between the cells.
Once these initial studies were carried out, they would provide an indication of
potential molecules and their cellular locations, which were influencing migration in
CD44 treated macrophages. Identification of these molecules would allow use of
chemical inhibitors could be used to confirm their role in migration.
SUMMARY
Augmentation of macrophage phagocytosis by apoptotic neutrophils as a result of
CD44 mAb induced cross-linking may be a potential target for therapeutic
intervention in chronic inflammatory conditions. Here it has been demonstrated that
this increase in phagocytosis is long-lived and that cross-linking of CD44 can
augment phagocytosis for up to 24 hours and possibly longer. Interestingly, it was
observed that CD44 augmentation of macrophage phagocytosis is reduced in the
absence of divalent cations. This suggests that the mechanism consists of both a
cation-dependent and cation-independent component. Further investigation of the
divalent cation independent component indicated that CD32 on the apoptotic
neutrophil was playing a role in CD44 augmented phagocytosis. These observations
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lead to the development of a hypothesis whereby the 5A4 antibody acts as a bridge
between CD44 on the macrophage and CD32 on the apoptotic neutrophil, effectively
tethering the two together.
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Chapter 4
SIGNALLING IN RESPONSE TO CD44 CROSS-LINKING ON
THE MACROPHAGE SURFACE
INTRODUCTION
The previous chapter described how cross-linking of CD44 on the macrophage
surface by bivalent antibodies resulted in a rapid and long-lasting augmentation of
phagocytosis of apoptotic neutrophils. The observed effect consisted of two distinct
components - divalent cation-independent and divalent cation-dependent. Using a
number of inhibitors of known phagocytic receptors for apoptotic cells, it was
possible to elucidate the mechanism of the divalent cation-independent component of
CD44 augmented phagocytosis of apoptotic neutrophils. Data presented in the
previous chapter demonstrated that CD32 on the apoptotic neutrophil interacted with
the Fc region of anti-CD44 antibody, 5A4, which was bound to CD44 on the
macrophage surface. The mechanism behind the divalent cation dependent
component has proved more difficult to clarify. Two possible mechanisms have
been suggested. Firstly, the rapid, yet prolonged change in macrophage behaviour
suggested that generation of an intracellular signal might not be directly responsible
for the augmentation of phagocytosis. An alternative that does not require a direct
intracellular signal was that there might be a redistribution ofCD44 molecules on the
macrophage surface leading to exposure of "masked" receptors, which promote
phagocytosis of apoptotic neutrophils. However, data from preliminary experiments
investigating changes in macrophage surface membrane distribution ofCD44 did not
appear to support this hypothesis as no major alterations were observed. Secondly,
there was a possibility that cross-linking of CD44 on the macrophage surface results
in intracellular signalling cascades, which induce prolonged changes within the
macrophage resulting in an increased capacity for phagocytosis of apoptotic
neutrophils. Cross-linking of CD44 might initiate changes in cytoskeletal
organisation or regulation, activation of phagocytic receptors for apoptotic cells or
changes in gene expression that influence macrophage behaviour.
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To investigate the role of signalling events occuring as a result of CD44 cross-
linking, I used microspheres coated with anti-CD44 F(ab')2 fragments to directly
cross-link surface receptors. Providing that the antibody-coated microsphere was not
internalised following binding to the macrophage surface and was not able to co-
cross-link other membrane receptors or FcR, this system might represent an ideal
method for investigating changes in localisation of signalling molecules within the
macrophage. This approach has been used previously with great success, especially
with regard to integrin function. Miyamoto and colleagues examined cytoskeletal
responses to integrin ligation in fibroblasts using microspheres coated with integrin
ligands (Miyamoto, Teramoto et ah, 1995). They successfully elucidated signalling
molecules and cytoskeletal proteins recruited at different stages of the adhesion
response to integrin ligation. Furthermore, Green et al used different sizes of
microspheres coated with anti-L-selectin antibodies to investigate levels of selectin
ligation required for neutrophil activation (Green, Pearson et ah, 2003). These
studies provide precedence for use of antibody-coated microspheres to successfully
investigate spatial and temporal changes during the signalling response to receptor
ligation.
Actin
In order to investigate signalling in response to CD44 cross-linking, I first had to
select a number of signalling molecules known to be associated with CD44 or the
phagocytic process. The cytoskeleton consists of actin filaments, which determine
cell morphology, motility and endocytic capability (Yin & Hartwig, 1988).
Phagocytosis of apoptotic cells is also an actin-dependent process; during
phagocytosis the macrophage forms processes to surround an apoptotic cell, leading
to actin-dependent internalisation of the apoptotic cell (Aderem & Underhill, 1999).
Therefore, it was possible that the dynamics of actin remodelling were altered in




Talin is a 270 kDa actin-binding protein that localizes to focal adhesions. Two talin
molecules bind to form a homodimer with an antiparallel orientation. The N-
terminal of talin can bind both phospholipids and focal adhesion kinase (FAK), while
the C-terminal can bind actin and vinculin (Hemmings, Rees et al., 1996;Borowsky
& Hynes, 1998). Talin can also bind the beta tails of integrin molecules, a step that
is essential for integrin activation (Sampath, Gallagher et al., 1998). Moreover, talin
is essential for formation of focal adhesions, as knocking out talin genes in
embryonic stem cells abolishes focal adhesion and stress fibre formation (Priddle,
Hemmings et al., 1998).
Vinculin
Vinculin is a 117 kDa protein that also localizes to focal adhesions. The globular
head region of vinculin (Vh) contains the binding sites for talin and alpha-actinin
whereas its rod-like tail domain (Vt) contains the binding sites for F-actin and
paxillin (Steimle, Hoffert et al., 1999). In its resting state, vinculin is held in a closed
conformation through interactions between its head (Vh) and tail (Vt) domains.
Vinculin is an essential regulator of both cell-cell (cadherin-mediated) and cell-
matrix (integrin-talin-mediated focal adhesions) junctions, and it anchors these
adhesion complexes to the actin cytoskeleton by binding to talin in integrin
complexes or to actin in cadherin junctions (Goldmann, Kaufmann et al., 1992)
Rac2
Rac2 belongs to the Rho family GTPases, which consists of small (approximately
21000 molecular weight) GTP-binding proteins. GTPases have intrinsic ability to
catalyse the conversion of bound GTP to GDP. When bound to GTP, Rho proteins
are active and can interact with their downstream targets. Once bound to GDP, they
undergo conformational change resulting in a reduced affinity for their targets and
they become inactive (figure 4.1). Cycling of GTPases between active and inactive
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conformations is mediated by guanine nucleotide exchange factors (GEFs) and
GTPase activating proteins (GAPs). GEFs promote exchange of GDP for GTP
leading to activation of GTPases (Schmidt, Diriong et al., 2002). GAPs, in contrast,
stimulate the intrinsic GTPase activity, resulting in inactivation (Moon & Zheng,
2003). Racl and Rac2 are 92% identical and have similar GTP binding and GTP
hydrolysis motifs to other members of the Ras superfamily. Racl is expressed in a
wide range of tissue types; however Rac2 is primarily expressed in myeloid cells
(Didsbury, Weber et ah, 1989).
One GEF in particular has been associated with CD44 signalling. Tiaml was first
identified while using proviral tagging to identify genes that confer invasive
properties upon tumour cells (Habets, Scholtes et ah, 1994). Tiaml can activate
Racl in vitro as well as in vivo and it is this property, which leads to induction of an
oncogenic phenotype in NIH3T3 cells (Michiels, Habets et ah, 1995;van Leeuwen,
van der Kammen et ah, 1995). Tiaml has also been shown to link CD44 to Racl
signalling in breast cancer cells leading to increased motility of tumour cells
(Bourguignon, Zhu, Shao, & Chen, 2000). However, preliminary experiments within
our group have failed to show any link between Tiaml and CD44 augmented




Activation and inhibition ofRlio family GTPases.
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Furthermore, GTPases have the ability to regulate ezrin, radixin, moesin family
(ERM) proteins. Rac and ERM proteins are both required for membrane ruffling and
lamellipodium extension. They are also important in cell migration and for the
production of reactive oxygen species in phagocytes (Ridley, 2001 ;Bretscher,
Edwards et ah, 2002).
PKC
Protein Kinase C (PKC) is a kinase that exists in a number of isoforms with different
tissue specificity and is involved in a number of signalling pathways. PKC is
activated by diacylglycerol, derived from cleavage of membrane lipids (Blumberg,
1988). Activation of ERM proteins requires phosphorylation of a threonine residue,
which stabilises the proteins structure and prevents it folding into an inactive
conformation (Gautreau, Louvard et ah, 2000;Nakamura, Amieva et ah, 1995). In
the case of ezrin, several kinases have been found to have the ability to
phosphorylate this threonine residue including PKCa, PKC0, Cdk5 and MRCK (Ng,
Parsons et ah, 2001;Matsui, Maeda et ah, 1998;Nakamura, Yamashita et ah, 2002).
In human melanoma cells, PKC has been shown to regulate the association of CD44
with ezrin. Once PKC is activated it dephosphorylates Ser325 in the cytoplasmic tail
of CD44 and phosphorylates Ser291. This change in phosphorylation can alter the
ability of the melanoma cell to migrate as dominant negative mutants (Ser291—►
Ala291) lose the ability to undergo chemotaxis (Legg, Lewis et ah, 2002).
ERK 1/2
The extracellular signal-related protein kinases 1/2 (ERK1/2, p44/42) are one of the
groups of MAP kinases found in mammalian cells. They are activated by dual
phosphorylation of the tripeptide motif Thr-Glu-Tyr by MAP kinase kinases MKK1
and MKK2. MAP kinase kinases are activated by MAP kinase kinase kinases
(MKKK), which can themselves be activated by a number of different upstream
signals. One of these can be mediated through small G proteins - ERK can be
activated by Ras through the Raf family ofMKKK (summarised in figure 4.2).
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FIGURE 4.2
A schematic diagram of the signallingpathway leading to ERK activation.
ERK1/2 have been shown to play a large number of roles within the immune
response. ERK can regulate production of TNFa, as murine macrophages treated
with the ERK inhibitor PD98059 are deficient in TNFa production when exposed to
LPS (Dumitru, Ceci et al., 2000). Interestingly, hyaluronan binding to CD44 has
been shown to induce production ofTNFa (Noble, Lake et ah, 1993).
Ezrin
Ezrin belongs to the ERM (ezrin, radixin, moesin) family of proteins, which are
enriched in membrane structures such as microvilli, membrane ruffles and cell-cell
junctions (Amieva & Furthmayr, 1995;Berryman, Franck et ah, 1993). ERM family
proteins have been shown to link integral membrane proteins to the cortical actin
cytoskeleton (Tsukita & Yonemura, 1999). All three ERM proteins are known to
bind CD44, providing a link between CD44 and the actin cytoskeleton in both BHK
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cells and mouse fibroblasts (Tsukita, Oishi et al., 1994). In leukocytes, moesin has
the highest level of expression, whereas there are little or no detectable levels of
radixin. However, ezrin has been linked to potent phagocytic activity of melanoma
cells, which makes it an ideal candidate for linking to CD44 in this system (Lugini,
Lozupone et al., 2003).
RESULTS & DISCUSSION
CD44 surface expression
To investigate whether ligation of CD44 on the macrophages surface results in a
major change in surface expression as determined by immunofluorescent
microscopy, human monocyte-derived macrophages were treated at both 4°C and
37°C with CD44 mAb, 5A4 for 1 hour. The macrophages were then fixed,
permeabilised and stained with goat anti-mouse Alexa Fluor 488. The distribution of
CD44 on macrophages incubated at 37°C was then compared to that observed for
those incubated at 4°C, which should not have undergone any changes in expression
or distribution of receptors due to the inhibition of lateral membrane movement or
receptor internalisation at low temperature.
Immunofluorescence microscopy analysis suggested that ligation of CD44 on the
macrophage surface induces the membrane of the macrophage to undergo ruffling
(figure 4.3). These ruffles appear rich in CD44 and stain very brightly. In contrast,
at 4°C the macrophage surface is more uniformly stained with very little ruffling and
the cells adopting a more rounded morphology.
However, these results were very difficult to quantify despite being representative of
repeated observations. Moreover, using standard immunofluorescence microscopy
there were limitations as to how accurately macrophages could be photographed at
the same cross-section of the cell. To address this problem, con-focal microscopy
was carried out using macrophages treated and fixed as previously described. This
allowed cross-sections through macrophages to be photographed at 2pm optical
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sections (supplementary figures provided on CD-ROM). This con-focal
microscopy analysis revealed a similar pattern of staining as described above, even




Macrophage expression ofCD44 after 60 min at 4°C or 37°C
Macrophages were treated with either mouse IgGl negative control (control) or 5A4 for 60min.
Cells were incubated at 4°C or 37°C as indicated. After gentle washing, macrophages were fixed
with PBS without Ca2+/Mg2+ containing 3% paraformaldehyde for 20min at room temperature,
washed and permeabilised with 0.1% Triton X-100 in PBS without Ca2+/Mg2+ for 4min at room
temperature. After further washing, macrophages were stained with goat anti-mouse alexa fluor
488 for 30min on ice in the dark.
Photographs are representative of three experiments.
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However, it would be necessary to undertake some level of quantification to
confirm these alterations. This would involve using computational analysis to
compare untreated and CD44 treated macrophages. There are a number of
programmes available that would allow this to be carried out, for example the
UTHSCSA Image Tool. In order to investigate changes between untreated and
CD44 treated macrophages, it would be essential to define what a "normal"
macrophage looked like. A number of untreated macrophages could be selected and
compared by measuring their lengths, areas and diameters to give an idea of an
average cell. The same could then be done for CD44 treated macrophages and the
results compared. Areas of bright staining could also be quantified by setting a
threshold to define normal staining from brightly stained areas, allowing areas of
bright staining to be counted and compared. This threshold would have to be set at a
high enough level to eliminate baseline staining and generate a manageable number
of results. However, it would be important to maintain a fair comparison between
untreated and CD44 treated macrophages. To do this, untreated and CD44 treated
macrophages from each donor would have to be compared separately in terms of
shape and staining. Moreover, a large number of macrophages from each donor
would have to be isolated, possibly using MACS (magnetic cell sorting) to select a
pure population of macrophages. These cells can then be analysed using
immunofluorescence microscopy as before to give a clearer indication of any
changes that occur in response to CD44 treatment.
CD44 surface expression timecourse
To further characterise these changes in membrane expression of CD44, I examined
the distribution of CD44 in a time-course experiment. In these experiments,
macrophages were incubated with 5A4 at both 4°C and 37°C for 0, 15, 30, 45 and
60min. They were then fixed, permeabilised and stained as before to provide a
temporal analysis ofCD44 receptor distribution.
From these experiments, it was possible to observe that the macrophage begins to
undergo membrane changes between 0 and 15 min with ruffles forming within 15
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minutes. As noted above, these ruffles were found to be rich in CD44. However,




45 min 60 min
FIGURE 4.4a
The surface expression ofCD44 on macrophages at 4°C.
Macrophages were incubated with either mouse IgGl negative control or 5A4 for the length of
time indicated at 4°C. After gentle washing, the macrophages were fixed with PBS without
Ca2+/Mg2+ containing 3% paraformaldehyde for 20min at room temperature, washed and
permeabilised with 0.1% Triton X-100 in PBS without Ca2+/Mg2+ for 4min at room temperature.
After further washing, macrophages were stained with goat anti-mouse alexa fluor 488 for 30min
on ice in the dark.






45 min 60 min
FIGURE 4.4b
The surface expression ofCD44 on macrophages at 37°C.
Macrophages were incubated with either mouse Ig negative control or 5A4 for the length of time
indicated at 37°C. After gentle washing, the macrophages were fixed with PBS without Ca27Mg2*
containing 3% paraformaldehyde for 20min at room temperature, washed and permeabilised with
0.1% Triton X-100 in PBS without Ca2+/Mg2+ for 4min at room temperature. After further
washing, macrophages were stained with goat anti-mouse alexa fluor 488 for 30min on ice in the
dark.
Photographs are representative of three experiments.
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37°C or 4°C (figure 4.4b), making it difficult to determine whether or not CD44
redistributes at 37°C or not. It is possible that any redistribution that occurs may be
too subtle to be observed using the indirect immunofluorescence microscopy
techniques used here and with the resolution of the microscope available.
During these studies, I observed that CD44-treated macrophages appeared to retract
slightly in comparison to control macrophages (figures 4.4a and b) giving the cells a
more "stellate" appearance. Again, although this change in morphology was
repeatedly observed, quantification would be required to determine how
representative the cellular retraction is within the CD44-treated macrophage
populations.
Migration of macrophages in response to treatment with F(ab')2
fragments
As demonstrated in chapter 3, binding of intact CD44 mAb to macrophages resulted
in an impaired ability to migrate into a mechanical "wound" created in a monolayer
of macrophages. To examine whether this effect required only CD44 antibody
FIGURE 4.5
Macrophage migration in response to anti-CD44 F(ab')2 fragments
Macrophages were incubated with either IMDM alone (black line),5A4 (light grey line) or anti-
CD44 f(ab')2 fragments (dark grey line) for 15min, washed and the monolayer wounded using a
pastette. Migration was recorded over a 20 hour period. (n=3)
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binding interactions or whether an Fc receptor mediated component was involved,
macrophages were treated with either IMDM alone, intact anti-CD44 (5A4) antibody
or anti-CD44 F(ab')2 fragments and their ability to migrate into a wound in the
monolayer recorded using time-lapse microscopy.
Over the 9 hour time period analysed in these experiments, it was clear that
preincubation of macrophages with intact CD44 antibody or F(ab')2 fragments
resulted in a reduction in migration of macrophages into a wound (figure 4.5 and
movies provided on CD-ROM). However, the reduction in migration following
binding of CD44 F(ab')2 fragments was much smaller in comparison to the intact
antibody, suggesting that antibody - Fc interactions with FcR may be responsible for
the reduced migration of macrophages. These findings would need to be validated
by careful repetition of these experiments. In particular, the rates of migration in
individual experiments appeared to be dependent upon the extent of confluency of
macrophage monolayers (data not shown) with more confluent monolayers resulting
in increased migration.
Microsphere assay to investigate macrophage signalling
In view of the fact that soluble antibody induced "cross-linking" did not noticeably
alter receptor distribution, I next sought a method for inducing specific receptor
engagement that would allow localisation of signalling molecules within the
macrophage. I therefore decided to use antibody-coated microspheres as a method
for inducing local "clustering" of receptors. I envisaged that the microspheres could
be used to "cross-link" CD44 on the macrophage surface, without being internalised,
giving an ideal system to visualise possible molecular mechanisms engaged at the
site ofmicrosphere binding. Initially, I used 6pm streptavidin-coated microspheres
that had been pre-incubated with biotinylated anti-CD44 F(ab')2 fragments. 6pm
microspheres were chosen as they are roughly equivalent to the dimensions of an
apoptotic neutrophil. Furthermore, other studies using ligand-coated microspheres to
examine neutrophil function found that 6pm microspheres were able to induce
functional responses whereas 1pm microspheres were not (Walker, Ruchaud-
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Flow cytometric analysis ofmicrosphere binding to macrophages
Macrophages were incubated with anti-CD44 F(ab')2 coated microspheres for 30min at 37°C.
After gentle washing, levels of microsphere binding to macrophages were assessed using flow
cytometry.
Sparagano et al., 2004). In addition, microspheres of this size would be more readily
visualised by light microscopy. I assessed the extent of binding of these
microspheres to macrophages using both flow cytometry and microscopy.
Association of fluorescent antibody-conjugated microspheres to macrophages was
clearly demonstrated using flow cytometry (figure 4.6) and furthermore allowed for
discrimination between macrophages that had different numbers of microspheres
associated.
One problem with flow cytometry is that it is difficult to distinguish bound versus
internalised particles. Using phase-contrast microscopy binding of the antibody-
conjugated microspheres bound to macrophages was clearly seen (figure 4.7).
Initially, I used IgGl-conjugated control microspheres to investigate non-specific
association, which although there was some binding to the macrophage surface, the
extent of binding was lower than that seen for the CD44-conjugated microsphere.
However, it remained possible that binding of the IgGl control was due to Fc
receptors on the macrophage, I therefore decided to use anti-VCAM-1 F(ab')2
fragments bound to streptavidin-coated microspheres. The lack of an Fc component
on antibodies recognising either CD44 or VCAM-1 would eliminate any
involvement of Fc receptor-mediated effects. Furthermore, since VCAM-1 is not
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Binding ofantibody coatedmicrospheres to macrophages
Macrophages were incubated with microspheres conjugated to either a control antibody (mouse
IgGl) or anti-CD44 F(ab')2 fragments for 30min at 37°C, washed with PBS without Ca2+/Mg2+ and
mounted on microscope slides.
Photographs are representative of three experiments.
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Microsphere internalisation
I considered it important that the antibody-coated microsphere used in these
experiments cross-linked cell surface CD44. It was therefore essential to be certain
that the microspheres were not internalised by macrophages. I incubated
macrophages with either anti-CD44 or anti-VCAM F(ab')2 coated microspheres for
30min, at a ratio of approximately 1 microsphere per macrophage, and then fixed
them. The slides were then stained with goat anti-mouse-IgG-FITC to determine
whether or not the microspheres had been internalised. Since internalised
microspheres should not be stained, any visible FITC fluorescence would indicate
that the microspheres remained on the surface of the macrophage and thus accessible
for antibody binding. In contrast, if the microspheres were internalised then little or
no staining would occur.
Using immunofluorescence microscopy, FITC stained microspheres were clearly
observed with very little background staining (figure 4.8a). These data suggest that
all of the microspheres are bound to the macrophage surface and not internalised. To
confirm that the microspheres were not being internalised, con-focal microscopy was
used, since this would allow serial optical sections (at 2 pM) to be scanned through
the cell body. Using this combination of both phase-contrast and con-focal
fluorescent microscopy, microspheres could be clearly observed to be bound to the




Lack of internalisation of anti-CD44 F(ab')2 coated microspheres by macrophages.
Macrophages were incubated with either IMDM alone (control), anti-VCAM F(ab')2 fragment
conjugated microspheres (VCAM) or anti-CD44 F(ab')2 fragment conjugated microspheres (CD44)
for 30min at 37°C. After washing, macrophages were fixed with PBS without Ca2+/Mg2+
containing 3% paraformaldehyde for 20min at room temperature and then incubated with GAM-
FITC for 30min on ice, washed and mounted on microscope slides. Photographs are representative
of three experiments.
The two lower figures are taken from con-focal microscopy analysis of microsphere binding. They
were prepared and stained as described in figures 4.12 and 4.16.
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Interestingly, although the microspheres appeared to be "cupped" by the surface
membrane of the macrophage, there was no evidence to suggest that the
microspheres were being internalised in anyway in con-focal analysis (fig 4.8b).
Macrophage signalling in response to F(ab')2 coated microspheres
Having demonstrated that the anti-CD44 F(ab')2 coated microspheres had the ability
to bind to CD44 without being internalised, it was possible to use them to investigate
localisation of signalling molecules within the macrophage. Either CD44 or
VCAM1-coated microspheres were bound to the macrophage surface and then the
cells fixed and stained for a number of intracellular signalling molecules that the
current literature had highlighted as being possibly involved in CD44 signalling.
Actin
Given the critical role of actin in macrophage adhesion and phagocytosis, I decided
to investigate the distribution of actin. Following binding of CD44 F(ab')2 coated
microspheres to macrophages, actin was found to have a "speckled" appearance
(figure 4.9), probably representing bundles of actin filaments within the
cytoskeleton. In unstimulated macrophages, these are present throughout the cell.
However, in those macrophages incubated with CD44 F(ab')2 coated microspheres,
these actin structures appeared to be localised within the macrophage, often in
proximity to a microsphere. Although this was generally the case, there were
microspheres bound to some macrophages which had no actin bundles nearby. One
possibility is that this may be a consequence of microspheres being bound for
different lengths of time and that actin filament redistribution changes over time. In
order to address this possibility, I could do a timecourse allowing the microspheres to
bind for different periods of time, stain as normal and then compare differences in
filament distribution at different timepoints.
Talin & Vinculin
Given the changes in actin described above and that the principal CD44 ligand,
hyaluronan, has been shown to promote protein phosphorylation and focal adhesion




Localisation ofactin after cross-linking ofCD44 with F(ab')2 coatedmicrospheres.
Macrophages were incubated with either mouse Ig control, 1MDM alone, anti-VCAM F(ab')2
fragment conjugated microspheres (VCAM) or anti-CD44 F(ab')2 fragment conjugated
microspheres (CD44) for 30min at room temperature. Cells were then washed, fixed with PBS
without Ca2'/Mg2' containing 3% paraformaldehyde for 20min at room temperature and
permeabilised with 0.1% Triton X-100 in PBS without Ca2+/Mg2+ for 4min at room temperature.
After further washing, macrophages were incubated with with rhodamine phalloidin 488 for 30min
on ice. After washing, macrophages were mounted on slides and analysed using
immunofluorescent microscopy.
These photographs are representative of three experiments.
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FIGURE 4.10
Localisation oftalin to the macrophage membrane in response to cross-linking ofCD44 by
F(ab')2 coatedmicrospheres.
Macrophages were incubated with either mouse Ig control, IMDM alone, anti-VCAM F(ab')2
fragment conjugated microspheres (VCAM) or anti-CD44 F(ab')2 fragment conjugated
microspheres (CD44) for 30min at room temperature. Cells were then washed, fixed with PBS
without Ca2+/Mg2+ containing 3% paraformaldehyde for 20min at room temperature, and
permeabilised with 0.1% Triton X-100 in PBS without Ca2+/Mg2+ for 4min at room temperature
before incubation with an anti-talin antibody for 30min on ice. After further washing, the
macrophages were stained with a goat anti-mouse (Fc specific) secondary antibody for 30min on
ice. After washing, macrophages were mounted on slides and analysed using immunofluorescent
microscopy.
These photographs are representative of three experiments.
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neutrophil motility (Hakansson L., Hallgren R. et al., 1980), I decided it would be
interesting to investigate the possible involvement of talin and vinculin in signalling
through CD44.
Microsphere induced cross-linking of CD44 on the macrophage surface was
observed to lead to bright staining of talin at the region where the microsphere was
bound to the macrophage (figure 4.10). This observation raises the possibility that
talin may be specifically recruited following CD44 cross-linking. Although in this
experiment background staining levels were quite high, it is still possible to observe
definite changes in the staining present in macrophages with anti-CD44 microspheres
bound to them. In contrast, it was not possible to see changes in vinculin distribution
after cross-linking of CD44 (figure 4.11). The staining pattern for vinculin in
untreated macrophages and macrophages treated with anti-VCAM microspheres was
similar to that observed in macrophages treated with anti-CD44 microspheres.
These observations are interesting as talin has been shown to link to other molecules
through vinculin. Our results suggest that this is not the case during the macrophage
response to anti-CD44 microspheres. Talin can also link to actin directly, which my
results suggest are involved in the macrophage response to anti-CD44 microspheres.
However, one possibility is that recruitment and activation of vinculin occurs after
recruitment of talin and thus, requires a longer period of time than that used in these
assays. In order to investigate this further, it would be necessary to incubate the
macrophages with anti-CD44 microspheres for differing lengths of time prior to
examining talin and vinculin distribution. Another approach would be to investigate
other signalling molecules known to interact with vinculin, such as paxillin,
vasodilator-stimulated phosphoprotein (VASP) and actin-related protein 2/3
(Arp2/3). If these molecules were shown to be redistributed then this may support




Cross-linking ofCD44 on macrophage surface does not result in changes in Vinculin
distribution.
Macrophages were incubated with either mouse Ig control, IMDM alone, anti-VCAM F(ab')2
fragment conjugated microspheres (VCAM) or anti-CD44 F(ab')2 fragment conjugated
microspheres (CD44) for 30min at room temperature. Cells were then washed, fixed with PBS
without Ca2+/Mg2+ containing 3% paraformaldehyde for 20min at room temperature and
permeabilised with 0.1% Triton X-100 in PBS without Ca2+/Mg2+ for 4min at room temperature,
before incubation with an anti-vinculin antibody for 30min on ice. After further washing, the
macrophages were stained with a goat anti-mouse (Fc specific) secondary antibody for 30min on
ice. After washing, macrophages were mounted on slides and analysed using immunofluorescent
microscopy.
These photographs are representative of three experiments.
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Rac2
Previous work within our group has suggested that Rac2 might have a role in CD44
augmented phagocytosis, therefore I decided to investigate the involvement of Rac2
further using the CD44 F(ab')2 coated microspheres. Staining of CD44 stimulated
macrophages for Rac2 showed FITC localisation in the membrane under and
surrounding the microsphere (figure 4.12). This effect was not observed with either
VCAM F(ab')2 coated microspheres or in untreated macrophages. These data
strongly support the suggestion that CD44 cross-linking leads to Rac2 activation and
redistribution to the region ofCD44 cross-linking.
Protein Kinase C
Following crosslinking of CD44 on the macrophage surface, PKC relocation to the
area surrounding the microsphere was observed (figure 4.13). In control
macrophages, PKC staining was observed throughout the cytoplasm, in comparison
to macrophages incubated with the anti-CD44 microspheres, which have much
brighter staining near to the microsphere. These observations suggest that PKC is
co-localising with CD44 in response to microsphere binding.
It would have been interesting to develop these studies using other approaches. One
alternative would have been to look at specific phosphorylation events in
macrophages following cross-linking of CD44. To do this, phospho-specific e.g
phospho-tyrosine, phospho-threonine or phospho-serine specific antibodies could
have been used to identify localisation of phosphorylated proteins in macrophages
with microspheres bound. However, although these antibodies are available,
experience within the laboratory suggests that they exhibit high levels of non-specific
binding, which could cause difficulties in interpretation of staining patterns.
Mouse Ig Control Control
CD44 CD44
FIGURE 4.12
Rac2 localisation to the macrophage surface upon cross-linking ofCD44
Macrophages were incubated with either mouse Ig control, IMDM alone, anti-VCAM F(ab')2
fragment conjugated microspheres (VCAM) or anti-CD44 F(ab')2 fragment conjugated
microspheres (CD44) for 30min at room temperature. Cells were then washed, fixed with PBS
without Ca2+/Mg2+ containing 3% paraformaldehyde for 20min at room temperature and
permeabilised with 0.1% Triton X-100 in PBS without Ca2+/Mg2+ for 4min at room temperature
before incubation with an anti-Rac2 antibody for 30min on ice. After further washing, the
macrophages were stained with goat anti-rabbit Alexa Fluor 488 for 30min on ice. After washing,
macrophages were mounted on slides and analysed using immunofluorescent microscopy. These
photographs are representative of three experiments.
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FIGURE 4.13
Changes in PKC distribution in response to CD44 cross-linking on the macrophage surface.
Macrophages were incubated with either mouse Ig control, IMDM alone, anti-VCAM F(ab')2
fragment conjugated microspheres (VCAM) or anti-CD44 F(ab')2 fragment conjugated
microspheres (CD44) for 30min at room temperature. Cells were then washed, fixed with PBS
without Ca2+/Mg2+ containing 3% paraformaldehyde for 20min at room temperature and
permeabilised before incubation with an anti-PKC antibody for 30min on ice. After further
washing, the macrophages were stained with a goat anti-mouse (Fc specific) secondary antibody
for 30min on ice. After washing, macrophages were mounted on slides and analysed using
immunofluorescent microscopy. These photographs are representative of three experiments.
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ERK
Next, to examine the link between the changes described above and downstream
signalling events, macrophage lysates were analysed for ERK 1/2 expression and
activation. Lysates were made from control and CD44 stimulated macrophages in
the presence and absence of PD98059, which inhibits activation of ERK. The lysates
were run on a gel and western blotting for both total and phosphorylated (activated)
ERK carried out.
The level of total ERK, both activated and unactivated in the samples was of a
similar level indicating that protein loading was the same in the different samples
(figure 4.14a). Although, the levels of phosphorylated ERK were clearly reduced in
response to PD treatment, there were no observable differences between control and
CD44-stimulated macrophages in terms of ERK phosphorylation. To investigate the
possibility that early or late activation of ERK had been missed, macrophage lysates
were made at differing time-points after treatment with anti-CD44 antibody. These
lysates were separated by SDS-PAGE, and western blotting used to determine levels
of total and phosphorylated ERK. The level of total ERK observed at each time-
point was similar as was the level of phosphorylated ERK, suggesting that ERK
activation does not occur up to 60 minutes after stimulation ofmacrophages through
CD44 (figure 4.14b). Therefore, it seems very unlikely that ERK activation plays a
major role in CD44 augmented phagocytosis.
As an alternative approach, the effect of ERK inhibition upon CD44 augmented
phagocytosis was investigated. As before, control and CD44 treated macrophages
were treated with PD98059 for 15min prior to assessment of phagocytosis of
apoptotic neutrophils. As predicted from the biochemical analysis described above,
PD98059 treatment of macrophages had no effect upon either control or CD44
augmented phagocytosis of apoptotic neutrophils (figure 4.15a). This data supports
my observation that CD44 stimulated macrophages have similar levels of activated
ERK to control macrophages and that ERK does not contribute to the phagocytic
process.
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In view ofmy earlier data relating to the effects ofCD44 upon migration and the
clear role of ERK in some cellular migration events, I decided to examine the role or
ERK activation in macrophage migration. Time-lapse microscopy was carried out as
previously described. Control and CD44-treated macrophage migration was
compared to that in the presence of PD98059 (figure 4.15b). Migration of CD44-
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FIGURE 4.14
ERK1/2 expression and activation in response to CD44 stimulation
a. Macrophages lysates were made from macrophages incubated with IMDM alone or anti CD44
antibody in the presence and absence ofPD98059. The lysates were separated using SDS-PAGE
and western blotted for levels of total and phosphorylated ERK.
b. Lysates were made from macrophages incubated with either IMDM alone or CD44-antibody for
differing lengths of time. The lysates were then separated by SDS-PAGE and western blotted for
levels of total and phosphorylated ERK.
These gels are representative of three experiments.
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treated macrophages was once again reduced when compared to untreated
macrophages. However, addition of PD98059 reduced the rate ofmigration in these
macrophages even further, suggesting that ERK activity may contribute to migration
of CD44-treated macrophages. These results imply that although ERK has a role in
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Analysis ofthe role ofERK in signalling in response to CD44 cross-linking.
a. Macrophages were incubated with IMDM alone or anti-CD44 antibody in the presence or
absence of PD98059 for 15 min, washed,and incubated with a suspension of aged neutrophils for
60min. After treatment with trypsin/EDTA, the percentage of macrophage phagocytosis was
determined using a flow cytometric assay. (n=3)
b. Macrophages were incubated with either IMDM alone (black diamonds), IMDM with PD98059
(grey triangles), anti-CD44 antibody (grey squares) or anti-CD44 antibody with PD98059 (grey
crosses) for 15min, washed and the monolayer wounded using a pastette. Migration was recorded
over a 20 hour period. (n=3)
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Ezrin
All the changes described above led me to consider whether ezrin was recruited to
sites of CD44 cross-linking. I observed that binding of CD44 F(ab')2 coated
microspheres to a macrophage resulted in recruitment of ezrin to the area of the
macrophage surface where the microsphere was bound (figure 4.16). This was
indicated by intense staining for ezrin in the membrane both under and near the
microsphere. This contrasted with the staining pattern for ezrin within control
macrophages, which was more uniform in appearance. For untreated controls, ezrin
was localised under the plasma membrane. Together, these observations suggest that
these changes may drive ezrin redistribution and that these alterations play a role in





Localisation ofezrin to areas ofcross-linking ofCD44 on the macrophage surface
Macrophages were incubated with either mouse Ig control, IMDM alone, anti-VCAM F(ab')2
fragment conjugated microspheres (VCAM) or anti-CD44 F(ab')2 fragment conjugated
microspheres (CD44) for 30min at room temperature. Cells were then washed, fixed with PBS
without Ca2+/Mg2+ containing 3% paraformaldehyde for 20min at room temperature and
permeabilised before incubation with an anti-ezrin antibody for 30min on ice. After further
washing, the macrophages were stained with a goat anti-mouse (Fc specific) secondary antibody
for 30min on ice. After washing, macrophages were mounted on slides and analysed using
immunofluorescent microscopy.
These photographs are representative of three experiments.
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SUMMARY
In early sections of this chapter, it was shown that augmentation of macrophage
phagocytosis of apoptotic neutrophils in response to CD44 cross-linking was not a
result of redistribution of CD44 molecules. These observations suggested that
signalling within the macrophage might contribute to the observed change in
phagocytic capacity. To investigate this possibility an assay was developed using
anti-CD44 F(ab')2 fragments conjugated to a 6pm microsphere. The microsphere
was used as a cross-linker of CD44, which was not internalised by the macrophage.
Imaging macrophage responses to cross-linking of CD44 by immunofluorescent
microscopy, allowed redistribution of potential components of a CD44-mediated
signalling cascade to be investigated. The data presented in this chapter supports a
role for actin, ezrin, PKC, Rac2 and talin as potential intermediates involved in
augmentation of macrophage phagocytic capacity for apoptotic neutrophils. In
contrast, these data suggest that vinculin may not be involved. Moreover, analysis of
ERK expression and its function in phagocytosis and migration suggested that
although it may have a role in migration, it is not involved in CD44 augmented
phagocytosis.
Chapter 5
CONCLUSIONS & FUTURE DIRECTIONS
115
Inadequate clearance of apoptotic cells by macrophages has been shown to contribute
to tissue damage and prevent resolution of the inflammatory response, resulting in a
variety of chronic diseases. The macrophages ability to phagocytose apoptotic
neutrophils can be influenced in a wide range of ways including interactions with
soluble mediators or extracellular matrix molecules. One such way is ligation of the
hyaluronan receptor, CD44, on the surface of monocyte-derived macrophages.
Crosslinking of CD44 by bivalent antibody on the macrophage surface results in an
increased capacity for phagocytosis of apoptotic neutrophils. This augmentation was
specific for apoptotic neutrophils, suggesting that CD44 has the potential to regulate
clearance of apoptotic neutrophils during the resolution of an inflammatory response.
The data presented here suggests that macrophage CD44 ligation by antibody results
in augmentation of macrophage phagocytosis, which peaks at 60 minutes. The
antibody-induced crosslinking of macrophage CD44 resulted in a long-lived change
in macrophage behaviour, which lasted up to 24 hours and possibly longer. CD44
antibody augmentation of phagocytosis was reduced in the absence of divalent
cations but not inhibited to as great an extent as baseline phagocytosis. This
suggested that the observed CD44/antibody effect consisted of two components - a
cation-independent component and a cation-dependent component. Further
investigation of the cation-independent component was carried out using a panel of
antibodies and ligands known to exert their effects in the absence of cations.
Interestingly, an antibody against CD32 (FcyRII) was shown to reduce CD44
augmented phagocytosis entirely in the absence of divalent cations. Experiments
blocking CD32 on macrophages or apoptotic neutrophils indicated that it was CD32
on the apoptotic neutrophil that was playing a role in CD44-antibody mediated
augmented phagocytosis. These observations suggest that the CD32 on the apoptotic
neutrophil was binding the anti-CD44 antibody, 5A4, allowing it to act as a bridge
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between the apoptotic neutrophil and the macrophage. It also highlighted the
need to use F(ab')2 fragments when carrying out studies of the effects of receptor
cross-linking.
The long-lived nature of CD44 antibody-mediated augmentation of phagocytosis
would be consistent with the augmentation being the result of changes in surface
distribution of CD44, as opposed to generation of an intracellular signal. However,
analysis of surface expression and distribution of CD44 on untreated and CD44-
treated macrophages by immunofluorescence microscopy did not appear to support
this hypothesis. Therefore, I decided to investigate the possibility of a intracellular
signal using anti-CD44 F(ab')2 conjugated microspheres. This method may more
closely approximate CD44 cross-linking induced by interaction with ligand. Data
presented in this thesis demonstrates that binding of these microspheres to the
macrophage provided one method for investigating changes in distribution of
cytoskeletal and signalling molecules within the macrophage. In response to CD44
cross-linking, changes in actin, ezrin, talin, PKC and Rac2 distribution were
observed, highlighting the possibility that they were contributing to CD44 augmented
phagocytosis.
These studies provide an insight into possible signalling mechanisms that might
contribute to CD44 augmented macrophage phagocytosis of apoptotic neutrophils.
Moreover, they form a basis for further work to clarify the signalling mechanisms
further and determine their role in augmented phagocytosis. It would be useful to
examine further the molecules that my results have shown to localise with ligated
CD44. One possible way to investigate this would be using fluorescence resonance
energy transfer (FRET), which can be used to show molecules in close proximity to
each other. In FRET, a donor fluorophore can transfer energy to an acceptor
providing that they are in close enough proximity. This transfer of energy results in
changes in fluorescence of the fluorophores that can be detected using fluorescent
microscopy. In the absence of receptor associations, uniform staining would be
observed. In contract, when FRET occurs there would be patches of different
coloured areas where the two molecules of interest are interacting. FRET has
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already been used successfully to examine the interaction between ezrin and
CD44 (Legg 2002). Therefore, I would use this system further to investigate the
potential interaction between CD44 and the molecules studied using the antibody
coated microspheres. FRET does have limitations, however, and these would have to
taken into account when using this system. One consideration is controlling the
concentration of donor and acceptor fluorophores, as FRET occurs most easily when
there are several acceptor fluorophores surrounding a donor fluorophore thus surface
receptor density has an effect. Moreover, the size and structure of the molecules
being investigated would also have to be taken into consideration as the donor and
acceptor molecules have to be in close enough proximity to allow energy transfer to
occur. Therefore, it would be essential to know where the fluorophores are binding
on the molecules under investigation and to understand how this relates to their
possible interactions.
Another approach would be to use the "yeast two-hybrid" system. In this system,
fusion proteins are constructed containing regions of the molecules of interest, such
as Rac2, talin and PKC, and either the binding domain or the activatory domain of
the Gal4 gene. The generated fusion proteins can then be transfected into yeast cells
using sonication or chemical means. If these proteins interact then the p-
Galactosidase gene becomes transcriptionally activated resulting in a white to blue
colour change on X-gal medium. This technique could allow identification of
signalling molecules co-localising with the cytoplasmic tail of CD44. It would then
be important to examine their contribution to the regulation of phagocytosis of
apoptotic neutrophils. In order to investigate this, macrophages could be treated
with specific inhibitors of signalling molecules to determine whether inhibition has
an effect upon CD44-mediated augmented phagocytosis of apoptotic neutrophils.
For example, Cytochalasin B could be used to disrupt the actin cytoskeleton allowing
investigation of its effects upon CD44-augmented phagocytosis. It is likely that this
approach would result in loss of phagocytic ability but it would be interesting to
compare both control and CD44-treated macrophages under these conditions. An
alternative approach would be to use Clostridium difficile toxin B, which selectively
inactivates Rac activity. Research has shown Rac2 deficient murine macrophages
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have defects in phagocytosis (Yamauchi 2004); therefore it seems highly possible
that inhibition of Rac2 would reduce phagocytosis in both control and CD44-treated
macrophages.
Another useful approach would be to compare the expression of signalling proteins
in both control and CD44-treated macrophages. This would allow any differences in
expression between control and CD44-treated macrophages to be highlighted and
investigated further. Lysates from control and CD44-treated macrophages could be
used in a proteomics based protein expression array. Comparison of protein
expression profiles from the two samples would allow changes in protein expression
to be identified. These types of arrays can generate a large number of results in a
reasonably short period of time, however, they are also very expensive. The results
obtained would allow a more targeted approach to investigating the changes
stimulated in macrophages in response to CD44-treatment. As an alternative to a
protein array, western blotting could be used to compare expression of proteins in
macrophage lysates.
In addition, subsequent studies examining the mechanisms and roles of CD44-
augmented phagocytosis might use chimeric CD4/CD44 molecules, which could be
transfected into macrophages or use of the HIV-TAT protein transduction system to
introduce different domains of the CD44 cytoplasmic tail. There are already
constructs for two chimeric molecules available, both of which have CD4
extracellular domains with a CD44 intracellular domain. The difference is in the
transmembrane domain which is CD4 in one and CD44 in the other. This
transmembrane domain in CD44 contains cysteine residues which are known to be
important in membrane receptor association (Liu 1996). Transfection of
macrophages with these chimeric molecules would allow the role of this intracellular
region to be investigated. Moreover, tranfection of CD44 negative cells with CD44
mutants lacking phosphorylation sites, the transmembrane cysteine residues or ezrin
binding sites could be compared to wild type CD44 in a "gain of function" approach.
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Macrophages from CD44 knockout mice could also be studied in terms of
migration and function in inflammatory conditions. However, there may be
compensatory mechanisms which function in place of CD44 augmented
phagocytosis. An alternative approach would be to use siRNAs (small interfering
RNAs) to "knockdown" the expression of the CD44 gene. However, one
disadvantage with this approach would be that CD44 is expressed at a high level,
meaning that a good level of knockdown would be difficult to achieve.
Another consideration is the difficulties of using a primary cell line. Macrophages
are a very heterogeneous population meaning that there is considerable variation in
responses when comparing cells derived from different donors. Moreover, it can be
difficult getting enough cells for biochemical analysis from human donors and
isolation of macrophages can often go wrong. Therefore, it would be worth
considering use of a macrophage cell line such as J774 or THP1. However, these
have problems in themselves as they don't exhibit true macrophage behaviour.
It would also be beneficial to study the response of macrophages to binding
Hyaluronan (HA) instead of anti-CD44 antibody. One approach would be to allow
macrophages to adhere to a tissue culture dish coated with HA. These macrophages
could then be examined to see if augmented phagocytosis of apoptotic neutrophils
takes place in response to HA binding. In addition other potential ligands that bind
to CD44 such as Osteopontin could also be examined in this way. This approach
would assist in identifying the CD44 ligand that triggers augmented phagocytosis of
apoptotic neutrophils by binding to macrophage CD44. Expression of CD44
enhances the ability of fibroblasts to bind to HA and migrate (Peck 1996).
Moreover, the binding of HA is regulated during development of macrophages, as
monocytes are negative for HA binding whereas macrophages are positive (Culty
1994). As monocytes differentiate they change expression ofCD44 isoforms, which
may explain this alteration in ability to migrate and bind HA. Therefore, it would
been of interest to investigate the effect of different of isoforms on CD44 migration
and phagocytosis.
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In summary, work presented in this thesis has investigated the role of CD44 in
regulating macrophage phagocytosis of apoptotic cells. I have developed a novel
microsphere-based system for examining the consequences ofCD44 ligation in intact
macrophages that could be used to define the underlying mechanisms.
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Divalent cation-dependent and -independent augmentation of macrophage
phagocytosis of apoptotic neutrophils by CD44 antibody
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SUMMARY
Phagocytosis of apoptotic neutrophils by macrophages is required for resolution of an inflammatory
response. Removal of intact apoptotic neutrophils prevents the release of cytotoxic granules that would
otherwise cause tissue damage and may lead to development of fibrosis. Importantly, macrophage
phagocytosis of apoptotic neutrophils fails to induce release of proinflammatory mediators, consistent
with a 'safe' pathway for disposal of potentially harmful inflammatory cells. One pathway for increasing
phagocytosis of apoptotic cells to allow matching of tissue phagocyte capacity to apoptotic cell load in
vitro is via antibody-mediated cross-linking of CD44, providing a mechanism for limiting tissue damage
during resolution of inflammation. In this study, we have defined divalent cation-dependent and
-independent actions of the CD44 antibody. For the divalent cation-independent CD44 antibody effect,
we provide evidence that 'enabled' CD32 on the apoptotic neutrophil binds to intact CD44 antibody on
the macrophage surface. One implication is that macrophages can phagocytose apoptotic neutrophils
that are 'tethered' to the macrophage surface in a manner that is independent of defined apoptotic
mechanisms. These data also provide an explanation for the greater efficacy of intact CD44 antibody
when compared with F(ab')2 fragments.
Keywords apoptosis inflammation granulocyte macrophage phagocytosis
INTRODUCTION
icrophage phagocytosis of apoptotic neutrophils is an essential
Dcess in the normal resolution of an inflammatory response
. Although the physiological fate of neutrophils recruited to
lammatory sites is to undergo apoptosis, a process which
lintains membrane integrity and prevents the release of cyto-
dc granules, uncontrolled granule content release may contrib-
; to host tissue damage that is associated with development of
ease. Apoptotic neutrophils are therefore swiftly recognized
d then phagocytosed by local macrophages [1], Importantly,
;estion of apoptotic neutrophils by macrophages does not
mulate the release of proinflammatory mediators, thereby pro-
ling a mechanism for the safe disposal of potentially harmful
lammatory cells [2], However, if the rate of cell death by apo-
tsis exceeds the rate of clearance by macrophages, apoptotic
Is can undergo secondary necrosis, resulting in the release of
totoxic substances and damage to surrounding tissues. Indeed,
paired clearance of apoptotic neutrophils has been linked to
; development of inflammatory conditions such as acute
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respiratory distress syndrome (ARDS), fibrosing alveolitis, rheu¬
matoid arthritis and ulcerative colitis [3]. We have previously
identified CD44 as a potentially novel mechanism for rapidly
matching tissue phagocyte capacity to apoptotic cell load that is
distinct from soluble mediators or cell-cell interactions [4,5],
Ligation of CD44 may therefore determine the rate of apoptotic
neutrophil clearance by macrophages, a finding supported by
recent in vivo studies [6],
CD44 is a cell-surface glycoprotein expressed on many cell
types such as leucocytes, erythrocytes, fibroblasts and a number of
tumour cells [7]. It is heavily glycosylated and can be expressed as
a number of variant isoforms that may influence its function [8,9].
CD44 acts as a receptor for a variety of extracellular matrix mol¬
ecules including hyaluronan [10,11], flbronectin [12], fibrin [13]
and collagen [14,15], Many diverse functions have been attributed
to CD44 including involvement in cellular adhesion and migra¬
tion, activation and proliferation of lymphocytes, cytocidal activ¬
ity of natural killer (NK) cells and tumour metastasis [7], Binding
of bivalent CD44 monoclonal antibody (MoAb) has been shown
to augment macrophage phagocytosis of apoptotic neutrophils
[16],This effect appears to be specific for apoptotic neutrophils, as
phagocytosis of apoptotic lymphocytes or erythrocytes opsonized
with immunoglobulin was not augmented after MoAb-induced
cross-linking of macrophage CD44. Although the mechanism of
1004 Blackwell Publishing Ltd 447
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this effect remains to be fully characterized, CD44 MoAb
may promote redistribution of cell surface CD44 facilitating
phagocyte-apoptotic neutrophil interactions, or alternatively may
transduce a signal within the macrophage that alters phagocytic
capacity.
To characterize further the molecular basis for the augmen¬
tation of macrophage phagocytosis of apoptotic neutrophils fol¬
lowing CD44 MoAb binding, we have undertaken studies of the
effects of depletion of divalent cations. In previous studies using
microscopy-based assay systems, vigorous washing of adherent
macrophages was required to ensure removal of bound target
cells leading to detachment of macrophages (approximately 20%
of total cells [17]), an effect that was greater when divalent cation-
free conditions were used. We have therefore used a carefully val¬
idated technique for assessment of phagocytosis by flow cytome¬
try which obviates the need for washing,minimizing the impact of
cell losses that limit microscopy-based studies. In this report, we
have identified both divalent cation-independent and -dependent
components to the augmentation of phagocytosis following
CD44 MoAb binding to macrophages. For the divalent cation-
independent effect, blockade of CD32 on the apoptotic neutro¬
phil was found to be inhibitory. In support of this finding, F(ab')2
fragments of C.D44 MoAb fail to augment phagocytosis in a
cation-deplete environment. While these findings are somewhat
counter-intuitive, as both apoptotic and non-apoptotic neutro¬
phils express CD32, our recent studies have demonstrated that
CD32 is enabled on apoptotic neutrophils [18], In summary, aug¬
mentation of macrophage phagocytosis of apoptotic neutrophils
by CD44 MoAb involves two distinct effects: first, a direct effect
of cross-linking that is observed with F(ab')2 fragments of
CD44 MoAb that requires the presence of divalent cations; and
secondly, a divalent cation-independent tethering of apoptotic




All cell culture materials were from Invitrogen (Paisley, UK) and
other reagents were from Sigma (Poole, UK) unless stated other¬
wise. The following MoAb were used: 5A4 (anti-CD44, a kind
gift of Dr Graeme Dougherty, San Francisco, CA, USA) 1V3
(anti-CD32 Fab' fragments for function blocking studies;
Medarex, Annandale, NJ, USA), IVC7 (anti-CD36; CLB,
Amsterdam), 61D3 (anti-CD14 provided by Dr A. Devitt, Edin¬
burgh, UK), DFT-1 (anti-CD43, Serotec, Oxford. UK) and T29/33
(anti-CD45, DakoCytomation, Ely, UK). IgGl isotype control
MoAb was purchased from Beckman-Coulter, High Wycombe
(UK). All MoAb were used at saturating concentrations as deter¬
mined by indirect immunofluorescence techniques and flow cyto¬
metric analysis (FACSCaliber, Becton-Dickinson, Oxford, UK).
Purification of CD44 F(ab)2 antibodies
CD44 MoAb (5A4) was purified from hybridoma supernatant
using protein A affinity chromatography and pepsin digestion
(1% wt/wt) to generate F(ab')2 fragments. Residual intact anti¬
body was removed by three rounds of depletion using protein A
agarose affinity resin and the resulting F(ab')2 fragments were
analysed using sodium dodecyl sulphate-polyacrylamide gel elec¬
trophoresis (SDS-PAGE) under non-reducing conditions to con¬
firm purity. Indirect immunofluorescence analysis together with
flow cytometry was used to confirm that preparation of antibody
fragments did not compromise binding and that antibody frag¬
ments were used at saturating concentrations in other assays.
Cell isolation
Monocytes and neutrophils were isolated from human peripheral
blood by dextran sedimentation and discontinuous Percoll™
(Amersham Pharmacia, St Albans, UK) gradient centrifugation,
as described previously [19], Mononuclear cells were suspended
at 4 x 10'Vml in IMDEM and allowed to adhere to cell culture
plates during incubation at 37°C for 1 h. Non-adherent cells
(mostly lymphocytes) were removed and adherent cells were
washed three times in Hanks' balanced salt solution without Ca2+/
Mg2+. Adherent monocytes (approximately 90% CD14+) were
then cultured in Iscove's modification of Dulbecco's modified
Eagles' medium (IDMEM) containing 10% autologous serum for
5 days (monocyte-derived macrophages). Neutrophils were incu¬
bated at 2 x 107/ml with 22 pM 5-chloromethylfluorescein diace-
tate (CMFDA, Molecular Probes, Oregon, USA) at 37°C for
15 min. Labelled neutrophils were then cultured at 4 x 10f'/ml in
IDMEM with 10% autologous serum for 24 h, during which time
they underwent spontaneous apoptosis [1]. Apoptosis was
assessed either by microscopic inspection of cytocentrifuge prep¬
arations that had been stained with Diff-Quik™ (Baxter Health¬
care, Glasgow, UK) as per the manufacturer's protocol, or
alternatively assessed by dual immunofluorescence analysis using
annexinV-FITC in combination with propidium iodide to deter¬
mine the proportions of apoptotic and necrotic cells.
Phagocytosis of apoptotic neutrophils
Macrophage phagocytosis of apoptotic neutrophils was assessed
using a flow cytometric assay that has been validated carefully
to quantify internalization of apoptotic targets and not surface
binding [17], Monocyte-derived macrophages were washed with
IDMEM and incubated with CD44 MoAb diluted in IDMEM for
15 min at 37°C. Excess MoAb was removed and monocyte-
derived macrophages washed with 25 mM Hepes (pH 7-4) buff¬
ered saline (HBS) prior to adding 2 x 106 CMFDA-labelled apo¬
ptotic neutrophils in 0-5 ml of either IDMEM, chelex-treated
IDMEM (divalent cation-depleted) or HBS (divalent cation-free)
to each well for 60 min at 37°C. At the end of the assay, a solution
of 0-25% trypsin/1 mM EDTA was added to each well and the
cells incubated at 37°C for 15 min to detach all monocyte-derived
macrophages and remove non-internalized neutrophils. After a
further 15 min incubation on ice, the proportion of macrophages
that exhibited increased fluorescence (corresponding to phagocy¬
tosis of fluorescently labelled apoptotic neutrophils) was deter¬
mined by flow cytometry using a FACSCalibur analyser with post-
acquisition data analysis performed using CELLQUEST software
(Becton-Dickinson).
The effects of andbody/ligand inhibitors upon phagocytosis
Monocyte-derived macrophages were washed with HBS without
Ca2+/Mg2+ and incubated with CD44 MoAb diluted in HBS for
15 min at 37°C. Unbound antibody was washed off and monocyte-
derived macrophages were pretreated with saturating concentra¬
tions of putative inhibitory MoAb, or 1 mg/ml fucoidan (scaven¬
ger receptor inhibitor) or 50 U/ml heparin (heparan sulphate
proteoglycan inhibitor) prior to assessment of phagocytosis of
apoptotic neutrophils using the flow cytometric assay described
above.
© 2004 B hickwell Publishing Ltd, Clinical and Experimental Immunology, 138:447-452
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RESULTS
rcrophage phagocytosis of apoptotic neutrophils in divalent-
iion depleted conditions is augmented by CD44 MoAb
e requirement for the presence of either CaJ+ or Mgi+ for
hesion molecules to bind to their cognate ligands provides a
iple method for discrimination of potential receptor pathways
'olved in CD44 MoAb-augmented phagocytosis of apoptotic
utrophils. Control (untreated) or CD44 MoAb-treated mono-
:e-derived macrophages were challenged with apoptotic neu-
iphils in the presence or absence of divalent cations and the
rcentage of phagocytosis was determined (Fig. 1). For control
tnocyte-derived macrophages, the absence of divalent cations
BS) virtually eliminated phagocytosis. To confirm that this
ect was not due to a change in media conditions used, we deter-
ned the levels of phagocytosis in IDMEM that had been
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depleted specifically of divalent cations using chelex resin. Phago¬
cytosis in IDMEM was reduced from 34-2 + 6 to 6-6 ± 2 in chelex-
treated IDMEM. In contrast, CD44 MoAb-treated macrophage
phagocytosis of apoptotic neutrophils was still observed in the
absence of divalent cations, suggesting that CD44 MoAb binding
to monocyte derived macrophages may allow engagement of dis
tinct divalent cation-independent apoptotic cell recognition
mechanisms.
CD32 is required for CD44 MoAb augmented phagocytosis of
apoptotic neutrophils in the absence of divalent cations
To investigate the molecular basis for the CD44 MoAb aug¬
mented phagocytosis, we tested the effects of inhibitors of
putative divalent cation-independent recognition pathways.
Pretreatment with fucoidan (scavenger receptor inhibitor), hep¬
arin (heparan sulphate proteoglycan inhibitor), anti-CD36 or
anti-CD14 prior to incubation with apoptotic neutrophils under
divalent cation free conditions failed to inhibit the CD!! MoAb
augmented phagocytosis (Fig. 2). In contrast, CD32 MoAb com¬
pletely blocked CD!! MoAb augmented macrophage phagocy
tosis of apoptotic neutrophils in the absence of divalent cations
(Fig. 2). We did not observe inhibition of phagocytosis by
CD32 MoAb in the presence of divalent cations (data not shown).
Role of macrophage or apoptotic neutrophil CD32 in CD44
MoAb augmented phagocytosis
We next used MoAb preincubation strategies to determine
whothcr CD32 was required on the macrophage or the neutro
phil or both cell types. When macrophages were pretreated with
CD32 MoAb there was no inhibitory effect upon CD44
MoAb augmented phagocytosis in divalent cation free conditions
(Fig. 3). These data suggested that macrophage CD32 was not
mediating the divalent cation-independent CD44 MoAb-
augmented phagocytosis. In contrast, when neutrophils were
preincubated with CD32 MoAb, divalent cation-independent
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1. CD44 MoAb-augmented macrophage phagocytosis of apoptotic
itrophils in the presence and absence of divalent cations. Adherent
nan monocyte-derived macrophages were preincubated with either
'44 MoAb or medium alone for 15 min, washed and then incubated with
f-CFDA-labelled apoptotic neutrophils in the presence or absence of
alent cations as indicated for 60 min. (a) Typical flow cytometric profiles
nonstrating macrophage phagocytosis of fluorescent apoptotic neutra¬
ls are shown, (b) Phagocytosis of apoplotic neutrophils by macrophages
owing incubation with CD44 MoAb (grey bars) or IDMEM (black
s) was determined in duplicate samples by flow cytometry. Results are























Fig. 2. The effect of inhibitory antibodies and ligands upon CD44 MoAb-
augmented phagocytosis of apoptotic neutrophils by macrophages. Mac¬
rophages were incubated with CD44 MoAb (grey bars) or IDMEM (black
bars) for 15 min, washed and then incubated with the antibody/ligand
indicated for a further 15 min. Macrophages were incubated with apop¬
totic neutrophils for 60 min in the absence of divalent cations. Macrophage
phagocytosis of apoplotic neutrophils in duplicate samples was then deter
mined by flow cytometry. Results are expressed as mean ± s.e*m. of at least
three independent experiments.
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Fig. 3. Effect of pretreatment of macrophages or neutrophils with anti-
CD32 MoAb. Macrophages or apoptotic neutrophils were preincubated
with CD32 MoAb for 15 min and then washed with medium. Macrophages
were the incubated with either CD44 MoAb (grey bars) or IDMEM (black
bars) for 15 min. washed and incubated with apoptotic neutrophils in the
absence of divalent cations for 60 min. Macrophage phagocytosis of apo¬
ptotic neutrophils in duplicate samples was then determined for each
experiment by flow cytometry. Results shown are mean ± s.e.m. of at least
three independent experiments.
another receptor for IgG (CD16), apoptosis is associated with
>90% reduction in surface expression of this receptor [19] and
CD16 blockade does not prevent aggregated murine IgG
binding to apoptotic neutrophils [18]. These data imply that
CD32 on the apoptotic neutrophil is able to mediate binding to
intact CD44 MoAb bound to macrophages. Based upon these
results, one prediction would be that binding of antibody to any
highly expressed macrophage surface receptor would also aug¬
ment phagocytosis under divalent cation-free conditions.
Effects ofMoAb binding to other highly expressed macrophage
receptors
We next tested whether binding of MoAb to other highly
expressed surface receptors would also augment macrophage
phagocytosis of apoptotic neutrophils. Macrophages were incu¬
bated with MoAb of the same isotype (IgGl) against either
CD43, CD44 or CD45, molecules that are expressed at similar
levels on the macrophage surface (data not shown).We found that
preincubation of macrophages with CD43 MoAb resulted in a
slight augmentation of phagocytosis in the presence of divalent
cations (from 18-8 ± 7% to 33-5 ± 7%, n = 3) when compared to
medium alone. In a separate series of experiments, CD45 MoAb
pretreatment also increased phagocytosis of apoptotic neutro¬
phils in the presence of divalent cations from 24-4 ± 3% to
37-7 ± 6% (n = 3). In contrast, CD44 treatment resulted in a
robust increase of phagocytosis in the presence of divalent cations
(66-6 ± 8% and 64-4 ± 5% for the CD43 MoAb and CD45 MoAb
experiments, respectively). These observations would be consis¬
tent with macrophage-bound antibody providing a ligand for neu¬
trophil receptors for IgG and thereby contributing to apoptotic
cell uptake. Based upon these observations, we would have pre¬
dicted that CD43 antibodies would also augment phagocytosis
under divalent cation-free conditions. However, examination of
macrophage phagocytosis following treatment with CD43 MoAb
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Fig. 4. Distinct effects of MoAb binding to highly expressed receptors and
CD44 MoAb. Macrophages were preincubated with either CD44 MoAh
or CD43 MoAb or untreated control for 15 min. washed and then incu¬
bated with apoptotic neutrophils in the absence of divalent cations for
60 min. Macrophage phagocytosis of apoptotic neutrophils in duplicate
samples was then determined by flow cytometry. Results are shown as
mean ± s.e.m. of six independent experiments.
Effects of CD44 Ffab^ fragments upon phagocytosis of
apoptotic neutrophils
We next investigated the effects of F(ab')2 fragments of
CD44 MoAb. In the presence of divalent cations, treatment of
macrophages with F(ab')2 resulted in augmentation of phagocy¬
tosis of apoptotic neutrophils. In contrast, in the absence of
divalent cations there was no effect (Fig. 5). These data demon¬
strate a specific effect of ligation of CD44 by MoAb upon mac¬
rophage phagocytic function that is independent of involvement
of CD32.
DISCUSSION
In this study, we have used removal of divalent cations to elimi¬
nate the potential contribution of integrins [20] or C-type lectins
[21] to CD44 MoAb-mediated augmentation of macrophage
phagocytosis of apoptotic neutrophils. We have confirmed that
phagocytosis of apoptotic neutrophils by untreated macrophages
requires exclusively divalent cation-dependent recognition
pathways. In contrast, we found that CD44 MoAb augmented
macrophage phagocytosis had both divalent cation-dependent
and independent components. Our data suggest that augmenta¬
tion of apoptotic cell phagocytosis by macrophages following
CD44 MoAb treatment in the absence of divalent cations
requires tethering of the apoptotic neutrophils via CD32 to CD44
antibodies bound to the macrophage surface. This interaction may
facilitate engagement of apoptotic cell recognition pathways that
lead subsequently to internalization. Despite similar levels of
binding of CD44 and CD43 MoAb (both IgGl) to the macroph¬
age surface, we failed to observe increased phagocytosis by
CD43 MoAb in the absence of divalent cations. At present the
reason for this difference is not clear. One possibility is that this
may reflect the differences in the distribution of CD44 and CD43
in the macrophage membrane.
Data from in vitro studies of macrophage recognition of apo¬
ptotic cells has implicated involvement of a number of distinct,
unrelated molecular pathways (reviewed in [22]). It has been
proposed recently that many of these molecules or even well-
established opsonins [23] may be involved in tethering of
apoptotic targets. It is possible that internalization of tethered
© 2004 Blackwell Publishing Ltd, Clinical and Experimental Immunology, 138:447-452





























5. Effects of CD44 F(ab')2 fragments upon macrophage phagocytosis
apoptotic neutrophils, (a) Macrophages were preincubated with intact
>44 MoAb (grey bars), CD44 F(ab')2 fragments (white bars) or medium
ne (black bars) for 15 min, washed and then incubated with apoplotic
ltrophils for 60 min in the presence of divalent cations. Macrophage
jgocytosis of apoptotic neutrophils in duplicate samples was then deler-
led by flow cytometry. Results are shown as the mean ± s.e.m. of five
ependent experiments. Macrophages were incubated with intact
>44 MoAb (grey bars), CD44 F(ab')2 fragments (white bars) or medium
ne (black bars) for 15 min, washed and then incubated with apoplolic
ltrophils for 60 min in the absence of divalent cations. Macrophage
igocylosis of apoptotic neutrophils in duplicate samples was then deter-
led by flow cytometry. Results are shown as the mean ± s.e.m. of five
ependent experiments.
Dptotic targets is then driven via a common phosphatidylserine
:eptor-dependent mechanism [24]. Recently we have demon-
ated that CD32 expressed on apoptotic neutrophils becomes
abled', mediating binding to multimeric IgG [18]. Thus, despite
overall reduction in levels of expression of CD32 on apoptotic
.ltrophils when compared with non-apoptotic neutrophils, we
ye demonstrated that only apoptotic neutrophils become teth-
:d to CD44 MoAb bound to the macrophage surface and that
iding is mediated by CD32 on the neutrophil. Although it is
ssible that both apoptotic and non-apoptotic neutrophils are
e to bind to CD44 MoAb on the macrophage surface and that
r assay conditions only allow detection of phagocytosis, we sug-
:t that our data indicate that apoptotic neutrophils tether spe-
cally to antibody bound to the macrophage surface.
In this study we have demonstrated that anti-CD44 F(ab/)2
fragments were capable of augmenting phagocytosis of apoptotic
neutrophils, eliminating possible Fc receptor-dependent effects in
the augmentation of phagocytosis of apoptotic neutrophils fol¬
lowing CD44 ligation. As found for untreated macrophages,
phagocytosis requires the presence of divalent cations, raising the
possibility that CD44 MoAb mediated cross-linking increases the
efficiency of existing recognition pathways. One cautionary note
is that promotion of apoptotic neutrophil tethering by MoAb
bound to the macrophage surface (see Fig. 4) may act to counter
inhibitory effects of antibodies in other studies of apoptotic tar¬
gets bearing Fc receptors and potentially 'mask' true inhibition.
Such a possibility may account for lesser inhibition of macroph¬
age uptake of CD32 bearing cell types compared with CD32 neg¬
ative apoptotic targets [25]. Finally, our data have important
implications for use of antibodies to investigate apoptotic cell
clearance in vivo. While the shorter in vivo half-life of proteolytic
fragments of antibodies may restrict their use therapeutically and
in functional studies [26], intact antibodies may have additional
regulatory effects upon macrophage clearance of CD32 express¬
ing apoptotic cells.
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Background: Phagocytic removal of apoptotic cells is an
important regulatory event in development, tissue ho
moeostasis, and inflammation. There are several method-
ologic problems with most in vitro studies of the molec¬
ular mechanisms of apoptotic cell phagocytosis. First, cell
loss occurs during rigorous washing of adherent macro¬
phages required to ensure removal of noningested parti¬
cles. Second, discrimination of adherent or internalised
apoptotic cells is difficult. Third, microscopic quantifica¬
tion is time consuming and has the potential for significant
interobserver error. Fourth, subsequent analysis of phago¬
cyte populations is difficult.
Methods: We used a flow cytometric method that allows
quantification of phagocytosis of fluorescently labelled
apoptotic cells with the use of multiparameter flow cyto¬
metric analysis.
Results: Phagocytosis of apoptotic cells was validated by
use of inhibitors (cytochalasins) or low temperature and
counterstaining with cell surface markers for the phago¬
cytic targets to exclude binding to the phagocytic surface.
Populations of phagocytic macrophages were sorted, and
the presence of internalized apoptotic material was vali¬
dated by microscopy.
Conclusions: The technique we used in this study allows
observer-independent analysis of phagocytosis of apopto¬
tic cells by macrophages. Importantly, phagocytic or
nonphagocytic populations could be subjected to further
characterization with the use of flow cytometry with ad¬
ditional fluorochrome reagents and can be re-cultured to
study underlying regulatory mechanisms. Cytometry
Part A 51A:7-15, 2003. © 2002 Wiley-Liss, Inc.
Key terms: phagocytosis; macrophage; apoptotic cells
Since the first description of apoptosis as a mechanism
of cell death required for the physiologic removal of cells
in many processes (1), there has been an increasing inter¬
est in the mechanisms that underlie the rapid recognition
and engulfment of apoptotic cells (2,3). Current assays for
the quantification of the uptake of apoptotic cells by
phagocytes are broadly based on assays that measure cell-
to-cell adhesion and are potentially flawed by several prob¬
lems. Adherent phagocyte populations are overlaid with
apoptotic targets in suspension and then cocultured for
different periods according to the cell population under
study. Rigorous washing used to dislodge adherent cells
before assessment of phagocytosis may lead to loss of
phagocytes, thereby skewing the apparent magnitude of
the overall phagocytic response. Further, use of mixed
populations of apoptotic and nonapoptotic "targets"
makes discrimination of internalisation from adherence of
cells to the macrophage surface difficult. In addition, sep¬
aration of phagocytic and nonphagocytic cells is not
readily achieved with conventional plate- or slide-based
assays, thus precluding further culture or examination of
other functional capacities of phagocytic cells. Moreover,
counting plates is time consuming and carries a risk of
significant intra- and interobserver errors.
We therefore developed a flow cytometry- based quan¬
titation method to specifically address these problems. We
used the distinct scatter characteristics of macrophages
and apoptotic targets and specific fluorochromes to allow
discrimination of nonphagocytosed apoptotic targets,
nonphagocytic macrophages, and macrophages that have
internalised apoptotic cells, thereby eliminating the re¬
quirement for washing. Acquisition of large amounts of
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data is rapid and observer-independent. This cytometry-
based assay is robust, with similar data acquired using
FACSCalibur (Becton-Dickinson, Oxford, UK) and Epics
XL (Beckman Coulter, High Wycombe, UK) cell analysers.
The methodology described herein may be readily
adapted to analysis of other phagocytes or phagocytic
targets, including cell lines. We found that cell popula¬
tions of interest can be collected by cell sorting, allowing
further analysis of such cells by direct inspection (micros¬
copy), counterstaining of any antigens required, or recul-
turing the cells for further functional analysis. This assay
will provide unique opportunities for the characterisation
of the process of apoptotic cell phagocytosis.
MATERIALS AND METHODS
Reagents
CellTracker Green (5-chloromethylfluorescein diac-
etate; CMFDA) was purchased from Molecular Probes (Lei¬
den, The Netherlands). Cytochalasin D and propidium
iodide were obtained from Sigma (St. Louis, MO). Annexin
V Fluo was obtained from Boehringer Mannheim (Mann¬
heim, Germany). The following monoclonal antibodies
(mAbs) were used: CD44 mAb (5A4, immunoglobulin [Ig]
Gj, provided by Dr. G. Dougherty, University of California,
San Francisco), CD14 mAb (UCHM1, IgG2a), and CD16
mAb (3G8, IgG,, provided by Dr. J. Unkeless, Mount Sinai
School ofMedicine, New York, NY); all hybridoma culture
supernatants were used at saturating concentrations. Phy-
coerythrin indodicarbocyanine (PECy5)- conjugated
CD 15 mAb was purchased from Beckman Coulter. Poly¬
clonal goat anti-mouse IgG F(ab')2 RPE antibody was ob¬
tained from DAKO (Copenhagen, Denmark). CD62L mAb
(Leu-8, lgG2b) was supplied by Becton-Dickinson. Trypsin/
ethylene-diaminetetra-acetic acid (EDTA) solution was ob¬
tained from GIBCO Life Technologies (Paisley, UK). Tis¬
sue culture plastics were manufactured by Falcon (Becton-
Dickinson).
Cellular Isolation and Culture
Human peripheral blood mononuclear cells and neutro¬
phils were isolated by using dextran sedimentation and
centrifugation with discontinuous Percoll gradients, as
described elsewhere (4,14). Monocytes were enriched by
selective adherence and monocyte-derived macrophages,
typically greater than 85% CD14+, were differentiated by
culture for 5-7 days in Iscove's modification of Dulbecco's
modified Eagle's medium (IDMEM; ijfc Technolo¬
gies) containing 10% autologous serum. Polymorphonu¬
clear cells, with more than 95% neutrophils when Giemsa-
stained cytocentrifuge preparations were examined by
microscopy, were resuspended at 20 X 106/ml in IDMEM
and incubated with CMFDA at a final concentration of 22
pM (20 min, 37°C). The neutrophil suspension was then
diluted with IDMEM to a final cell density of 4 X 106/ml
and cultured in IDMEM containing 10% autologous serum
(20 h, 37°C). A group I Burkitt lymphoma cell line, Mutu
I, induced into apoptosis by 16 h of incubation with 1
pg/ml of the calcium ionophore ionomycin (CN Bio¬
sciences, Nottingham, UK), was used as the source of
apoptotic lymphocytes (5) and labelled with CMFDA as
described for neutrophils. Before use in the phagocytosis
assay, the percentage of apoptotic cells was estimated by
microscopic examination of cytocentrifuge preparations
and Annexin V/propidium iodide staining and flow cytom¬
etry.
Microscopy-Based Phagocytosis Assay
Adherent macrophages were incubated with apoptotic
neutrophils or lymphocytes suspended at 5 X 106/ml for
30 min at 37°C, thus providing a phagocyte-to-target ratio
of approximately 1:10. Adherent macrophages were vig¬
orously washed with ice-cold Hank's balanced saline so¬
lution, fixed in 2.5% glutaraldehyde, and stained for my¬
eloperoxidase with 0.1 mg/ml of dimethoxy benzidine
and 0.03% (v/v) hydrogen peroxide in phosphate buffered
saline (PBS), as previously described (6). The percentage
of macrophages that had interacted with one or more
peroxidase-positive apoptotic neutrophils was quantified
by examination with an inverted microscope with at least
500 cells per well counted per replicate.
Flow Cytometry-Based Phagocytosis Assay
The assay was performed essentially as described
above. However, after incubation of macrophages with
apoptotic targets, the medium was removed by careful
pipetting to minimise disturbance of the sedimented cells.
Wells were then incubated with Trypsin/EDTA for 20 min
at 37°C followed by another 20 min at 4°C. Cells were
then harvested with a 1,000-pl micropipette; optimal re¬
moval of macrophages required vigorous pipetting. Plates
were inspected with a phase-contrast microscope to ver¬
ify that all macrophages had been successfully removed.
The unfixed samples were then analysed by flow cytom¬
etry with a FACSCalibur with CellQuest software (Becton-
Dickinson) or an Epics XL (Beckman Coulter) with
EXP032 software. Neutrophil and macrophage popula¬
tions were identified by their distinct laser scatter prop¬
erties. A minimum of 6,000 events within the macrophage
gate was acquired. The number of the FL1+ events in the
macrophage gate was divided by the total number of
macrophages to obtain the percentage of macrophages
that had internalised neutrophils. Cells harvested from
wells were incubated with 10 pi of rabbit serum (10 min,
4°C) to minimise nonspecific antibody binding to Fc re¬
ceptors and then incubated with anti-CD15-PECy5 alone,
CD14, or isotype control antibody followed by anti-mouse
IgG-PECy5 (45 min, 4°C), washed twice, and then anal¬
ysed by flow cytometry.
Cell Sorting
Subpopulations of cells identified as described above
were sorted with a FACSVantage (Becton-Dickinson). All
cells were kept at 4°C in medium containing 1% human
serum albumin to minimise further phagocytosis and/or
degradation of internalised particles. Cytocentrifuge prep¬
arations of the sorted cell populations were prepared,
immediately fixed in methanol, and stained with DiffQuik.
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Fig. 1. Labelling of neutrophils with 5-chloromethylfluorescein diacetate (CMFDA) does not affect constitutive neutrophil apoptosis or macrophage
phagocytosis. A: After incubation of neutrophils with CMFDA in serum-free medium for 20 min, more than 99% of cells became FL1+ (top). Histogram
overlay: left, unlabelled cells; right, labelled cells. After undergoing constitutive apoptosis for 20 h, the fluorescence intensity was slightly reduced, with
the appearance of an FLl-low subpopulation (bottom). B: Neutrophils aged with or without CMFDA lost their surface markers CD16 and CD62L to similar
extents. In addition, similar proportions of neutrophils labelled with or without CMFDA become Annexin V positive. The mean ± standard error of the
mean of three experiments are shown for CD 16 and CD62L, and those of six experiments are shown for Annexin V. C: Neutrophils were aged for 20 h
in the presence or absence of CMFDA, and phagocytosis was assessed with a well-validated plate assay performed as described in Materials and Methods.
The data (a minimum of 500 cells per replicate) represent the mean ± standard error of the mean of five independent experiments, each carried out in
quadruplicate.
Images of sorted cells were obtained with a CoolSNAP
Camera and OpenLAB software on a G4 Power Macintosh
desktop computer using a Zeiss Axiovert SI00 inverted
microscope.
Fixing Protocol
Cell samples as harvested from the wells were washed
in PBS and resuspended in paraformaldehyde (1%, meth¬
anol free, 20°C). After 20 min the samples were washed in
PBS and "quenched" with ammonium sulphate (50 mM,
10 min) and then stored at 4°C in the dark in PBS con¬
taining 0.1% azide and 0.1% human serum albumin.
Statistics
All results are expressed as mean ± standard error of
the mean, where n represents the number of independent
experiments using macrophages from different donors,
conducted in triplicate unless stated otherwise. Results
were analysed by analysis of variance and the Tukey-
Kramer multiple comparison test.
RESULTS
CMFDA Reliably Labels Neutrophils and Does Not
Affect the Apoptotic Process
Flow cytometric analysis of samples from unlabelled
and CMFDA-labelled neutrophil preparations confirmed
that high levels of uniformly FL1+ cells were present
when compared with unlabelled cells (Fig. 1A). Neutro¬
phils that had undergone constitutive apoptosis during in
vitro culture for 18-24 h still exhibited high levels of
fluorescence, although we consistently noted a small de-
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crease in overall levels of fluorescence. To be certain that
CMFDA labelling did not adversely alter the apoptotic
program in a way that might accelerate constitutive cell
death or affect functional studies of phagocytosis, we
examined changes in surface molecule expression. Data
shown in Figure IB demonstrate that CMFDA labelling
does not affect the changes in surface expression of CD 16
and CD62L, which we and others previously demon¬
strated to be markedly downregulated when neutrophils
undergo constitutive apoptotic cell death (7). In addition,
we assessed the binding of Annexin V to measure expo¬
sure of phosphatidylserine on the outer leaflet of the cell
membrane (8). Importantly, we found no significant dif¬
ference in the percentage of labelled or unlabelled neu¬
trophils that had undergone apoptosis (Fig IB), suggesting
that CMFDA labelling does not reduce neutrophil viability.
Further, these data illustrate that labelling of neutrophil
populations does not affect membrane alterations that
represent well-defined attributes associated with the in¬
trinsic apoptotic program. In addition, the percentage of
macrophages that had internalised apoptotic cells as quan¬
tified by microscopy was similar for labelled and unla¬
belled apoptotic targets (Fig. 1C). In a separate series of
experiments, we tested whether viability of macrophages
was altered after internalisation of apoptotic cells. In these
experiments, we found no difference in the numbers of
adherent macrophages when comparing those that had
internalised CMFDA targets with macrophages that had
not been exposed to apoptotic targets (91.8 ± 7.2 and
90 ± 7 macrophages per high power field, respectively).
Further, we confirmed that macrophages that had been
exposed to apoptotic neutrophils and then detached with
trypsin/EDTA retained viability (not shown) and adhered
equally well to tissue culture plastic when compared with
macrophages that had not been exposed to apoptotic cells
(106.3 ± 9 vs. 98.6 ± 3.2 cells per high powered field,
respectively). We believe these data indicated that fluo¬
rescent labelling of apoptotic targets with CMFDA is min¬
imally disruptive for the process of phagocyte recognition
and subsequent internalisation.
Characterisation of Macrophage Phagocytosis of
Apoptotic Cells Using Flow Cytometry
Examination of apoptotic cell populations by flow cy¬
tometry revealed two distinct neutrophil populations in
terms of fluorescence, despite a uniform initial labelling
profile. These distinct populations (Figs. 1A and 3A) were
sorted and the FLl-bright population was found to com¬
prise intact neutrophils with apoptotic and nonapoptotic
morphologies. In contrast, the FLl-dim population repre¬
sented cellular debris and cells that lacked nuclei, possibly
representing late apoptotic cells (6) that had extruded
nuclear material (data not shown).
A gate for acquisition of macrophage data was deter¬
mined from examination of CMFDA-labelled neutrophils
(Fig. 2, top) and macrophages labelled with CD14 mAb
(Fig. 2, bottom). The appearance of a population of FL1 +
macrophages after 30 min of incubation with apoptotic
neutrophils is shown in Figure 3A. Although the these
cp
o
Fig. 2. Typical laser scatter properties of cells used to determine ac¬
quisition gates. Dot-plots show forward (FSC) and side scatter (SSC) for
aged neutrophils labelled with 5-chloromethylfluorescein diacetate (top).
Macrophages harvested from adherent culture as described in Material
and Methods were counterstained with CD 14 to confirm the laser scatter
properties of macrophages (Rl; bottom). A few contaminating lympho¬
cytes (LQ are present in these samples. Rl was used as the acquisition
gate for phagocytosis assessment. Data are representative of at least six
independent experiments.
cells (Rl) were easily distinguished from the FL1 cells
(R2), we also observed cells with intermediate fluores¬
cence (R3). To confirm that Rl and R2 represented phago¬
cytic and nonphagocytic macrophages, respectively, and
to investigate the nature of the intermediate R3 macro¬
phages, all cell populations were sorted with a FACSVan-
tage. Cytocentrifuge preparations of the sorted popula¬
tions (Fig. 3B) were analysed by light microscopy (Fig. 3C)
and showed that cells in Rl consisted predominantly of
macrophages that had ingested apoptotic cells (96 ± 2%).
Consistent with the suggestion that R2 represented
nonphagocytic macrophages, we observed very few inter¬
nalised neutrophils in the sorted R2 population (1.1 ±
0.8%). Interestingly, macrophages in R3, which displayed
intermediate fluorescence on flow cytometry, also
showed only a very low percentage of uptake of neutro¬
phils (3 A 1.7%). However, when examined with a fluo¬
rescent microscope, these cells displayed a weak, diffuse
fluorescence of their cytoplasm, possibly as a result of
having internalised cellular debris (data not shown).
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Fig. 3. Flow cytometric analysis of cells detached after phagocytosis
assay. A: A typical two-parameter dot-plot of untreated macrophage pop¬
ulations after 30 min of incubation. The sort gates Rl, R2, and R3 are
highlighted. B: Sorted populations were reanalysed with a FACSCalibur to
confirm that they represent FL1+ and FL-1- populations. C: Cytocentri-
fuge preparations of sorted populations were examined by microscopy to
confirm that most cells in gate Rl had ingested apoptotic neutrophils
(96 ± 2%) and that cells in gates R2 and R3 had not (1.1 ± 0.8% and 3 —
1.7%, respectively). The percentages of macrophages with internalised
neutrophils were assessed microscopically by counting at least 200 cells
per replicate. Two independent cell sorts were performed, with similar













10° 10l 102 103 104
10° 101 102 103 104
S3
2 §
10° 10' 102 103 104
10° 10l 102 103 104
illP
10° 10' 102 103 104
PE-Cy5 Fluorescence
Fig. 4. Discrimination of internalised from bound particles by flow
cytometry. Aged neutrophils labelled with 5-chloromethylfluorescein di-
acetate (CMFDA) were stained with a phycoerythrin indodicarbocyanine
(PECy5) control antibody (first panel) or CD15-PECy5 (second panel),
demonstrating that CD15 reliably labels apoptotic neutrophils. FLl-bright
and FLl-dim populations shift equally (second panel). Macrophages that
had not been coincubated with apoptotic neutrophils do not show
significant levels of labelling CD15-PECy5 conjugate (third panel) but
could be specifically labelled with CDl4-PECy5 (fourth panel). Using
these controls to set the threshold for FL3 positivity, macrophages that
had been coincubated with apoptotic cells were stained with direct
CD15-PECy5 antibody (fifth panel). Note the lack of significant FL3
(CD 15) positivity in these cells, suggesting that the increase in FL1
fluorescence was due to internalised and not to externally bound neutro¬




Although we did not observe externally bound neutro¬
phils on the surface of sorted Rl macrophages, we wished
to confirm the extent of apoptotic cell binding indepen¬
dently of cell sorting, to eliminate the possibility that shear
stress during sorting might have dislodged externally
bound cells. Macrophages were therefore counterstained
with a PECy5-conjugated CD15 to identify surface bound
neutrophils (Fig. 4, upper panels). This antigen was cho¬
sen because the carbohydrate determinant was shown to
be resistant to trypsin treatment. To confirm resistance of
the CD 15 epitope to trypsin/EDTA treatment used to
detach macrophages, we tested the levels of surface ex-
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pression of CD15 on neutrophils treated with and without
trypsin/EDTA. In these experiments CD 15 levels (MFI,
arbitrary values) were found to be increased from 562 ±
10 to 637 ± 30 after trypsin/EDTA treatment. In contrast,
CD62L expression was drastically reduced from 200 ± 28
to 4 ± 1.3 after trypsin/EDTA treatment, thus confirming
that trypsin treatment was effective. Importantly, no sig¬
nificant FL3 fluorescence was detected in FLl-bright or
FLl-dim macrophage populations (Fig. 4, lower panels),
demonstrating that bound neutrophils do not contribute
significantly to the estimate of percentage of phagocyto¬
sis. As reported previously (9,18), although the extent of
phagocytosis showed interassay variability (mean, 23.64%;
range, 7.6 - 48%), intra-assay variability was low; for exam¬
ple, in one experiment for eight replicate wells, the mean
(standard deviation) estimate of phagocytosis was 34.6
(2.1).
Validation of Flow Cytometric Quantitation
To validate the flow cytometric assessment of phagocy¬
tosis, we examined enhancers or inhibitors of apoptotic
cell uptake that have been well characterised. Thus, cy-
tochalasin D, EDTA, and low temperature (4°C) inhibit
apoptotic cell uptake, whereas cross-linking macrophage
CD44 (10) markedly increases phagocytosis (Fig. 5A).
Analysis of some of these conditions had proven difficult
because cell detachment after treatment with EDTA or
low temperatures (4°C) can hinder assessment of phago¬
cytic potential. In contrast, because assessment of phago¬
cytosis by flow cytometry does not involve a wash step,
this concern is removed. We also examined the kinetics of
macrophage phagocytosis of apoptotic neutrophils in this
system. Examination of the percentage of phagocytic mac¬
rophages present after 30, 60, 90, and 120 min of co-
incubation with apoptotic targets showed that maximal
phagocytic response occurs after 90-120 min, suggesting
that conventional 30-min plate-based assays may underes¬
timate macrophage phagocytic capacity. Because the flow
cytometric-based quantification eliminates the require¬
ment for washing of macrophage monolayers, we next
investigated whether estimates of levels of phagocytosis
determined microscopically were affected by cell loss.
Apoptotic neutrophils were removed by pipetting with¬
out washing, or wells were washed three times before
assessment of phagocytosis by flow cytometry as previ¬
ously described for microscopy-based assays. When as¬
sessed by flow cytometry, we found a decrease in the
percentage of phagocytic macrophages after three
washes, suggesting that conventional assays further under¬
estimate phagocytic potential. Consistent with this sug¬
gestion, we found that a small but significant number of
phagocytic macrophages was present in the washing fluid
(Fig. 6). Interestingly, the proportion of phagocytic mac¬
rophages in the washes was higher than that measured for
the total population, implying that phagocytic cells may
selectively detach.
For reasons of practicality and resource management,
we were also interested to determine whether this flow
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Fig. 5. Characterization of flow cytometric determination of apoptotic
cell phagocytosis. A: Effect of known enhancers and inhibitors of apo¬
ptotic cell phagocytosis. Macrophages were treated with medium (con¬
trol), CD44 (antibody 5A4, 1:2 dilution of cell culture supernatant, 20 min
preincubation), ethylene-diaminetetra-acetic acid (EDTA; 5 mM), or cy-
tochalasin D (5 pg/ml) before coincubation with apoptotic neutrophils at
37°C for 30 min. In parallel, macrophages cultured on a separate plate
were incubated with apoptotic neutrophils at 4°C for 30 min. Data
represent the mean ± standard error of the mean percentage of fluores¬
cent macrophages from four independent experiments: baseline versus
CD44, P < 0.001; baseline versus EDTA, cytochalasin D, or 4°C, P <
0.001. B: Temporal analysis of apoptotic cell phagocytosis. Phagocytosis
was determined by flow cytometry after different periods of coincubation
of macrophages with apoptotic neutrophils. The data shown are from
5-14 independent experiments and indicated that phagocytosis is not
maximal at the 30-min time point used in most studies.
phagocytosis if the harvested cell suspensions were fixed
by using high-quality fixation methods and stored before
analysis. We acquired the samples as live cells and then
fixed them in formaldehyde (2.5% or 1%) or methanol-free
paraformaldehyde as described in Material and Methods
and performed repeated acquisitions over time. However,
we found a progressive increase in background fluores¬
cence intensity of the macrophage populations and a
diminished separation of neutrophils and macrophages by
forward scatter (data not shown). Thus, this assay does
not appear to be suited for fixing and storage of samples
beyond 24 h.
Flow Cytometric Analysis Is Broadly Applicable to
Other Cell Types
To determine whether this convenient flow cytometry-
based assay was more generally applicable to examining
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Fig. 6. Effect of washing on the percentage of macrophage phagocy¬
tosis recorded. Adherent macrophages in 48-weIl plates were coincu-
bated with 20-h cultured neutrophils labelled with 5-chloromethylfluores-
cein diacetate, as described in Materials and Methods. The medium was
then carefully removed by aspiration (no wash), and adherent macro¬
phages were then washed three times. A: Remaining adherent macro¬
phages were detached by using trypsin/ethylene-diaminetetra-acetic acid,
and the numbers of macrophages in samples were determined by micro¬
scopic examination with a haemocytometer. B: The percentage of phago¬
cytic macrophages in these samples was also assessed. Results are ex¬
pressed as the mean ± standard error of the mean of five independent
experiments conducted in triplicate.
other apoptotic cells, we next used CMFDA-labelled apo-
ptotic lymphocytes as targets. (Fig. 7A). Cell populations
were readily distinguished from each other by their for¬
ward and side scatter properties and phagocytic macro¬
phages became FL1+ (Fig. 7B). The phagocytic capacity of
THP-1 macrophage-like cells and COS-7 fibroblast-like
cells, the latter of which is widely used for transfectlon
studies, could also be easily evaluated because the distinct
laser scatter properties allowed identification of "free"
apoptotic neutrophils or lymphocytes (data not shown).
Although the present data were acquired with a FACSCali-
bur, similar results could be obtained with a different cell
analyser (e.g., Epics XL; data not shown).
DISCUSSION
Apoptosis and the subsequent removal of apoptotic
cells by macrophages and other cells have been recog¬
nised as important events in development, tissue ho-
moeostasis, initiation of immune responses, and resolu¬
tion of inflammation (3,11,12). Further understanding of
the mechanisms of recognition, engulfment, and espe¬
cially the fate of the apoptotic target inside the phagocyte
requires a robust, reproducible method for quantification
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Fig. 7. Typical laser properties of the Burkitt lymphoma cell line Mutu
I and human macrophages. A: Mutu I populations labelled with 5-chlo-
romethylfluorescein diacetate (CMFDA) are FL1 + , with a small proportion
of cellswith lesser side scatter displaying a lesser fluorescence intensity in
FL1 similar to the pattern seen in neutrophils. B: A gate for macrophage
acquisition was determined based on forward and side scatter properties
of the cell populations (Rl, verified by CD 14 staining). LC, lymphocytes.
C: Macrophages that had ingested fluorescent Mutu I cells became green
(R2). In this representative experiment of three that were performed,
64.7% of macrophages had ingested apoptotic Mutu I cells.
widely used to evaluate and quantify the interaction of
macrophages with apoptotic cells have multiple short¬
comings. Although apoptotic targets have been labelled
with fluorescent dyes in the past, the assessment of the
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phagocytic response had been made only by fluorescent
microscopy, and microscopic quantification has similar
problems (5,13). Use of a colorimetric assay for phagocy¬
tosis (15), although removing observer bias, still requires
vigorous washing of the cells and fails to provide informa¬
tion regarding the proportions of cells that are phagocytic,
and phagocytic populations need to be lysed and there¬
fore cannot be recovered.
Surprisingly, many studies of the phagocytosis of apo-
ptotic cells have not used flow cytometry-based assays
(16). Galati et al. used flow cytometry to investigate the
degree of uptake of labelled apoptotic Jurkat cells by
peripheral blood leukocytes in samples of whole blood
(17). As expected, there was only low-level uptake in
patients pretreated with granulocyte-macrophage colony-
stimulating factor and no phagocytosis in healthy individ¬
uals, which is consistent with the observation that periph¬
eral blood monocytes show a poor uptake of apoptotic
cells (18). Flow cytometry has been used to reliably quan¬
tify phagocytosis of bacteria, malarial parasites, liposomes,
zymosan particles, latex beads, unopsonised environmen¬
tal particles, platelets, and erythrocytes (19-26). We have
demonstrated that quantification of macrophage phagocy¬
tosis by flow cytometry is a robust and reproducible. Large
amounts of data could be acquired quickly, particularly in
conditions in which conventional assays are known to be
unreliable, for example, in the treatment of macrophages
with antibodies or cell signalling inhibitors. We also dem¬
onstrated that flow cytometry can be used to reliably
distinguish bound from internalised apoptotic targets.
Flow cytometric quantification of phagocytosis has the
technical advantage of removal of observer error, assess¬
ment of large numbers of cells, and high sample through¬
put. We have shown that this technique is readily ex¬
tended to other apoptotic targets and should be
applicable to other phagocytic cells, such as COS-7, a cell
line commonly used for transfection of components of the
phagocytic machinery (5).
One unique advantage of flow cytometric quantification
is that vigorous washing steps can be eliminated. Indeed,
the recorded percentage of phagocytosis was decreased
after washing of adherent macrophage monolayers. Fur¬
ther, we found that the relative percentage of phagocytic
macrophages present in the washing fluid was higher than
that for the total population, implying that phagocytic
macrophages may be selectively detached during wash¬
ing. This is likely to have considerable implications if
macrophages are treated with agents that disrupt adhe¬
sion, such as antibodies, peptides, or cytoskeletal inhibi¬
tors. Similarly, highly phagocytic dexamethasone-treated
macrophages exhibit altered adhesion status when com¬
pared with untreated cells and are prone to detachment
(27). Use of flow cytometric quantification also would
permit assessment of phagocytosis in suspension culture.
Another important aspect of the flow cytometric assess¬
ment of phagocytosis is that the phagocytes studied are
available for further analysis. Macrophages that have in¬
gested CMFDA-labelled targets and are subsequently de¬
tached for flow cytometric analysis remain viable and can
be readily sorted into phagocytic and nonphagocytic sub¬
sets. We have shown that re-culturing phagocytic sub-
populations for further functional analysis is feasible, al¬
lowing investigation of other macrophage functions,
including potential for phagocytosis of further apoptotic
targets or other particles. It should also be possible to
undertake phenotypic and functional analyses, for exam¬
ple, gene profiling of phagocytic subsets of cells and
assessment of levels of intracellular cytokines or signalling
molecules in permeabilised cells.
CONCLUDING REMARKS
The advantages of flow cytometry- based quantification
of apoptotic cell phagocytosis when using the assay de¬
scribed in this paper will provide new opportunities for
the analysis of the mechanisms and consequences of the
uptake of apoptotic cells by phagocytes in vitro.
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abstract
Understanding the cellular and molecular mechanisms that determine whether inflammation
resolves or progresses to scarring and tissue destruction should lead to the development of
effective therapeutic strategies for inflammatory diseases. Apoptosis of neutrophil granulocytes
is an important determinant of the resolution of inflammation, providing a mechanism for down-
regulation of function and triggering clearance by macrophages without inducing a pro¬
inflammatory response. However, if the rate of cell death by apoptosis is such that the
macrophage clearance capacity is exceeded, apoptotic cells may progress to secondary necrosis,
resulting in the release of harmful cellular contents and in damage to the surrounding tissue.
There are many possible ways in which the rate and capacity of the macrophage-mediated
clearance of apoptotic cells may be enhanced or suppressed. Ligation of human macrophage
surface CD44 by bivalent monoclonal antibodies rapidly and profoundly augments the capacity
of macrophages to phagocytose apoptotic neutrophils in vitro. The molecular mechanism behind
this effect and its potential significance in vivo is a current focus of research.
NEUTROPHIL APOPTOSIS PROMOTES THE
RESOLUTION OF INFLAMMATION
During inflammation, neutrophils are stimulated to
release granule enzymes, oxidants and inflammatory
mediators by bacterial products, cytokines and adhesion
to matrix components and neighbouring cells [1], Un¬
controlled or inappropriate release of these histotoxic
substances may result in damage to host tissues and
prolong the inflammatory response. Indeed, neutrophils
have been implicated in the pathogenesis of a variety of
serious inflammatory diseases, such as fibrosing alveo¬
litis, adult respiratory distress syndrome, rheumatoid
arthritis and ulcerative colitis [2], Neutrophil apoptosis
results in the loss of expression of adhesion molecules [3]
and greatly reduced responsiveness to external stimuli
[4], so that these cells become functionally isolated from
their environment. In contrast with necrosis, apoptosis is
associated with preservation of plasma membrane in¬
tegrity, so that release of harmful neutrophil contents is
limited, and the inert neutrophils are phagocytosed by
local macrophages. Furthermore, phagocytosis of apop¬
totic granulocytes by human macrophages in vitro does
not stimulate the release of macrophage-derived pro¬
inflammatory mediators (in contrast with ingestion of
particles opsonized with immunoglobulin) [5-7], In this
way, by down-regulating neutrophil functions and trig¬
gering 'silent' clearance by phagocytes, apoptosis
provides a mechanism for the safe disposal of potentially
destructive inflammatory cells. Evidence for a role for
leucocyte apoptosis in the resolution of inflammation is
supported by the observation that apoptotic granulocytes
* This paperwas presented at the Glaxo/MRS Young Investigator session at theMRS Meeting, Royal College of Physicians, London,
on 1 June 2001.
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can be identified within phagocytic vacuoles in macro¬
phages from inflamed joints [8] and the airways of
asthmatic patients [9].
RECOGNITION OF APOPTOTIC CELLS
Clearly, macrophages must be able to recognize changes
on the surface of the apoptotic cell that distinguish it
from a healthy viable cell. Multiple macrophage surface
receptors have been implicated in the recognition and
clearance of apoptotic cells [10-12]. Similarly, in the
nematode Caenorhabditis elegans, at least six different
genes have been discovered that seem to be required for
effective removal of dying cells by phagocytes [13]. The
reasons for this redundancy are unclear, but a number of
the implicated molecules may be revealed to be indirect
regulators of apoptotic cell phagocytosis, rather than true
apoptotic cell receptors [14].
During the development of C. elegans, the generation
of 959 somatic nuclei is accompanied by the death of 131
cells, and a number of mutations that affect the processes
of cell death and the engulfment of dead cells have been
identified. Mutations in one of any six genes, ced-1, -2,
-3, -6, -7 or -10, prevents some cell corpses from being
engulfed, although in all of these mutants most cells
were engulfed normally. In contrast, a major defect in
engulfment can be found in double mutants in which one
mutation is in ced-2, -3 or-10, and the other mutation is
in ced-1, -6 or -7 [13]. This observation suggested that the
two sets of genes act in parallel processes that are partially
redundant. We now know that the proteins encoded by
ced-2, ced-1 and ced-10 are similar to human Crkll, Crk-
binding protein DOCK180 and Rac respectively, and
that these molecules comprise a pathway that controls
Figure I Engulfment genes in C. elegans
The genes that are involved in the engulfment of cell corpses during the
development of the nematode C. elegans have been divided into two functionally
redundant groups (ced-llced-61 ced-1 and ced-21 ced-51 ced-10). These have been
cloned and sequenced, providing evidence for a role for similar molecules in the
phagocytosis of apoptotic cells in higher animals.
the organization of the actin cytoskeleton and the
extension of cell processes [15]. Mammalian homologues
of ced-1, ced-6 and ced-7 have also been identified (Figure
1). Thus the characterization of C. elegans genes that are
involved in the phagocytic clearance of cellular corpses in
the nematode has elucidated potential roles for a number
of key elements of cytoskeletal regulation and signal
transduction.
REGULATION OF THE PHAGOCYTOSIS OF
APOPTOTIC CELLS
If the rate of cell death by apoptosis is such that the
clearance capacity of macrophages is exceeded, apoptotic
cells may become necrotic, resulting in the release of
harmful cellular contents and damage to the surrounding
tissue (Figure 2). In support of this suggestion, treat¬
ment of mice with anti-Fas antibody triggered a massive
wave of apoptosis in the liver, and the animals developed
extensive hepatic necrosis and died [16]. Similarly,
induction of apoptosis in the rat lung led to pulmonary
fibrosis [17]. We propose that in these situations the
hepatic and pulmonary macrophages respectively were
unable to clear the load of apoptotic cells with which they
were faced. Similar situations could arise if neutrophil
apoptosis were to be induced deliberately as part of a
therapeutic strategy for inflammatory diseases. Such
potential future approaches may therefore have to include
a way of concurrently augmenting the clearance effi¬
ciency of local macrophages.
Macrophage phagocytic capacity in vitro may be
influenced by soluble mediators such as cytokines [18]
and prostaglandins [19], or by glucocorticoid hormones
[14,20]. In addition, the interaction of surface adhesion
molecules with neighbouring cells and components of
the extracellular matrix may profoundly influence many
aspects of cellular behaviour, including phagocytosis
[21]. CD44 is a surface receptor that has been implicated
in cell adhesion to a variety of matrix components,
including fibronectin, and may be associated with cyto¬
skeletal proteins and intracellular signalling pathways
[22]. CD44 was therefore an attractive target for our
further investigation of how the phagocytosis of apop¬
totic cells by macrophages may be regulated.
STRUCTURE AND FUNCTION OF CD44
The CD44 gene in humans consists of 50-60 kb located
on the short arm of chromosome 11. Some of the 20 or
more exons are constitutively transcribed, but a sequence
of at least 10 exons (exons 6a-14) undergoes variable
splicing, giving rise to an additional peptide sequence
between amino acids 202 and 203 in the membrane-
proximal domain of the CD44 protein [23,24] (Figure 3).
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Figure 2 Neutrophil apoptosis and phagocytic clearance by macrophages in the resolution of inflammation

















Figure 3 Diagrammatic representation of CD44
CD44 comprises a large extracellular ligand-binding domain, an alternatively spliced membrane-proximal domain containing sites for linkage of large sugars, a highly
conserved transmembrane sequence, and a short cytoplasmic tail containing phosphorylation sites.
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In practice, only relatively few variant isoforms of CD44
(CD44v isoforms) containing certain combinations of
variably spliced CD44 exons have been found to be
expressed in human cells. The most prevalent form of
CD44, termed CD44S ('standard') or CD44H ('haema¬
topoietic'), contains no additionally spliced exon pro¬
ducts. CD44S is a single-chain type I transmembrane
protein containing 341 amino acids, with a predicted
molecular mass of 40 kDa. However, extensive post-
translational glycosylation results in CD44S having an
apparent molecular mass on SDS/PAGE of 80-100 kDa.
The expression of variant isoforms along with differential
glycosylation alters the range of potential ligands the cell
may respond to [25,26],
CD44 is expressed by many cell types, including
leucocytes, erythrocytes, fibroblasts, endothelial and
epithelial cells, and a variety of tumour cells [22],
Unusually for a cell surface receptor, CD44 seems to
have broad ligand specificity, and has been proposed
to bind the extracellularmatrix molecules hyaluronan [27,
28], fibronectin [29], collagen [30] and fibrin [31,32], In
addition, CD44 may bind to the proteoglycan serglycin
found in lymphocyte and mast cell granules [33], to the
extracellular phosphoprotein osteopontin [34], and to
CD44 molecules on neighbouring cells [35], The in¬
teraction of cell surface CD44with hyaluronan is thought
to be important in a variety of cell adhesion-related
phenomena, but the functional relevance of the binding
of CD44 to other putative ligands is poorly understood at
present. Many diverse functions have been attributed to
CD44, including involvement in cellular adhesion and
migration, lymphocyte activation and proliferation, cyto-
cidal activity of natural killer cells and tumour metastasis
[36]. In other experimental systems, anti-CD44 anti¬
bodies can block the migration ofmurine pro-T cells into
the thymus [36,37] and prevent leucocyte extravasation at
sites of inflammation [38]. Moreover, they can also
stimulate leucocyte adhesion [39] and augment T cell
activation [40], suggesting that CD44 does indeed signal
within the cell. This idea is supported further by the
discovery that CD44 plays a role in cell spreading [41],
and cross-linking of CD44 on T cells is known to activate
the tyrosine kinase p56!ck [42], Src-family kinases have
been shown to participate in CD44-mediated signalling
resulting in cell spreading in CD45-deficient T cells [43].
CD44 IS IMPORTANT IN INFLAMMATION
In recent years, several different observations have
implicated CD44 in the regulation of the inflammatory
response. Freshly isolated peripheral blood monocytes
express CD44S strongly [44], and the differentiation of
monocytes into macrophages during in vitro culture is
associated with increased expression of variant isoforms,
while CD44S expression persists at high levels [45,46].
Elevated local concentrations of CD44 ligands (such as
hyaluronan and fibronectin) that follow tissue injury are
likely to be important mediators of macrophage function
as the inflammatory response progresses. Expression of
the variant isoforms (CD44v6 and CD44v9) by mono-
cyte-like THP-1 cells can be up-regulated following
exposure to the inflammatory cytokines tumour necrosis
factor a (TNFa) and interferon-y [44], and macrophage
expression of some CD44 isoforms is increased at sites of
chronic inflammation [46], In vivo, systemic admini¬
stration of anti-CD44 monoclonal antibodies reduced
the severity of joint inflammation in mice with ex¬
perimental arthritis [38,47].
While these studies provide circumstantial evidence for
the involvement of CD44 in inflammation, more direct
proof has come very recently from studies of lung
inflammation in CD44-deficient knockout mice. Teder
and colleagues [48] demonstrated that CD44-deficient
mice exhibited unremitting and often fatal inflammation
following bleomycin-induced lung injury compared with
wild-type animals. The increased propensity to develop
severe pneumonitis could be largely reversed by repopu-
lating the bone marrow of the CD44-deficient mice with
CD44+ wild-type cells, demonstrating a critical role
for CD44 expressed by macrophages or other haemato¬
poietic cells in the resolution of lung inflammation.
CD44 LIGATION AUGMENTS THE
PHAGOCYTOSIS OF APOPTOTIC
NEUTROPHILS
To assess the role of macrophage CD44 in the phago¬
cytosis of apoptotic neutrophils in vitro, anti-CD44
antibodies were used as convenient experimental surro¬
gates for the natural ligand(s) of CD44. Adherent human
monocyte-derived macrophages were incubated with
anti-CD44 monoclonal antibodies for 20 min immedi¬
ately prior to assessment of phagocytosis of apoptotic
neutrophils using a well characterized assay [8,49]. A
control antibody (W6/32, against a non-polymorphic
determinant on MHC class I) was chosen which, like the
CD44 antibodies, bound strongly to human monocyte-
derived macrophages. In this series of experiments,
binding of anti-CD44 antibodies resulted in a dramatic
increase in the macrophage-mediated phagocytosis of
apoptotic neutrophils (Figure 4). Control antibody
W6/32 had no significant effect, and neither did anti¬
bodies specific for integrin a5, /?1 or /?2 subunits [50].
Conventionally, an in-well plate assay has been used to
determine the proportion of phagocytic macrophages in
experiments like these. However, there are several dis¬
advantages to this approach: counting cells is somewhat
subjective and prone to inter-observer variation; there is
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Figure 4 The anti-CD44 antibody 5A4 augments the macrophage-mediated phagocytosis of apoptotic neutrophils
Shown are representative micrographs from one experiment demonstrating the macrophage-mediated phagocytosis of apoptotic neutrophils following incubation with
medium alone (left panel) or the anti-CD44 antibody 5A4 (right panel). After thorough washing and fixation, cells were stained for myeloperoxidase. Apoptotic neutrophils
were 100% myeloperoxidase-positive (dark reaction product), while macrophages were myeloperoxidase-negative. 5A4-treated wells show increases both in the
proportion of macrophages that had phagocytosed apoptotic neutrophils and in the number of neutrophils per phagocytosing macrophage. The lower panels show results
from a different experiment using a flow-cytometry-based phagocytosis assay to assess the effects of the anti-CD44 antibody 5A4. The percentages of macrophages that
had ingested or not ingested fluorescent green-labelled aged neutrophils are shown.
often variability between samples due to the limited
number of cells that can be counted; and counting is time
consuming. Also, selective detachment of phagocytic
macrophages may occur during the washing process
required following the assay, leading to an underestimate
of phagocytosis. These problems may be circumvented
by using a new flow-cytometry-based assay for mea¬
suring phagocytosis (H. Jersmann, S. Vivers, K. Ross,
S. Brown and I. Dransfield, unpublished work). In
this assay, neutrophils are labelled with a fluorescent
green cytoplasmic dye and then aged in vitro in the usual
way to induce apoptosis. When these apoptotic cells are
phagocytosed, the green-labelled macrophages can be
identified by flow cytometric analysis. This assay can
be used to determine the number of macrophages that
have phagocytosed apoptotic neutrophils within a
certain period of time, without needing to wash the cells,
so avoiding the potential problem of selective detach¬
ment. Some typical flow cytometry profiles are shown
in Figure 4.
Our analysis was extended to include other antibodies
that recognize specific variant isoforms of CD44 ex¬
pressed by human monocyte-derived macrophages.
Interestingly, anti-CD44 antibodies that define the
CD44v3 (antibody 3G5) or CD44vlO (2G1) isoforms, or
a hyaluronan-binding-associated epitope (7F4), failed to
augment phagocytosis, despite binding to macrophages.
However, it is difficult to completely discount a role for
specific isoforms of CD44 in the regulation of phago¬
cytosis of apoptotic neutrophils based on the lack of an
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effect of single antibodies. Incubation of macrophages
with monovalent Fab' antibody fragments was shown to
have no effect on phagocytosis, whereas bivalent F(ab')2
fragments augmented the phagocytosis of apoptotic
neutrophils. This observation clearly rules out a role for
macrophage Fey receptors. The lack of an effect of Fab'
fragments of anti-CD44 antibodies indicates that bivalent
antibody binding is required for the augmented phago¬
cytosis of apoptotic neutrophils. The requirement for
bivalent antibody is important, because it alludes to the
possible underlying mechanism of action of CD44
ligation in these experiments. If simple masking of a
CD44 epitope by an intact antibody was responsible for
the observed effect, then monovalent Fab' fragments
would be expected to act similarly. The requirement for
bivalent binding implies that receptor cross-linking is a
prerequisite, which then leads to initiation of intracellular
signal transduction [51]. In physiological situations it is
likely that CD44 on the macrophage surface would be
cross-linked by large multivalent ligands in the extra¬
cellular matrix. However, we have excluded a role for the
principal CD44 ligand hyaluronan, since the addition of
soluble hyaluronan or adhesion of macrophages to
hyaluronan-coated plastic did not significantly influence
the phagocytic uptake of apoptotic neutrophils.
regulated by the guanine nucleotide exchange factor
Tiaml, which has been suggested to associate with CD44
in breast tumour cells [54], The cytoplasmic domain of
CD44 may also associate directly with the Src-family
kinases Lck and Fyn in lymphocytes [55], and may
rapidly induce tyrosine phosphorylation of p56lcli [42].
Src kinase activity may in turn result in the phosphory¬
lation of Pyk2, a focal adhesion kinase (FAK) family
member. A downstream target of both FAK and Pyk2
is paxillin, an important component of focal adhesions.
CELL-LINEAGE-SPECIFIC SURFACE
ALTERATIONS DURING APOPTOSIS
Ligation of CD44 on human monocyte-derived macro¬
phages by bivalent monoclonal antibodies rapidly and
specifically augmented the phagocytosis of apoptotic
neutrophils, but had no detectable effect on the phago¬
cytosis of other particles or apoptotic lymphocytes.
These results indicate that apoptosis may be associated
with the expression of cell-specific markers that signal
recognition and phagocytosis by macrophages [50],
MECHANISMS OF CD44-AUGMENTED
PHAGOCYTOSIS
We have considered a number of possibilities with regard
to how the ligation of CD44 exerts its effect on the
phagocytosis of apoptotic neutrophils. First, if CD44
were a constitutive negative regulator of apoptotic cell
uptake, anti-CD44 antibodies could lead to the redis¬
tribution of CD44 into patches on the macrophage
surface, thus allowing room for other receptors to interact
with the apoptotic target. However, we could see no
evidence of CD44 redistribution, as determined by
fluorescence microscopy. Secondly, stimulation of CD44
may signal within the cell to promote phagocytosis. In
support of this suggestion, the cytoplasmic tail of CD44
has been reported to interact with the cytoskeleton and
with intracellular transduction molecules [52].We believe
that the CD44-directed recruitment of these effectors
should provide the key to understanding the mechanism
behind the augmented phagocytosis of apoptotic neutro¬
phils. The small Rho-like GTPases such as Rac (anal¬
ogous to ced-10), Rho and cdc42 act as molecular
switches that control the organization of the actin
cytoskeleton [15], which is critical for particle engulfment
during phagocytosis. In mouse mammary epithelial cells,
ligation of CD44 triggers activation of Racl that results
in rearrangements of the actin cytoskeleton [53]. Mem¬
brane recruitment of molecules such as Racl may be
OTHER REGULATORS OF THE CLEARANCE
OF APOPTOTIC CELLS
Some inflammatory mediators', such as prostaglandins,
signal through activation of adenylate cyclase and el¬
evation of intracellular cAMP levels. Prostaglandins can
influence the immune response in a number of different
ways, but prostaglandins E2 and D2 are capable of in¬
hibiting the macrophage-mediated phagocytosis of
apoptotic neutrophils in vitro [19]. Moreover, treatment
ofmacrophages with amembrane-permeable analogue of
cAMP also inhibited the uptake of apoptotic neutrophils
[19]. Elevated levels of cAMP had no effect on FcyR-
mediated phagocytosis, indicating specificity for the
inhibition of apoptotic cell uptake. Elevation of cAMP
concomitantly induced phenotypic alterations in the
macrophage, including changes in the localization of
actin and talin into discrete structures. Similar results
have been observed when staining for vinculin, paxillin
and tyrosine-phosphorylated proteins, suggesting that
cAMP may uncouple adhesion receptors from cyto¬
plasmic cytoskeletal elements, resulting in the observed
morphological alterations.
Corticosteroids are used widely in the treatment of
inflammatory diseases, and are known to inhibit inflam¬
matory cell recruitment and dampen cellular respon¬
siveness. They also have diverse effects on inflammatory
cell apoptosis, promoting the apoptosis of thymocytes
and eosinophils while inhibiting neutrophil apoptosis
[56]. Treatment of human macrophages with glucocorti-
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coids markedly increased their capacity to phagocytose
apoptotic neutrophils in vitro [57]. In contrast with
CD44 ligation, the effect of glucocorticoids requires
several hours of treatment and is inhibited by the protein
synthesis blocker cycloheximide [14]. Also, phagocytic
effects are not restricted to apoptotic target cells of the
neutrophil lineage. Human monocytes treated with
the glucocorticoid dexamethasone in vitro mature into a
homogeneous population of macrophages with a typi¬
cally smaller, more rounded appearance than untreated
cells. This is associated with reduced expression of
pl30Cas [14], an adaptor molecule that is predicted to
disrupt Crk-DOCKl 80 (ced-2-ced-5) complexes, which
are important for cell adhesion. This, combined with
reduced phosphorylation and recruitment of paxillin and
Pyk2 to sites of adhesion, may account for the changes in
cell morphology and phagocytic capacity that accompany
steroid hormone treatment [14]. Despite the rounded
appearance of dexamethasone-treated cells, they remain
highly membrane-active and can be observed rapidly
contracting and expanding cellular processes. This may
be attributable to increased levels of active GTP-bound
Rac in the dexamethasone-treated macrophages [14].
The adhesive state of a macrophage can modulate the
phagocytic potential of the cell. The adhesion of macro¬
phages to fibronectin, vitronectin or collagen VI in¬
creased the proportion of macrophages that ingested
apoptotic neutrophils [58], Macrophage adhesion to
fibronectin may involve CD44, which can be ligated via
heparin-binding sites. Heparin completely inhibited the
augmentation by fibronectin of macrophage-mediated
phagocytosis [58]. Despite this, treatment of macro¬
phages with a proteolytic fragment of fibronectin which
contained the major heparin-binding sites was unable to
augment phagocytosis. This seems to suggest that, if
fibronectin is a ligand for CD44 in this system, generation
of a signal for augmented phagocytosis may require
binding to more than one receptor. It is possible that
the binding of a specific repertoire of macrophage ad¬
hesion receptors can influence the cell's potential for
phagocytosis of apoptotic neutrophils. Macrophage pro¬
duction and deposition of matrix molecules in vitro may
play a role in regulating the observed levels of phago¬
cytosis of apoptotic cells.
Cytokines present at sites of inflammation have
the potential to modulate cell behaviour, including the
phagocytosis of a wide range of targets. A whole host of
cytokines, including granulocyte-macrophage colony-
stimulating factor (GM-CSF), transforming growth fac-
tor-ySl, interferon-y, interleukin-lySand TNFa, have been
shown to increase the uptake of apoptotic neutrophils by
macrophages after a 4h incubation. [18]. GM-CSF,
interferon-y, interleukin-1/? and TNFa all play important
roles in the initiation and amplification of an immune
response. Moreover, they are present at sites of inflamma¬
tion where monocytes mature into macrophages. There¬
fore these cytokines may assist in preparing macrophages
to clear senescent neutrophils once they have undergone
apoptosis.
CONCLUSION
The phagocytosis of apoptotic neutrophils, but not
apoptotic lymphocytes, by human monocyte-derived
macrophages is rapidly augmented following ligation of
CD44 by bivalent antibodies in vitro. These observations,
together with the lack of effect of anti-CD44 antibodies
on the macrophage-mediated phagocytosis of other
particles, imply that CD44 may regulate the differential
clearance of apoptotic leucocytes during the evolution of
inflammatory responses. We reproducibly observe a
dramatic effect of CD44 ligation in a simple 30 min in-
well phagocytosis assay, but this could feasibly translate
into a massive extra capacity for clearance of apoptotic
neutrophils in vivo, as the inflammatory process evolves
over hours or days. The precise molecular pathway
recruited following CD44 ligation remains to be defined.
The rapidity of the effect of anti-CD44 antibodies and
the requirement for bivalent binding suggests that lig¬
ation of macrophage CD44 by antibodies may trigger
intracellular signalling pathways that lead to increased
phagocytosis of apoptotic neutrophils. Rather than con¬
tinuing to screen individual candidate receptors using
inhibitory ligands or antibodies, we believe that a more
promising approach will be to pursue the underlying
regulatory mechanism by analysis of the intracellular
molecular events and the functional responses that occur
following macrophage CD44 ligation.
ACKNOWLEDGMENTS
This work was funded by the Medical Research Council
and by a University of Edinburgh Faculty of Medicine
fellowship.
REFERENCES
1 Hogg, N. and Landis, R. C. (1993) Adhesion molecules in
cell interactions. Curr. Opin. Immunol. 5, 383-390
2 Weiss, S. J. (1989) Mechanisms of disease: tissue
destruction by neutrophils. N. Engl. J. Med. 320, 365-376
3 Dransfield, I., Stocks, S. C. and Haslett, C. (1995)
Regulation of cell adhesion molecule expression and
function associated with neutrophil apoptosis. Blood 85,
3264-3273
4 Whyte, M. K. B., Meagher, L. C., MacDermot, J. and
Haslett, C. (1993) Impairment of function in aging
neutrophils is associated with apoptosis. J. Immunol. 150,
5124-5134
5 Meagher, L. C., Savill, J. S., Baker, A., Fuller, R. W. and
Haslett, C. (1992) Phagocytosis of apoptotic neutrophils
does not induce macrophage release of thromboxane B2.
J. Leukocyte Biol. 52, 269-273
© 2007 The Biochemical Society and the Medical Research Society
448 S. Vivers, I. Dransfield and S. P. Hart
6 Stern, M., Savill, J. S. and Haslett, C. (1996) Human
monocyte-derived macrophage phagocytosis of senescent
eosinophils undergoing apoptosis: mediation by
av/?3/CD36/thrombospondin recognition mechanism and
lack of phlogistic response. Am. J. Pathol. 149, 911-921
7 Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W.,
Westcott, J. Y. and Henson, P. M. (1998) Macrophages
that have ingested apoptotic cells in vitro inhibit
proinflammatory cytokine production through
autocrine/paracrine mechanisms involving TGF-beta,
PGE2, and PAF. J. Clin. Invest. 101, 890-898
8 Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J.,
Henson, P. M. and Haslett, C. (1989) Macrophage
phagocytosis of aging neutrophils in inflammation:
programmed cell death in the neutrophil leads to its
recognition by macrophages. J. Clin. Invest. 83, 865-875
9 Woolley, K. L., Gibson, P. G., Carty, K., Wilson, A. J.,
Twaddell, S. H. and Woolley, M.J. (1996) Eosinophil
apoptosis and the resolution of airway inflammation in
asthma. Am. J. Respir. Crit. Care Med. 154, 237-243
10 Savill, J. S., Fadok, V. A., Henson, P. M. and Haslett, C.
(1993) Phagocyte recognition of cells undergoing
apoptosis. Immunol. Today 14, 131-136
11 Hart, S. P., Haslett, C. and Dransfield, I. (1996)
Recognition of apoptotic cells by phagocytes. Experientia
52,950-956
12 Devitt, A., Moffatt, O. D., Raykundalia, C., Capra, J. D.,
Simmons, D. L. and Gregory, C. D. (1998) Human CD14
mediates recognition and phagocytosis of apoptotic cells.
Nature (London) 392, 505-509
13 Ellis, R. E., Yuan, J. and Horvitz, H. R. (1991)
Mechanisms and functions of cell death. Annu. Rev. Cell
Biol. 7, 663-698
14 Giles, K. M., Hart, S. P., Haslett, C., Rossi, A. G. and
Dransfield, I. (2000) An appetite for apoptotic cells:
controversies and challenges. Br. J. Haematol. 109, 1-12
15 Caron, E. (2000) Phagocytosis: Rac and roll over the
corpses. Curr. Biol. 10, R489-R491
16 Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M. et al.
(1993) Lethal effect of the anti-Fas antibody in mice.
Nature (London) 364, 806-809
17 Hagimoto, N., Kuwano, K., Miyazaki, H. et al. (1997)
Induction of apoptosis and pulmonary fibrosis in mice in
response to ligation of Fas antigen. Am. J. Respir. Cell.
Mol. Biol. 17, 272-278
18 Ren, Y. and Savill, J. S. (1995) Proinflammatory cytokines
potentiate thrombospondin-mediated phagocytosis of
neutrophils undergoing apoptosis. J. Immunol. 154,
2366-2374
19 Rossi, A. G., McCutcheon, J. C., Roy, N., Chilvers,
E. R., Haslett, C. and Dransfield, I. (1998) Regulation of
macrophage phagocytosis of apoptotic cells by cAMP.
J. Immunol. 160, 3562-3568
20 Liu, Y., Cousin, J. M., Hughes, J. et al. (1999)
Glucocorticoids promote nonphlogistic phagocytosis of
apoptotic leukocytes. J. Immunol. 162, 3639-3646
21 Brown, E. J. (1986) The role of extracellular matrix
proteins in the control of phagocytosis. J. Leukocyte
Biol. 39, 579-591
22 Lesley, J., Hyman, R. and Kincade, P. W. (1993) CD44
and its interaction with the extracellular matrix. Adv.
Immunol. 54, 271-335
23 Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis,
F. B., Gerth, U. and Bell, J. I. (1992) Genomic structure
of DNA encoding the lymphocyte homing receptor
CD44 reveals at least 12 alternatively spliced exons.
Proc. Natl. Acad. Sci. U.S.A. 89, 12160-12164
24 Cooper, D. L. and Dougherty, G. J. (1995) To
metastasize or not ? Selection of CD44 splice sites. Nat.
Med. (N.Y.) 1, 635-637
25 Katoh, S., Zheng, Z., Oritani, K., Shimozato, T. and
Kincade, P. W. (1995) Glycosylation of CD44 negatively
regulates its recognition of hyaluronan. J. Exp. Med. 182,
419-429
26 Lesley, J., English, N., Perschl, A., Gregoroff, J. and
Hyman, R. (1995) Variant cell lines selected for
alterations in the function of the hyaluronan receptor
CD44 show differences in glycosylation. J. Exp. Med.
182,431-437
27 Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C.
and Seed, B. (1990) CD44 is the principal cell surface
receptor for hyaluronate. Cell 61, 1303-1313
28 Culty, M., Miyake, K., Kincade, P. W., Silorski, E.,
Butcher, E. C. and Underhill, C. (1990) The hyaluronate
receptor is a member of the CD44 (H-CAM) family of
cell surface glycoproteins. J. Cell Biol. Ill, 2765-2774
29 Jalkanen, S. and Jalkanen, M. (1992) Lymphocyte CD44
binds the COOH-terminal heparin-binding domain of
fibronectin. J. Cell Biol. 116, 817-825
30 Faassen, A. E., Schrager, J. A., Klein, D. J., Oegema,
T. R., Couchman, J. R. and McCarthy, J. B. (1992) A cell
surface chondroitin sulphate proteoglycan,
immunologically related to CD44, is involved in type I
collagen-mediated melanoma cell motility and invasion.
J. Cell Biol. 116, 521-531
31 Henke, C. A., Roongta, U., Mickelson, D. J., Knutson,
J. R. and McCarthy, J. B. (1996) CD44-related
chondroitin sulfate proteoglycan, a cell surface receptor
implicated with tumor cell invasion, mediates endothelial
cell migration on fibrinogen and invasion into a fibrin
matrix. J. Clin. Invest. 97, 2541-2552
32 Svee, K., White, J., Vaillant, P. et al. (1996) Acute lung
injury fibroblast migration and invasion of a fibrin matrix
is mediated by CD44. J. Clin. Invest. 98, 1713-1727
33 Toyama-Sorimachi, N., Sorimachi, H., Tobita, Y. et al.
(1995) A novel ligand for CD44 is serglycin, a
hematopoietic cell lineage-specific proteoglycan. Possible
involvement in lymphoid cell adherence and activation.
J. Biol. Chem. 270, 7437-7444
34 Weber, G. F., Ashkar, S., Glimcher, M. J. and Cantor, H.
(1996) Receptor-ligand interaction between CD44 and
osteopontin (Eta-1). Science 271, 509-512
35 Droll, A., Dougherty, S. T., Chiu, R. K. et al. (1995)
Adhesive interactions between alternatively spliced CD44
isoforms. J. Biol. Chem. 270, 11567-11573
36 Lesley, J., Kincade, P. W. and Hyman, R. (1993)
Antibody-induced activation of the hyaluronan receptor
function of CD44 requires multivalent binding by
antibody. Eur. J. Immunol. 23, 1902-1909
37 Kawakami, N., Nishizawa, F., Sakane, N. et al. (1999)
Roles of integrins and CD44 on the adhesion and
migration of fetal liver cells to the fetal thymus.
J. Immunol. 163, 3211-3216
38 Mikecz, K., Brennan, F. R., Kim, J. H. and Giant, T. T.
(1995) Anti-CD44 treatment abrogates tissue oedema and
leukocyte infiltration in murine arthritis. Nat. Med. 1,
558-563
39 Aho, R., Jalkanen, S. and Kalimo, H. (1994) CD44-
hyaluronate interaction mediates in vitro lymphocyte
binding to the white matter of the central nervous system.
J. Neuropathol. Exp. Neurol. 53, 295-302
40 Pierres, A., Lipcey, C., Mawas, C. and Olive, D. (1992) A
unique CD44 monoclonal antibody identifies a new T
cell activation pathway. Eur. J. Immunol. 22, 413-417
41 Santos-Argumedo, L., Kincade, P. W., Partida-Sanchez, S.
and Parkhouse, R. M. E. (1997) CD44-stimulated
dendrite formation ('spreading') in activated B cells.
Immunology 90, 147-153
42 Taher, T. E. I., Smit, L., Griffioen, A. W., Schilder-Tol,
E. J. M., Borst, J. and Pals, S. T. (1996) Signaling through
CD44 is mediated by tyrosine kinases. J. Biol. Chem. 271,
2863-2867
43 Li, R., Wong, N., Jabali, M. D. and Johnson, P. (2001)
CD44-initiated cell spreading induces Pyk2
phosphorylation, is mediated by Src family kinases, and is
negatively regulated by CD45. J. Biol. Chem. 276,
28767-28773
44 MacKay, C. R., Terpe, H.-J., Stauder, R., Marston, W. L.,
Stark, H. and Gunthert, U. (1994) Expression and
modulation of CD44 variant isoforms in humans. J. Cell
Biol. 124, 71-82
45 Culty, M., O'Mara, T. E., Underhill, C., Yeager, H. and
Swartz, R. P. (1994) Hyaluronan receptor (CD44)
expression and function in human peripheral blood
monocytes and alveolar macrophages. J. Leukocyte Biol.
56,605-611
© 2002 The Biochemical Society and the Medical Research Society
Role of macrophage CD44 in disposal of inflammatory cell corpses 449
46 Levesque, M. C. and Haynes, B. F. (1996) In vitro culture
of human peripheral blood monocytes induces
hyaluronan binding and up-regulates monocyte variant
CD44 isoform expression. J. Immunol. 156, 1557-1565
47 Verdrengh, M., Holmdahl, R. and Tarkowski, A. (1995)
Administration of antibodies to hyaluronan receptor
(CD44) delays the start and ameliorates the severity of
collagen II arthritis. Scand. J. Immunol. 42, 353-358
48 Teder, P., Vandivier, R. W., Jiang, D. et al. (2002)
Resolution of lung inflammation by CD44. Science 296,
155-158
49 Newman, S. L., Henson, J. E. and Henson, P. M. (1982)
Phagocytosis of senescent neutrophils by human
monocyte-derived macrophages and rabbit inflammatory
macrophages. J. Exp. Mea. 156, 430-442
50 Hart, S. P., Dougherty, G. J., Haslett, C. and Dransfield,
I. (1997) CD44 regulates phagocytosis of apoptotic
neutrophil granulocytes, but not apoptotic lymphocytes,
by human macrophages. J. Immunol. 159, 919-925
51 Sanchez-Mejorada, G. and Rosales, C. (1998) Signal
transduction by immunoglobulin Fc receptors.
J. Leukocyte Biol. 63, 521-533
52 Isacke, C. M. (1994) The role of the cytoplasmic domain
in regulating CD44 function. J. Cell Sci. 107, 2353-2359
53 Oliferenko, S., Kaverina, I., Small, J. V. and Huber, L. A.
(2000) Hyaluronic acid (HA) binding to CD44 activates
Racl and induces lamellipodia outgrowth. J. Cell Biol.
148,1159-1164
54 Bourguignon, L. Y. W., Zhu, H., Shao, L. and Chen,
Y. W. (2000) CD44 interaction with Tiaml promotes
Racl signaling and hyaluronic acid-mediated breast
tumor cell migration. J. Biol. Chem. 275, 1829-1838
55 Ilangumaran, S., Briol, A. and Hoessli, D. C. (1998)
CD44 selectively associates with active Src family protein
tyrosine kinases Lck and Fyn in glycosphingolipid-rich
plasma membrane domains of human peripheral blood
lymphocytes. Blood 91, 3901-3908
56 Kato, T., Takeda, Y., Nakada, T. and Sendo, F. (1995)
Inhibition by dexamethasone of human neutrophil
apoptosis in vitro. Nat. Immun. 14, 198-208
57 Liu, Q. A. and Hengartner, M. O. (1998) Candidate
adaptor protein CED-6 promotes the engulfment of
apoptotic cells in C. elegans. Cell 93, 961-972
58 McCutcheon, J. C., Hart, S. P., Canning, M., Ross, K.,
Humphries, M.J. and Dransfield, I. (1998) Regulation of
macrophage phagocytosis of apoptotic cells by adhesion
to fibronectin. J. Leukocyte Biol. 64, 1-8
© 2002 The Biochemical Society and the Medical Research Society
